Method and system for patient-specific blood flow modeling - Patents.com
A three-dimensional modeling system for coronary blood flow allows non-invasive assessment of coronary artery lesions, addressing the limitations of current methods by providing accurate functional data on coronary artery disease, thus reducing invasive procedures and costs.
Patent Information
- Application Number
- JP2023104134
- Authority / Receiving Office
- JP · JP
- Patent Type
- Patents
- Current Assignee / Owner
- Priority Date
- 2011-01-25
- Filing Date
- 2023-06-26
- Publication Date
- 2024-11-26
- Estimated Expiration
- 2031-07-29
AI Technical Summary
Current diagnostic methods for coronary artery disease, such as coronary computed tomography angiography (CCTA) and diagnostic cardiac catheterization, fail to provide accurate, non-invasive assessment of the functional significance of coronary artery lesions, leading to unnecessary invasive procedures and potential risks for patients.
A system and method using patient-specific data to create a three-dimensional model of the heart and simulate coronary blood flow, enabling non-invasive determination of fractional coronary flow reserve (FFR) and other blood flow characteristics, allowing for the assessment of lesion significance without invasive tests.
Enables accurate, non-invasive assessment of coronary artery lesions, reducing the need for invasive procedures and providing data for informed treatment decisions, thereby minimizing patient risk and medical costs.
Smart Images

Figure 0007590499000001 
Figure 0007590499000002 
Figure 0007590499000003
Abstract
Description
[Technical field]
[0001] explanation Priority This application claims the benefit of priority from U.S. Provisional Application No. 61 / 401,462, filed August 12, 2010, U.S. Provisional Application No. 61 / 401,915, filed August 20, 2010, U.S. Provisional Application No. 61 / 402,308, filed August 26, 2010, U.S. Provisional Application No. 61 / 402,345, filed August 27, 2010, and U.S. Provisional Application No. 61 / 404,429, filed October 1, 2010, which are incorporated by reference in their entireties herein.
[0002] Embodiments include methods and systems for fluid flow modeling, and more particularly, for patient-specific blood flow modeling. [Background technology]
[0003] Coronary artery disease may cause coronary lesions, such as stenosis (abnormal narrowing of blood vessels), in the blood vessels that supply blood to the heart. As a result, blood flow to the heart may be restricted. Patients with coronary artery disease may experience chest pain, referred to as chronic stable angina on physical exertion or unstable angina at rest. More severe symptoms of the disease may lead to myocardial infarction or heart attack.
[0004] There is a need to provide more accurate data related to coronary lesions, such as size, shape, location, functional significance (e.g., whether the lesion affects blood flow), etc. Patients suffering from chest pain and / or showing signs of coronary artery disease may undergo one or more tests that may provide some indirect evidence related to coronary lesions. For example, non-invasive tests may include electrocardiograms, biomarker assessment from blood tests, treadmill tests, echocardiography, single positron emission computed tomography (SPECT), and positron emission tomography (PET). However, these non-invasive tests do not usually provide a direct assessment of coronary lesions or assess blood flow. Non-invasive tests may provide indirect evidence of coronary lesions by looking for changes in the electrical activity of the heart (e.g., using electrocardiography (ECG)), myocardial performance (e.g., using stress echocardiography), myocardial perfusion (e.g., using PET or SPECT), or metabolic changes (e.g., using biomarkers).
[0005] For example, anatomical data can be obtained non-invasively by coronary computed tomography angiography (CCTA). CCTA can be used to image patients with chest pain and involves the use of computed tomography (CT) techniques to image the heart and coronary arteries after intravenous injection of a contrast agent. However, CCTA cannot provide direct information about the functional significance of a coronary lesion, such as whether the lesion affects blood flow. Furthermore, because CCTA is merely a diagnostic test, it cannot be used to predict changes in coronary blood flow, blood pressure, or myocardial perfusion under other physiological conditions, such as exercise, nor can it be used to predict the outcome of an intervention.
[0006] Thus, patients may require invasive testing, such as diagnostic cardiac catheterization, to visualize coronary lesions. Diagnostic cardiac catheterization may involve performing conventional coronary angiography (CCA) to gather anatomical data of coronary lesions by providing physicians with images of the size and shape of the arteries. However, CCA does not provide data to assess the functional significance of coronary lesions. For example, physicians may not be able to diagnose whether a coronary lesion is harmful without identifying whether the lesion is functionally significant. Thus, CCA has led to what some interventional cardiologists call an "oculostenotic reflex," in which they insert stents into any lesions found during CCA, regardless of whether the lesion is functionally significant. As a result, CCA may lead to unnecessary surgery for patients, which may expose the patient to secondary risks and may result in unnecessary medical costs for the patient.
[0007] In diagnostic cardiac catheterization, the functional significance of coronary lesions can be invasively assessed by measuring the fractional flow reserve (FFR) of the lesions observed. FFR is defined as the ratio of the mean blood pressure downstream of the lesion divided by the mean blood pressure upstream of the lesion, e.g., aortic pressure, under conditions of increased coronary blood flow induced, e.g., by intravenous administration of adenosine. This blood pressure can be measured by inserting a pressure wire into the patient. Thus, the decision to treat a lesion based on an identified FFR is made after the initial costs and risks of diagnostic cardiac catheterization have already occurred.
[0008] Thus, there is a need for methods to non-invasively assess coronary anatomy, myocardial perfusion, and coronary blood flow. Such methods and systems can benefit cardiologists who diagnose and plan treatment for patients suspected of having coronary artery disease. Furthermore, there is a need for methods to predict coronary blood flow and myocardial perfusion under conditions that cannot be directly measured, such as exercise, and to predict the outcome of pharmacological, interventional, and surgical treatments on coronary blood flow and myocardial perfusion.
[0009] It is to be understood that both the foregoing general description and the following detailed description are exemplary and explanatory only and are not restrictive of the present disclosure. Summary of the Invention [Means for solving the problem]
[0010] According to one embodiment, a system for determining cardiovascular information of a patient includes at least one computer system configured to receive patient-specific data related to a geometry of the patient's heart and generate a three-dimensional model representing at least a portion of the patient's heart based on the patient-specific data, the at least one computer system further configured to generate a physics-based model related to blood flow characteristics of the patient's heart and determine fractional coronary flow reserve in the patient's heart based on the three-dimensional model and the physics-based model.
[0011] According to another embodiment, a method for determining patient-specific cardiovascular information using at least one computer system includes inputting patient-specific data related to a geometry of the patient's heart into the at least one computer system, and generating, using the at least one computer system, a three-dimensional model representing at least a portion of the patient's heart based on the patient-specific data. The method further includes generating, using the at least one computer system, a physics-based model related to blood flow characteristics of the patient's heart, and determining, using the at least one computer system, fractional coronary flow reserve in the patient's heart based on the three-dimensional model and the physics-based model.
[0012] According to another embodiment, a non-transitory computer readable medium for use on at least one computer system is provided that includes computer executable programming instructions for implementing a method for determining patient-specific cardiovascular information. The method includes receiving patient-specific data related to a geometry of the patient's heart and generating a three-dimensional model representing at least a portion of the patient's heart based on the patient-specific data. The method further includes generating a physics-based model related to blood flow characteristics of the patient's heart and determining fractional coronary flow reserve in the patient's heart based on the three-dimensional model and the physics-based model.
[0013] According to another embodiment, a system for planning a treatment for a patient includes at least one computer system configured to receive patient-specific data related to a geometry of a patient's anatomical structure and create a three-dimensional model representing at least a portion of the patient's anatomical structure based on the patient-specific data, the at least one computer system further configured to determine first information related to a characteristic of blood flow within the patient's anatomical structure based on the three-dimensional model and a physics-based model related to the patient's anatomical structure, modify the three-dimensional model, and determine second information related to a characteristic of blood flow within the patient's anatomical structure based on the modified three-dimensional model.
[0014] According to another embodiment, a non-transitory computer readable medium for use on a computer system is provided that includes computer executable programming instructions for executing a method for planning a treatment for a patient. The method includes receiving patient-specific data related to a geometry of a patient's anatomy and creating a three-dimensional model representing at least a portion of the patient's anatomy based on the patient-specific data. The method further includes determining first information related to a characteristic of blood flow within the patient's anatomy based on the three-dimensional model and a physics-based model related to the patient's anatomy, and determining second information related to a characteristic of blood flow within the patient's anatomy based on a desired change in the geometry of the patient's anatomy.
[0015] According to another embodiment, a method for planning a treatment for a patient using a computer system includes inputting patient-specific data related to a geometry of a patient's anatomical structure into the at least one computer system, and generating, using the at least one computer system, a three-dimensional model representing at least a portion of the patient's anatomical structure based on the patient-specific data. The method further includes determining, using the at least one computer system, first information related to a characteristic of blood flow within the patient's anatomical structure based on the three-dimensional model and a physics-based model related to the patient's anatomical structure. The method also includes modifying, using the at least one computer system, the three-dimensional model, and determining, using the at least one computer system, second information related to a characteristic of blood flow within the patient's anatomical structure based on the modified three-dimensional model.
[0016] According to another embodiment, a system for planning a treatment for a patient includes at least one computer system configured to receive patient-specific data related to a geometry of a patient's anatomical structure, generate a three-dimensional model representing at least a portion of the patient's anatomical structure based on the patient-specific data, and the at least one computer system is also configured to determine first information related to a characteristic of blood flow within the patient's anatomical structure based on the three-dimensional model and information related to a patient's physiological condition, modify the patient's physiological condition, and determine second information related to a characteristic of blood flow within the patient's anatomical structure based on the modified patient's physiological condition.
[0017] According to another embodiment, a non-transitory computer readable medium for use on a computer system is provided that includes computer executable programming instructions for implementing a method for planning a treatment for a patient. The method includes receiving patient-specific data related to a geometry of a patient's anatomical structure and creating a three-dimensional model representing at least a portion of the patient's anatomical structure based on the patient-specific data. The method further includes determining first information related to a characteristic of blood flow within the patient's anatomical structure based on the three-dimensional model and information related to a physiological condition of the patient, and determining second information related to a characteristic of blood flow within the patient's anatomical structure based on a desired change in the physiological condition of the patient.
[0018] According to another embodiment, a method for planning a treatment for a patient using at least one computer system includes inputting into the at least one computer system patient-specific data related to a geometry of an anatomical structure of the patient, and using the at least one computer system to generate a three-dimensional model representing at least a portion of the anatomical structure of the patient based on the patient-specific data. The method also includes using the at least one computer system to determine first information related to a characteristic of blood flow within the anatomical structure of the patient based on the three-dimensional model and information related to a physiological state of the patient. The method further includes using the at least one computer system to modify the physiological state of the patient, and using the at least one computer system to determine second information related to a characteristic of blood flow within the anatomical structure of the patient based on the modified physiological state of the patient.
[0019] According to another embodiment, a system for determining patient-specific cardiovascular information includes at least one computer system configured to receive patient-specific data related to a geometry of a patient's anatomy and generate a three-dimensional model representing at least a portion of the patient's anatomy based on the patient-specific data, the at least one computer system also configured to determine a total resistance associated with all flows through the portion of the patient's anatomy, and determine information related to a characteristic of blood flow within the patient's anatomy based on the three-dimensional model, the physics-based model associated with the patient's anatomy, and the determined total resistance.
[0020] According to another embodiment, a method for determining patient-specific cardiovascular information using at least one computer system includes inputting patient-specific data related to a geometry of a patient's anatomical structure into the at least one computer system, and generating, using the at least one computer, a three-dimensional model representing at least a portion of the patient's anatomical structure based on the patient-specific data. The method also includes determining, using the at least one computer, a total resistance associated with all flows through the portion of the patient's anatomical structure, and determining, using the at least one computer, information related to a characteristic of blood flow within the patient's anatomical structure based on the three-dimensional model, the physics-based model related to the patient's anatomical structure, and the determined total resistance.
[0021] According to another embodiment, a non-transitory computer readable medium for use on a computer system is provided that includes computer executable programming instructions for implementing a method for determining patient-specific cardiovascular information. The method includes receiving patient-specific data related to a geometry of a patient's anatomy and creating a three-dimensional model representing at least a portion of the patient's anatomy based on the patient-specific data. The method also includes identifying a total resistance associated with all flows through the portion of the patient's anatomy and determining information related to a characteristic of blood flow within the patient's anatomy based on the three-dimensional model, the physics-based model associated with the patient's anatomy, and the identified total resistance.
[0022] According to another embodiment, a system for providing patient-specific cardiovascular information using a website includes at least one computer system configured to enable a remote user to access the website, receive patient-specific data related to at least a portion of a geometry of the patient's anatomical structure, create a three-dimensional model representative of at least a portion of the patient's anatomical structure based on the patient-specific data, and reveal information related to blood flow characteristics within the patient's anatomical structure based on the three-dimensional model and a physiological state of the patient. The at least one computer system is also configured to communicate display information related to a first three-dimensional simulation of at least a portion of the patient's anatomical structure to the remote user using the website. The three-dimensional simulation includes the determined information related to blood flow characteristics.
[0023] According to another embodiment, a method for providing patient-specific cardiovascular information using a website includes using at least one computer system to enable a remote user to access the website and receiving patient-specific data related to the geometry of the patient's anatomical structure using the at least one computer system. The method also includes using the at least one computer system to create a three-dimensional model representing at least a portion of the patient's anatomical structure based on the patient-specific data, and using the at least one computer system to reveal information related to blood flow characteristics within the patient's anatomical structure based on the three-dimensional model and the patient's physiological condition. The method further includes using the at least one computer system to communicate display information related to a first three-dimensional simulation of at least a portion of the patient's anatomical structure to the remote user using the website. The three-dimensional simulation includes the revealed information related to blood flow characteristics.
[0024] According to another embodiment, a non-transitory computer-readable medium for use on a computer system is provided, the non-transitory computer-readable medium including computer-executable programming instructions for implementing a method for providing patient-specific cardiovascular information using a website. The method includes enabling a remote user to access the website, receiving patient-specific data related to the geometry of the patient's anatomical structure, and creating a three-dimensional model representing at least a portion of the patient's anatomical structure based on the patient-specific data. The method also includes revealing information related to blood flow characteristics within the patient's anatomical structure based on the three-dimensional model and a physics-based model related to the patient's anatomical structure, and communicating display information related to a first three-dimensional simulation of at least a portion of the patient's anatomical structure to the remote user using the website. The three-dimensional simulation includes the revealed information related to blood flow characteristics.
[0025] According to another embodiment, a system for determining patient-specific time-varying cardiovascular information includes at least one computer system configured to receive time-varying patient-specific data related to a geometry of at least a portion of a patient's anatomical structure at different time points and to create a three-dimensional model representing at least a portion of the patient's anatomical structure based on the patient-specific data, the at least one computer system also configured to determine information related to changes in blood flow characteristics over time within the patient's anatomical structure based on the three-dimensional model and a physics-based model related to the patient's anatomical structure.
[0026] According to another embodiment, a method for determining patient-specific time-varying cardiovascular information using at least one computer system includes receiving, using the at least one computer system, time-varying patient-specific data related to the geometry of the patient's anatomical structure at different time points. The method also includes generating, using the at least one computer system, a three-dimensional model representing at least a portion of the patient's anatomical structure based on the patient-specific data. The method further includes determining, using the at least one computer system, information related to the three-dimensional model and a physics-based model related to the patient's anatomical structure ...
[0027] According to another embodiment, a non-transitory computer readable medium for use on a computer system is provided that includes computer-executable programming instructions for implementing a method for determining patient-specific time-varying cardiovascular information, the method including receiving time-varying patient-specific data related to the geometry of a patient's anatomical structure at different time points, creating a three-dimensional model representing at least a portion of the patient's anatomical structure based on the patient-specific data, and determining information related to changes in blood flow characteristics over time within the patient's anatomical structure based on information related to the three-dimensional model and a physics-based model related to the patient's anatomical structure.
[0028] According to another embodiment, a system for determining cardiovascular information of a patient includes at least one computer system configured to receive patient-specific data related to a geometry and at least one material property of at least a portion of an anatomical structure of the patient, the anatomical structure including at least a portion of a blood vessel. The at least one computer system is further configured to generate a three-dimensional model representing the patient's anatomical structure based on the patient-specific data, and determine information related to characteristics of blood flow within the patient's anatomical structure based on the three-dimensional model and a physiological state of the patient. The at least one computer system is also configured to identify a location of plaque within the blood vessel.
[0029] According to another embodiment, a method for determining cardiovascular information of a patient using at least one computer system includes receiving, using the at least one computer system, patient-specific data related to a geometry and at least one material property of at least a portion of an anatomical structure of the patient, the anatomical structure including at least a portion of a blood vessel. The method also includes generating, using the at least one computer system, a three-dimensional model representing the patient's anatomical structure based on the patient-specific data, and determining, using the at least one computer system, information related to characteristics of blood flow within the patient's anatomical structure based on the three-dimensional model and a physiological condition of the patient. The method further includes identifying plaque within the blood vessel using the at least one computer system.
[0030] According to another embodiment, a non-transitory computer readable medium for use on a computer system is provided that includes computer executable programming instructions for implementing a method for determining cardiovascular information of a patient. The method includes receiving patient-specific data related to a geometry and at least one material property of at least a portion of an anatomical structure of the patient. The anatomical structure includes at least a portion of a blood vessel. The method also includes creating a three-dimensional model representing the patient's anatomical structure based on the patient-specific data, determining information related to characteristics of blood flow within the patient's anatomical structure based on the three-dimensional model and a physiological state of the patient, and identifying a location of plaque within the blood vessel.
[0031] According to another embodiment, a system for determining cardiovascular information of a patient includes at least one computer system configured to receive patient-specific data related to a geometry of at least a portion of an anatomical structure of the patient, the anatomical structure including at least a portion of a plurality of arteries and a tissue connecting at least a portion of the plurality of arteries, the at least one computer system further configured to create a three-dimensional model representative of the patient's anatomical structure based on the patient-specific data, divide at least a portion of the three-dimensional model representative of the tissue into segments, and determine information related to blood flow characteristics associated with at least one of the segments based on the three-dimensional model and a physiological state of the patient.
[0032] According to another embodiment, a method for determining cardiovascular information of a patient using at least one computer system includes receiving, using the at least one computer system, patient-specific data related to a geometry of at least a portion of an anatomical structure of the patient, the anatomical structure including at least a portion of a plurality of arteries and tissue connected to at least a portion of the plurality of arteries. The method also includes creating, using the at least one computer system, a three-dimensional model representative of the patient's anatomical structure based on the patient-specific data, and extending, using the at least one computer system, the three-dimensional model into an augmented model. The method further includes dividing, using the at least one computer system, at least a portion of the augmented model representative of the tissue into segments, and determining, using the at least one computer system, information related to blood flow characteristics associated with at least one of the segments based on the augmented model and a physiological state of the patient.
[0033] According to another embodiment, a non-transitory computer readable medium for use on a computer system is provided that includes computer executable programming instructions for implementing a method for determining cardiovascular information of a patient. The method includes receiving patient-specific data related to a geometry of at least a portion of an anatomical structure of the patient, the anatomical structure including at least a portion of a plurality of arteries and tissue connecting at least a portion of the plurality of arteries. The method also includes creating a three-dimensional model representative of the patient's anatomical structure based on the patient-specific data, dividing at least a portion of the three-dimensional model representative of the tissue into segments, and determining information related to blood flow characteristics associated with at least one of the segments based on the three-dimensional model and a physics-based model associated with the anatomical structure.
[0034] According to another embodiment, a system for determining cardiovascular information of a patient includes at least one computer system configured to receive patient-specific data related to a geometry of the patient's brain, the at least one computer system further configured to create a three-dimensional model representing at least a portion of the patient's brain based on the patient-specific data, and determine information related to characteristics of blood flow in the patient's brain based on the three-dimensional model and a physics-based model related to the patient's brain.
[0035] According to another embodiment, a method for determining patient-specific cardiovascular information using at least one computer system includes inputting patient-specific data related to a geometry of at least a portion of a plurality of cerebral arteries of the patient into the at least one computer system, the method also includes generating, using the at least one computer system, a three-dimensional model representative of at least a portion of the patient's cerebral arteries based on the patient-specific data, and determining, using the at least one computer system, information related to characteristics of blood flow within the patient's cerebral arteries based on the three-dimensional model and a physics-based model related to the patient's cerebral arteries.
[0036] According to another embodiment, a non-transitory computer readable medium for use on at least one computer system is provided that includes computer-executable programming instructions for implementing a method for determining patient-specific cardiovascular information, the method including receiving patient-specific data related to a geometry of a patient's brain, creating a three-dimensional model representing at least a portion of the patient's brain based on the patient-specific data, and determining information related to characteristics of blood flow in the patient's brain based on the three-dimensional model and a physics-based model related to the patient's brain. The present invention provides, for example, the following items. (Item 1) 1. A system for determining cardiovascular information of a patient, comprising: receiving patient-specific data relating to a cardiac geometry of said patient; creating a three-dimensional model representing at least a portion of the patient's heart based on the patient-specific data; creating a physics-based model relating to characteristics of the patient's cardiac blood flow characteristics; and A system comprising at least one computer system configured to determine fractional flow reserve in the patient's heart based on the three-dimensional model and the physics-based model. (Item 2) 2. The system of claim 1, wherein the three-dimensional model representing at least the portion of the patient's heart includes at least a portion of an aorta and at least a portion of a plurality of coronary arteries emanating from the portion of the aorta. (Item 3) the fractional flow reserve indicating a ratio of pressure in the aorta to pressure at a location within the plurality of coronary arteries; and 3. The system of claim 2, wherein the at least one computer system is configured to determine the fractional flow reserve at a plurality of locations within the plurality of coronary arteries. (Item 4) 2. The system of claim 1, wherein the patient-specific data includes image data. (Item 5) 5. The system of claim 4, wherein the image data is provided by computed tomography or magnetic resonance imaging techniques. (Item 6) 5. The system of claim 4, wherein the at least one computer system is configured to generate the three-dimensional model based on the image data by using the image data to identify a boundary of a coronary artery lumen of the patient's heart. (Item 7) 7. The system of claim 6, wherein the at least one computer system is configured to identify the location of the boundary based on changes in brightness values in the image data. (Item 8) 2. The system of claim 1, wherein the physics-based model includes at least one lumped parameter model representing blood flow through a boundary of the three-dimensional model. (Item 9) 2. The system of claim 1, wherein the at least one computer system is configured to determine the fractional flow reserve using parameters related to at least one of a level of hyperemia, a level of exercise, or a medication. (Item 10) 10. The system of claim 9, wherein the at least one computer system is configured to determine the fractional flow reserve using a parameter related to the level of hyperemia, the parameter related to the patient's coronary artery resistance, the patient's aortic blood pressure, or the patient's heart rate. (Item 11) 1. A method for determining patient-specific cardiovascular information using at least one computer system, comprising: inputting into said at least one computer system patient-specific data relating to the cardiac geometry of said patient; generating, with the at least one computer system, a three-dimensional model representative of at least a portion of the patient's heart based on the patient-specific data; generating, with the at least one computer system, a physics-based model relating to blood flow characteristics of the patient's heart; and and determining, with the at least one computer system, a fractional flow reserve in the patient's heart based on the three-dimensional model and the physics-based model. (Item 12) 12. The method of claim 11, further comprising identifying a location of a functionally significant stenosis in a coronary artery of the patient's heart based on the determined fractional coronary flow reserve. (Item 13) 12. The method of claim 11, wherein the three-dimensional model representing at least a portion of the patient's heart includes at least a portion of an aorta and at least a portion of a plurality of coronary arteries emanating from the portion of the aorta. (Item 14) the fractional flow reserve indicating a ratio of pressure in the aorta to pressure at a location in the plurality of coronary arteries; 14. The method of claim 13, wherein the fractional flow reserve is determined at multiple locations within the multiple coronary arteries. (Item 15) 15. The method of claim 14, wherein the patient-specific data includes image data of the patient's heart, and generating the three-dimensional model includes locating boundaries of the multiple coronary artery lumens of the patient's heart using the image data. (Item 16) Item 16. The method of item 15, wherein the boundary is located based on changes in luminance values in the image data. (Item 17) 1. A non-transitory computer readable medium, comprising: receiving patient-specific data relating to a cardiac geometry of the patient; creating a three-dimensional model representing at least a portion of the patient's heart based on the patient-specific data; creating a physics-based model relating to blood flow characteristics of the patient's heart; and determining fractional coronary flow reserve in the patient's heart based on the three-dimensional model and the physics-based model. (Item 18) The method further comprising: 20. The non-transitory computer-readable medium of claim 17, further comprising generating a three-dimensional simulation of the patient's heart illustrating the fractional flow reserve at a plurality of locations in the coronary arteries of the heart along three dimensions. (Item 19) 20. The non-transitory computer-readable medium of claim 18, wherein the fractional flow reserve is indicated on the three-dimensional simulation using color or shading, and changes in the fractional flow reserve are indicated by changes in color or shading. (Item 20) the three-dimensional model representing at least a portion of the patient's heart includes at least a portion of an aorta and at least a portion of a plurality of coronary arteries emanating from the portion of the aorta; 20. The non-transitory computer-readable medium of claim 19, wherein the three-dimensional simulation includes the fractional flow reserve at a plurality of locations in the coronary artery. (Item 21) 1. A system for planning a treatment for a patient, comprising: receiving patient-specific data relating to the geometry of an anatomical structure of the patient; creating a three-dimensional model representing at least a portion of the anatomical structure of the patient based on the patient-specific data; determining first information regarding a characteristic of blood flow within the anatomical structure of the patient based on the three-dimensional model and a physics-based model related to the anatomical structure of the patient; Modifying the three-dimensional model; and at least one computer system configured to determine second information regarding characteristics of the blood flow within the anatomical structure of the patient based on the modified three-dimensional model. (Item 22) 22. The system of claim 21, wherein the at least one computer system is further configured to modify the three-dimensional model based on input received from a user, the input including a selection of a treatment plan for the patient. (Item 23) the selected treatment plan is associated with a change in the geometry of the anatomical structure of the patient; 23. The system of claim 22, wherein the at least one computer system is further configured to modify the three-dimensional model based on the selected treatment plan. (Item 24) the received input includes a location on the patient's anatomical structure for changing the geometry of the anatomical structure, the location selected by the user; 24. The system of claim 23, wherein the at least one computer system is further configured to modify the three-dimensional model based on the selected treatment plan and the selected location. (Item 25) the selected treatment plan includes a plan to insert a stent into the selected location of the patient; 25. The system of claim 24, wherein the at least one computer system is further configured to modify the three-dimensional model by enlarging a lumen represented by the three-dimensional model. (Item 26) the selected treatment plan includes a plan to add a bypass to the selected location of the patient; and 25. The system of claim 24, wherein the at least one computer system is further configured to modify the three-dimensional model by adding a first bypass toward the lumen in the three-dimensional model. (Item 27) said at least one computer system, 22. The system of claim 21, further configured to determine differences between the first information and the second information at a plurality of locations within the anatomical structure of the patient. (Item 28) 22. The system of claim 21, wherein the first information and the second information each include at least one of blood pressure, blood velocity, blood flow, or fractional coronary flow reserve in the anatomical structure of the patient. (Item 29) 22. The system of claim 21, wherein the anatomical structure of the patient includes at least one of a portion of a plurality of arteries in the patient's heart, neck, head, chest, abdomen, arms, or legs. (Item 30) 1. A non-transitory computer readable medium, comprising: a method for planning a treatment for a patient, the method comprising: receiving patient-specific data relating to a geometry of an anatomical structure of the patient; and creating a three-dimensional model representing at least a portion of the anatomical structure of the patient based on the patient-specific data; 31. A non-transitory computer-readable medium for use on a computer system, the non-transitory computer-readable medium comprising computer-executable programming instructions for performing a method including: determining first information regarding characteristics of blood flow within the patient's anatomical structure based on the three-dimensional model and a physics-based model related to the patient's anatomical structure; and determining second information regarding the characteristics of blood flow within the patient's anatomical structure based on a desired change in geometry of the patient's anatomical structure. The method further comprising: modifying the three-dimensional model based on input received from a user selecting a treatment plan; 31. The non-transitory computer-readable medium of claim 30, further comprising revealing the second information based on the modification. (Item 32) the selected treatment plan is associated with a change in the geometry of the anatomical structure of the patient; 32. The non-transitory computer-readable medium of claim 31, wherein the at least one computer system is further configured to modify the three-dimensional model based on the selected treatment plan. (Item 33) the received input includes a location in the patient's anatomical structure for changing the geometry of the anatomical structure; 33. The non-transitory computer-readable medium of claim 32, wherein the at least one computer system is further configured to modify the three-dimensional model based on the selected treatment plan and the selected location. (Item 34) The method further comprising: 31. The non-transitory computer-readable medium of claim 30, further comprising determining a difference between the first information and the second information at a plurality of locations within the anatomical structure of the patient. (Item 35) 31. The non-transitory computer-readable medium of claim 30, wherein the first information and the second information each include a blood pressure, a blood velocity, a blood flow, or a fractional flow reserve in the anatomical structure of the patient. (Item 36) 31. The non-transitory computer-readable medium of claim 30, wherein the anatomical structure of the patient includes at least one of a portion of a plurality of arteries in the patient's heart, neck, head, chest, abdomen, arms, or legs. (Item 37) 1. A method for planning a patient's treatment using a computer system, comprising: inputting into at least one computer system patient specific data relating to the geometry of an anatomical structure of said patient; generating, with the at least one computer system, a three-dimensional model representative of at least a portion of the anatomical structure of the patient based on the patient-specific data; determining, with the at least one computer system, first information regarding a characteristic of blood flow within the anatomical structure of the patient based on the three-dimensional model and a physics-based model associated with the anatomical structure of the patient; modifying the three-dimensional model using the at least one computer system; and determining, using the at least one computer system, second information regarding characteristics of the blood flow within the anatomical structure of the patient based on the modified three-dimensional model. (Item 38) generating, with the at least one computer system, a three-dimensional simulation including the first information; generating, with the at least one computer system, a reduced order model based on the three-dimensional simulation; 39. The method of claim 37, wherein the second information is revealed using the reduced order model. Item 39. The method of item 38, wherein the reduced order model is a lumped parameter model. (Item 40) 38. The method of claim 37, wherein the three-dimensional model is modified based on a first input received from a user, the first input being indicative of a first treatment plan selected by the user, modifying, with the at least one computer system, the three-dimensional model based on a second input received from the user, separate from the first input, the second input indicating a second treatment plan selected by the user; and determining, with the at least one computer system, third information regarding characteristics of the blood flow within the anatomical structure of the patient based on the three-dimensional model modified based on the second input; and comparing the first and second treatment plans by comparing the second information to the third information. (Item 41) 1. A system for planning a treatment for a patient, comprising: receiving patient-specific data relating to the geometry of an anatomical structure of the patient; creating a three-dimensional model representing at least a portion of the anatomical structure of the patient based on the patient-specific data; determining first information regarding a characteristic of blood flow within the anatomical structure of the patient based on the three-dimensional model and information regarding a physiological state of the patient; Modifying the physiological condition of the patient; A system comprising at least one computer system configured to determine second information regarding a characteristic of the blood flow within the anatomical structure of the patient based on the modified physiological condition of the patient. (Item 42) 42. The system of claim 41, wherein the at least one computer system is further configured to modify the physiological condition of the patient based on input received from a user, the input including a selection of a treatment plan for the patient. (Item 43) the selected treatment plan is related to a change in at least one of the patient's cardiac output, level of exercise, level of hyperemia, or drug therapy; 43. The system of claim 42, wherein the at least one computer system is further configured to modify the physiological condition of the patient based on the selected treatment plan. (Item 44) 44. The system of claim 43, wherein the at least one computer system is further configured to modify the physiological condition of the patient by altering a parameter associated with blood flow through the anatomical structure of the patient. (Item 45) 45. The system of claim 44, wherein the altered blood flow-related parameter comprises at least one of coronary artery resistance, aortic blood pressure, or heart rate. (Item 46) said at least one computer system, Item 42. The system of item 41, further configured to determine differences between the first information and the second information at a plurality of locations within the anatomical structure of the patient. (Item 47) 42. The system of claim 41, wherein the first information and the second information each include at least one of blood pressure, blood velocity, blood flow, or fractional flow reserve in the anatomical structure of the patient. (Item 48) 42. The system of claim 41, wherein the anatomical structure of the patient includes at least one of a portion of a plurality of arteries in the patient's heart, neck, head, chest, abdomen, arms, or legs. (Item 49) 1. A non-transitory computer readable medium, comprising: a method for planning a treatment for a patient, the method comprising: receiving patient-specific data relating to a geometry of an anatomical structure of the patient; and creating a three-dimensional model representing at least a portion of the anatomical structure of the patient based on the patient-specific data; determining first information regarding a characteristic of blood flow within the anatomical structure of the patient based on the three-dimensional model and information regarding a physiological state of the patient; and and determining second information regarding characteristics of the blood flow within the anatomical structure of the patient based on changes in the physiological condition of the patient. (Item 50) 50. The non-transitory computer-readable medium of claim 49, wherein the second information is revealed based on a selected treatment plan associated with a change in at least one of the patient's cardiac output, heart rate, stroke volume, blood pressure, level of exertion or exercise, level of hyperemia, or drug therapy. (Item 51) 51. The non-transitory computer-readable medium of claim 50, wherein the method further comprises modifying the physiological condition of the patient by altering a parameter associated with blood flow through the anatomical structure of the patient. (Item 52) Item 52. The non-transitory computer-readable medium of Item 51, wherein the altered blood flow-related parameter comprises at least one of coronary artery resistance, aortic blood pressure, or heart rate. (Item 53) The method further comprising: 50. The non-transitory computer readable medium of claim 49, further comprising determining a difference between the first information and the second information at a plurality of locations within the anatomical structure of the patient. (Item 54) 50. The non-transitory computer-readable medium of claim 49, wherein the first information and the second information each include at least one of blood pressure, blood velocity, blood flow, or fractional coronary flow reserve in the anatomical structure of the patient. (Item 55) 50. The non-transitory computer-readable medium of claim 49, wherein the anatomical structure of the patient includes at least one of a portion of a plurality of arteries in the patient's heart, neck, head, chest, abdomen, arms, or legs. (Item 56) 1. A method for planning a treatment for a patient using at least one computer system, comprising inputting into the at least one computer system patient-specific data relating to the geometry of an anatomical structure of the patient; generating, with the at least one computer system, a three-dimensional model representative of at least a portion of the anatomical structure of the patient based on the patient-specific data; determining, with the at least one computer system, first information regarding a characteristic of blood flow within the anatomical structure of the patient based on the three-dimensional model and information regarding a physiological state of the patient; modifying the physiological condition of the patient using the at least one computer system; and and determining, using the at least one computer system, second information regarding characteristics of the blood flow within the anatomical structure of the patient based on the modified physiological condition of the patient. (Item 57) modifying the physiological condition of the patient includes altering a parameter relating to blood flow through the anatomical structure of the patient; 57. The method of claim 56, wherein the altered parameter comprises at least one of coronary artery resistance, aortic blood pressure, or heart rate. (Item 58) generating, with the at least one computer system, a three-dimensional simulation including the first information; and generating, with the at least one computer system, a reduced order model based on the three-dimensional simulation; 59. The method of claim 56, wherein the second information is revealed using the reduced order model. Item 59. The method of item 58, wherein the reduced order model is a lumped parameter model. (Item 60) 57. The method of claim 56, wherein modifying the physiological condition of the patient is based on a first input received from the user, the first input indicating a first treatment plan selected by the user, modifying, with the at least one computer system, the physiological condition of the patient based on a second input received from the user, separate from the first input, the second input indicating a second treatment plan selected by the user; determining, with the at least one computer system, third information regarding a characteristic of the blood flow within the anatomical structure of the patient based on the physiological condition modified based on the second input; and comparing the first and second treatment plans by comparing the second information with the third information. (Item 61) 1. A system for revealing patient-specific cardiovascular information, comprising: receiving patient-specific data relating to the geometry of an anatomical structure of the patient; creating a three-dimensional model representing at least a portion of the anatomical structure of the patient based on the patient-specific data; determining a total resistance associated with a total flow rate through the portion of the anatomical structure of the patient; a system comprising at least one computer system configured to determine information regarding characteristics of blood flow within the patient's anatomical structure based on the three-dimensional model, a physics-based model associated with the patient's anatomical structure, and the identified total resistance. (Item 62) 63. The system of claim 61, wherein the patient's anatomical structure includes at least a portion of an aorta and at least a portion of a plurality of coronary arteries emanating from the portion of the aorta, and the total resistance is related to a total flow through the plurality of coronary arteries. the at least one computer system identifying an individual resistance for each of the plurality of coronary arteries based on the determined total resistance; and Item 63. The system of item 62, further configured to determine the information regarding characteristics of the blood flow based on the identified individual resistances by incorporating the individual resistances into the physics-based model. (Item 64) said at least one computer system, receiving a measured blood pressure of the patient; Item 64. The system of item 63, further configured to determine the total resistance based on the measured blood pressure. (Item 65) Item 62. The system of item 61, wherein the at least one computer system is further configured to determine the total flow rate through the portion of the anatomical structure based on an determined mass or volume of at least the portion of the anatomical structure. (Item 66) 66. The system of claim 65, wherein the at least one computer system is further configured to identify the mass or volume of at least a portion of the anatomical structure using the patient-specific data. (Item 67) 70. The system of claim 66, wherein the patient-specific data includes image data, and the at least one computer system is further configured to use the image data to identify the mass or volume of at least a portion of the anatomical structure. (Item 68) 62. The system of claim 61, wherein the information includes blood pressure, blood velocity, or blood flow within the patient's anatomical structure. (Item 69) Item 62. The system of item 61, wherein the anatomical structure of the patient includes at least one of a portion of a plurality of arteries in the patient's heart, neck, head, chest, abdomen, arms, or legs. (Item 70) 1. A method for determining patient-specific cardiovascular information using at least one computer system, comprising: inputting into said at least one computer system patient specific data relating to the geometry of said patient's anatomical structures; generating, with at least one computer system, a three-dimensional model representative of at least a portion of the anatomical structure of the patient based on the patient-specific data; determining, with at least one computer, a total resistance associated with a total flow rate through the portion of the anatomical structure of the patient; and and determining, using at least one computer, information regarding characteristics of blood flow within the patient's anatomical structure based on the three-dimensional model, a physics-based model associated with the patient's anatomical structure, and the determined total resistance. (Item 71) identifying, with the at least one computer system, a mass or volume of at least a portion of the anatomical structure of the patient using the patient-specific data; and 71. The method of claim 70, further comprising using the at least one computer system to determine the total flow rate based on the determined mass or volume. (Item 72) 72. The method of claim 71, wherein the anatomical structure of the patient is the myocardium or brain of the patient. (Item 73) 72. The method of claim 71, further comprising measuring a blood pressure of the patient, and wherein the total resistance is determined based on the measured blood pressure. (Item 74) 74. The method of claim 73, wherein the anatomical structure of the patient includes at least a portion of a plurality of connecting arteries, The method further comprising: using the at least one computer system, determining an individual resistance for each of the plurality of arteries based on the determined total resistance. (Item 75) 71. The method of claim 70, wherein the information comprises blood pressure, blood velocity, or blood flow within the patient's anatomical structure. (Item 76) 71. The method of claim 70, wherein the anatomical structure of the patient includes at least one of a portion of a plurality of arteries in the patient's heart, neck, head, chest, abdomen, arms, or legs. (Item 77) 1. A non-transitory computer readable medium, comprising: receiving patient-specific data relating to a geometry of an anatomical structure of the patient; and generating a three-dimensional model representing at least a portion of the anatomical structure of the patient based on the patient-specific data; determining a total resistance associated with a total flow rate through the portion of the anatomical structure of the patient; and A non-transitory computer-readable medium for use on a computer system, comprising computer-executable programming instructions for implementing a method including determining information regarding characteristics of blood flow within the patient's anatomical structure based on the three-dimensional model, a physics-based model associated with the patient's anatomical structure, and the identified total resistance. (Item 78) the anatomical structure of the patient includes at least a portion of an aorta and at least a portion of a plurality of coronary arteries emanating from the portion of the aorta; Item 78. The non-transitory computer readable medium of item 77, wherein the total resistance is related to a total outflow through the plurality of coronary arteries. (Item 79) The method further comprising: 80. The non-transitory computer-readable medium of claim 77, further comprising determining the total flow rate through the portion of the anatomical structure based on an determined mass or volume of at least the portion of the anatomical structure. (Item 80) the patient-specific data includes image data, the method comprising: 80. The non-transitory computer-readable medium of claim 79, further comprising identifying the mass or volume of at least a portion of the anatomical structure using the image data. (Item 81) 1. A system for providing patient specific cardiovascular information using a website, comprising: enabling remote users to access the website; receiving patient-specific data relating to at least a portion of a geometry of an anatomical structure of the patient; 11. A system comprising: at least one computer system configured to: create a three-dimensional model representing at least a portion of the patient's anatomical structure based on the patient-specific data; reveal information regarding blood flow characteristics within the patient's anatomical structure based on the three-dimensional model and a physiological state of the patient; and communicate display information regarding a first three-dimensional simulation of at least the portion of the patient's anatomical structure, the three-dimensional simulation including the revealed information regarding the blood flow characteristics, to the remote user using the website. (Item 82) said at least one computer system, 82. The system of claim 81, further configured to receive input from the remote user via the website selecting a treatment plan for the patient. (Item 83) said at least one computer system, modifying at least one of the three-dimensional model or the physiological condition of the patient based on the received input; 83. The system of claim 82, further configured to determine second information regarding a characteristic of the blood flow within the anatomical structure of the patient based on the received input. (Item 84) said at least one computer system, 84. The system of claim 83, further configured to communicate display information regarding a second three-dimensional simulation of at least the portion of the anatomical structure of the patient, the second three-dimensional simulation including the revealed second information regarding the blood flow characteristics to the remote user using the website. (Item 85) 82. The system of claim 81, wherein the information regarding characteristics of the blood flow within the anatomical structure of the patient is further determined based on a stored physics-based model associated with the anatomical structure of the patient. (Item 86) 82. The system of claim 81, wherein the anatomical structure of the patient includes at least one of a portion of a plurality of arteries in the heart, neck, head, chest, abdomen, arm, or leg. (Item 87) 82. The system of claim 81, wherein the information includes blood pressure, blood velocity, or blood flow within the patient's anatomical structure. (Item 88) said at least one computer system, receiving patient-specific data for a plurality of patients; and 82. The system of claim 81, further configured to determine the information regarding the blood flow characteristics of the plurality of patients. (Item 89) Item 82. The system of item 81, wherein the at least one computer system is configured to enable multiple remote users to securely access the website. (Item 90) Item 82. The system of item 81, wherein the at least one computer system is configured to communicate display information regarding the three-dimensional model to the remote user using the website. (Item 91) 1. A method for providing patient specific cardiovascular information using a website, comprising: enabling remote users to access a website using at least one computer system; receiving, with the at least one computer system, patient-specific data relating to a geometry of an anatomical structure of the patient; generating, with the at least one computer system, a three-dimensional model representative of at least a portion of the anatomical structure of the patient based on the patient-specific data; and determining, with the at least one computer system, information regarding characteristics of blood flow within the anatomical structure of the patient based on the three-dimensional model and a physiological state of the patient; and and communicating, using the at least one computer system, display information regarding a first three-dimensional simulation of at least the portion of the anatomical structure of the patient, the three-dimensional simulation including the revealed information regarding characteristics of the blood flow, to the remote user using the website. (Item 92) 92. The method of claim 91, further comprising receiving, with the at least one computer system, input from the remote user using the website to select a treatment plan for the patient. (Item 93) modifying, with the at least one computer system, at least one of the three-dimensional model or the physiological condition of the patient based on the received input; and 93. The method of claim 92, further comprising determining, using the at least one computer system, second information regarding a characteristic of the blood flow of at least the portion of the anatomical structure of the patient based on the received input. (Item 94) 94. The method of claim 93, further comprising using the at least one computer system to communicate display information regarding a second three-dimensional simulation of the patient's anatomical structure, the second three-dimensional simulation including the revealed second information regarding the blood flow characteristics, to the remote user using the website. (Item 95) 1. A non-transitory computer readable medium and method for providing patient specific cardiovascular information using a website, comprising: enabling a remote user to access a website; receiving patient-specific data relating to a geometry of an anatomical structure of the patient; and generating a three-dimensional model representing at least a portion of the anatomical structure of the patient based on the patient-specific data; determining first information regarding a characteristic of blood flow within the anatomical structure of the patient based on the three-dimensional model and a physics-based model related to the anatomical structure of the patient; and A non-transitory computer-readable medium for use on a computer system, comprising computer-executable programming instructions for implementing a method comprising: generating a first three-dimensional simulation of at least the portion of the anatomical structure of the patient; and communicating display information regarding the three-dimensional simulation, including the revealed information regarding characteristics of the blood flow, to the remote user using the website. (Item 96) The method further comprising: 96. The non-transitory computer-readable medium of claim 95, further comprising receiving, using the website, an input from the remote user selecting a treatment plan for the patient. (Item 97) 96. The non-transitory computer-readable medium of claim 95, wherein the information regarding the blood flow characteristics of at least the portion of the anatomical structure of the patient is further characterized based on a stored physics-based model associated with the anatomical structure of the patient. (Item 98) 96. The non-transitory computer readable medium of claim 95, wherein the anatomical structure of the patient includes at least one of a portion of a plurality of arteries in the patient's heart, neck, head, chest, abdomen, arms, or legs. (Item 99) The method further comprising: receiving patient-specific data relating to a plurality of patients; and 96. The non-transitory computer readable medium of claim 95, further comprising determining the information regarding the blood flow characteristics of the plurality of patients. (Item 100) Item 96. The non-transitory computer-readable medium of item 95, wherein the at least one computer system is configured to enable multiple remote users to securely access the website. (Item 101) 1. A system for revealing patient-specific time-varying cardiovascular information, comprising: receiving time-varying patient-specific data relating to the geometry of at least a portion of an anatomical structure of the patient at different time points; creating a three-dimensional model representing at least a portion of the anatomical structure of the patient based on the patient-specific data; and 22. The system of claim 21, further comprising: at least one computer system configured to determine information regarding changes in blood flow characteristics over time within the patient's anatomical structure based on the three-dimensional model and a physics-based model related to the patient's anatomical structure. (Item 102) Item 102. The system of item 101, wherein the time-varying patient-specific data relates to the geometry of the anatomical structures of the patient at different points in time. (Item 103) Item 102. The system of item 101, wherein the patient-specific data includes image data at different time points throughout the cardiac cycle. (Item 104) the anatomical structure of the patient includes at least a portion of a plurality of connecting arteries of the patient; Item 102. The system of item 101, wherein the patient-specific data includes information regarding changes in the plurality of arterial vascular geometries. (Item 105) Item 105. The system of item 104, wherein the multiple arteries are located in the patient's heart, neck, head, chest, abdomen, arms, or legs. (Item 106) Item 102. The system of item 101, wherein the blood flow characteristics include at least one of blood pressure, blood velocity, or blood flow rate. (Item 107) said at least one computer system, Item 102. The system of item 101, further configured to reveal information regarding changes in characteristics of the blood flow over time at multiple locations along three dimensions within the anatomical structure of the patient. (Item 108) 1. A method for determining patient-specific time-varying cardiovascular information using at least one computer system, comprising: receiving, with at least one computer system, time-varying patient-specific data relating to the geometry of an anatomical structure of the patient at different time points; generating, with the at least one computer system, a three-dimensional model representative of at least a portion of the anatomical structure of the patient based on the patient-specific data; and and determining, using the at least one computer system, information regarding changes in blood flow characteristics over time within the patient's anatomical structure based on the information regarding the three-dimensional model and a physics-based model related to the patient's anatomical structure. (Item 109) 109. The method of claim 108, further comprising storing the physics-based model using the at least one computer system. (Item 110) 109. The method of claim 108, wherein the anatomical structure of the patient includes at least one of a portion of a plurality of arteries in the patient's heart, neck, head, chest, abdomen, arms, or legs. (Item 111) 109. The method of claim 108, wherein the time-varying patient-specific data relates to the geometry of the anatomical structure of the patient at different points in time. (Item 112) 19. The method of claim 108, wherein the patient-specific data includes image data at different time points throughout the cardiac cycle. (Item 113) the anatomical structure of the patient includes at least a portion of a plurality of connecting arteries of the patient; and 19. The method of claim 108, wherein the patient-specific data includes information regarding changes in vascular geometry of the plurality of arteries. (Item 114) 14. The method of claim 113, wherein the multiple arteries are located in the patient's heart, neck, head, chest, abdomen, arms, or legs. (Item 115) 1. A non-transitory computer readable medium, comprising: a method for determining patient-specific time-varying cardiovascular information, the method comprising: receiving time-varying patient-specific data relating to the geometry of an anatomical structure of the patient at different times; creating a three-dimensional model representing at least a portion of the anatomical structure of the patient based on the patient-specific data; A non-transitory computer readable medium for use on a computer system comprising computer executable programming instructions for implementing a method comprising revealing information relating to changes in characteristics of blood flow over time within the patient's anatomical structure based on information relating to the three-dimensional model and a physics-based model related to the patient's anatomical structure. (Item 116) Item 116. The non-transitory computer-readable medium of item 115, wherein the time-varying patient-specific data relates to the geometry of the anatomical structure of the patient at different points in time. (Item 117) Item 116. The non-transitory computer-readable medium of item 115, wherein the patient-specific data includes image data at different time points throughout a cardiac cycle. (Item 118) the anatomical structure of the patient includes at least a portion of a plurality of connecting arteries of the patient; and Item 116. The non-transitory computer-readable medium of item 115, wherein the patient-specific data includes information regarding changes in vascular geometry of the plurality of arteries. (Item 119) Item 119. The non-transitory computer readable medium of item 118, wherein the plurality of arteries are located in the patient's heart, neck, head, chest, abdomen, arms, or legs. (Item 120) Item 116. The non-transitory computer-readable medium of item 115, wherein the blood flow characteristics include at least one of blood pressure, blood velocity, or blood flow rate. (Item 121) 1. A system for determining cardiovascular information of a patient, comprising: receiving patient-specific data regarding a geometry and at least one material property of at least a portion of the patient's anatomical structure, the geometry and at least one material property of at least a portion of the anatomical structure, the at least a portion of the blood vessel; creating a three-dimensional model representing the anatomical structure of the patient based on the patient-specific data; determining information regarding characteristics of blood flow within the anatomical structure of the patient based on the three-dimensional model and the physiological state of the patient; The system comprises at least one computer system configured to identify a location of plaque within the blood vessel. (Item 122) Item 122. The system of item 121, wherein the at least one computer system is further configured to determine at least one of stress, pressure, force, or strain on the plaque. (Item 123) Item 122. The system of item 121, wherein the at least one computer system is further configured to assess the vulnerability of the plaque to rupture. (Item 124) Item 124. The system of item 123, wherein the at least one computer system is further configured to assess the vulnerability of the plaque to rupture based on a ratio of the plaque's force to the plaque's stress. (Item 125) the strength is determined based on a material property of the plaque; Item 125. The system of item 124, wherein the stress comprises an acute or cumulative stress due to blood flow forces or cardiac motion induced strain on the plaque. (Item 126) Item 122. The system of item 121, wherein the physiological condition of the patient includes at least one of the patient's cardiac output, heart rate, stroke volume, blood pressure, level of exertion or exercise, level of hyperemia, or drug therapy. (Item 127) Item 122. The system of item 121, wherein the location is identified by the at least one computer system or based on input from a user. (Item 128) 1. A method for determining cardiovascular information of a patient using at least one computer system, comprising: receiving, with at least one computer system, patient-specific data relating to a geometry and at least one material property of at least a portion of an anatomical structure of the patient, the anatomical structure including at least a portion of a blood vessel; generating, with the at least one computer system, a three-dimensional model representative of the anatomical structure of the patient based on the patient-specific data; determining, with the at least one computer system, information regarding characteristics of blood flow within the anatomical structure of the patient based on the three-dimensional model and a physiological state of the patient; and identifying plaque within the blood vessel with the at least one computer system. (Item 129) Item 129. The method of item 128, wherein the plaque is identified by the at least one computer system or based on input from a user. (Item 130) Item 129. The method of item 128, further comprising calculating at least one of pressure, force, or shear stress acting on a surface of the plaque. (Item 131) Item 131. The method of item 130, wherein the at least one of pressure, force, or shear stress is calculated based on the determined information regarding characteristics of the blood flow. (Item 132) Item 129. The method of item 128, wherein the blood flow characteristics include at least one of blood pressure, blood velocity, or blood flow rate. (Item 133) 129. The method of claim 128, wherein the patient-specific data comprises time-varying data regarding the geometry of at least a portion of the anatomical structure of the patient at different time points, The method further comprises determining information regarding deformation of said plaque over time. (Item 134) The information regarding the deformation of the plaque over time may be Item 134. The method of item 133, comprising at least one of longitudinal lengthening, longitudinal shortening, twisting, radial expansion, radial compression, or bending. (Item 135) 1. A non-transitory computer readable medium, comprising: receiving patient-specific data relating to a geometry and at least one material property of at least a portion of an anatomical structure of the patient, the anatomical structure including at least a portion of a blood vessel; creating a three-dimensional model representative of the patient's anatomical structure based on the patient-specific data; determining information regarding characteristics of blood flow within the anatomical structure of the patient based on the three-dimensional model and a physiological state of the patient; and and identifying a location of plaque within the blood vessel. (Item 136) Item 136. The non-transitory computer-readable medium of item 135, wherein the anatomical structure includes a plurality of arteries and at least a portion of tissue connecting with at least a portion of the plurality of arteries, the method further including identifying tissue segments of the anatomical structure that are affected by potential rupture of the plaque. (Item 137) Item 137. The non-transitory computer readable medium of item 136, wherein the method further comprises identifying potential pathways following the potential rupture of the plaque. (Item 138) Item 137. The non-transitory computer readable medium of item 136, wherein the method further comprises determining whether the tissue segment may be susceptible to the potential rupture of the plaque based on at least one of a size of the plaque or a size of at least a portion of the blood vessel downstream of the plaque. (Item 139) 140. The non-transitory computer readable medium of claim 136, wherein the method further comprises providing a visual indication to each of a plurality of tissue segments, each visual indication indicating a likelihood that the potential rupture of the plaque will affect the respective tissue segment. The anatomical structure includes at least a portion of a plurality of arteries and tissue connected to at least a portion of the plurality of arteries, and the method includes: Item 136. The non-transitory computer readable medium of item 135, further comprising determining an alteration in blood flow to at least a portion of the tissue due to potential rupture of the plaque. (Item 141) 1. A system for determining cardiovascular information of a patient, comprising: receiving patient-specific data regarding a geometry of at least a portion of the patient's anatomical structure, the at least a portion of the patient's anatomical structure including at least a portion of a plurality of arteries and tissue connecting at least a portion of the plurality of arteries; creating a three-dimensional model representing the anatomical structure of the patient based on the patient-specific data; Dividing at least a portion of the three-dimensional model representing the tissue into segments; The system comprises at least one computer system configured to determine information regarding a blood flow characteristic associated with at least one of the segments based on the three-dimensional model and a physiological state of the patient. (Item 142) Item 142. The system of item 141, wherein the blood flow characteristics include blood flow entering the at least one segment. (Item 143) the at least one computer system is further configured to further divide at least one of the segments into subsegments; and Item 142. The system of item 141, wherein the blood flow characteristics include blood flow entering at least one of the subsegments. (Item 144) Item 142. The system of item 141, wherein the at least one computer system is further configured to further divide the segments until a desired resolution is obtained. (Item 145) Item 142. The system of item 141, wherein the tissue is downstream of the plurality of arteries. (Item 146) the plurality of arteries are located at least partially in the patient's head or heart; 142. The system of claim 141, wherein the tissue comprises myocardial tissue or brain tissue. (Item 147) Item 142. The system of item 141, wherein the at least one computer system is further configured to determine a size of the segment based on a size of at least one artery of the plurality of arteries connected to the respective segment. (Item 148) Item 142. The system of item 141, wherein the physiological condition of the patient includes at least one of the patient's cardiac output, heart rate, stroke volume, blood pressure, level of exertion or exercise, level of hyperemia, or drug therapy. (Item 149) Item 142. The system of item 141, wherein the at least one computer is further configured to generate a three-dimensional simulation of the anatomical structure showing the information regarding characteristics of the blood flow associated with a plurality of the segments. (Item 150) Item 149. The system of item 149, wherein the blood flow characteristics include blood flow entering the respective segments, and variations in the blood flow entering the respective segments are indicated by variations in color or shading. (Item 151) 1. A method for determining cardiovascular information of a patient using at least one computer system, comprising: receiving, using the at least one computer system, patient-specific data relating to a geometry of at least a portion of an anatomical structure of the patient, the anatomical structure including at least a portion of a plurality of arteries and tissue connecting to at least a portion of the plurality of arteries; generating, with the at least one computer system, a three-dimensional model representative of the anatomical structure of the patient based on the patient-specific data; augmenting the three-dimensional model to form an augmented model using the at least one computer system; Dividing, with the at least one computer system, at least a portion of the augmented model representing the tissue into segments; and and determining, using the at least one computer system, information regarding blood flow characteristics associated with at least one of the segments based on the augmented model and a physiological condition of the patient. (Item 152) expanding the three-dimensional model includes expanding at least one of the arteries included in the three-dimensional model; dividing the at least one portion of the enlarged model includes dividing the enlarged portion of the at least one artery into segments; and Item 152. The method of item 151, wherein the information regarding the blood flow characteristics relates to at least one of the segments of the expanded portion. (Item 153) augmenting the three-dimensional model includes creating an additional branch of an artery that connects to at least one of the arteries included in the three-dimensional model; dividing the at least one portion of the augmented model includes dividing at least one of the additional branches into segments; and Item 152. The method of item 151, wherein the information regarding the blood flow characteristics relates to at least one of the segments of the at least one additional branch. (Item 154) Item 152. The method of item 151, further comprising determining a size of the segment based on a size of at least one artery of the plurality of arteries connected to the respective segment. (Item 155) Item 152. The method of item 151, further comprising determining a size of the segment based on the size of multiple adjacent arteries connecting to the respective segment. (Item 156) the plurality of arteries are located at least partially in the patient's head or heart; the tissue comprises cardiac tissue or brain tissue; Item 152. The method of item 151, wherein the three-dimensional model is expanded such that at least one artery of the plurality of arteries included in the three-dimensional model is expanded along or within the heart tissue or the brain tissue. (Item 157) 1. A non-transitory computer readable medium, comprising: receiving patient-specific data regarding a geometry of at least a portion of an anatomical structure of the patient, the anatomical structure including at least a portion of a plurality of arteries and tissue connecting at least a portion of the plurality of arteries; A non-transitory computer-readable medium for use on a computer system, comprising computer-executable programming instructions for implementing a method comprising: creating a three-dimensional model representing the anatomical structures of the patient based on the patient-specific data; dividing at least a portion of the three-dimensional model representing the tissue into segments; and determining information regarding blood flow characteristics associated with at least one of the segments based on the three-dimensional model and a physics-based model associated with the anatomical structures. (Item 158) The method further comprising: comparing the determined information with measured information regarding characteristics of the blood flow at a plurality of locations in the anatomical structure; and Item 158. The non-transitory computer-readable medium of item 157, further comprising adjusting the three-dimensional model or the physics-based model in response to the comparison. (Item 159) the physics-based model includes at least one lumped parameter model representing blood flow through a boundary of the three-dimensional model; and Item 159. The non-transitory computer-readable medium of item 158, wherein the at least one lumped parameter model is adjusted based on the comparison. (Item 160) Item 159. The non-transitory computer-readable medium of item 158, wherein the three-dimensional model or the physics-based model is adjusted until a difference between the revealed information and the measured information is below a threshold. (Item 161) Item 159. The non-transitory computer-readable medium of item 158, wherein the three-dimensional model is adjusted by expanding the three-dimensional model until a difference between the revealed information and the measured information is below a threshold. (Item 162) 1. A system for determining cardiovascular information of a patient, comprising: receiving patient-specific data relating to the geometry of the patient's brain; creating a three-dimensional model representing at least a portion of the patient's brain based on the patient-specific data; and at least one computer system configured to determine information regarding a characteristic of blood flow in the patient's brain based on the three-dimensional model and a physics-based model associated with the patient's brain. (Item 163) Item 163. The system of item 162, wherein the three-dimensional model representing at least the portion of the patient's brain includes at least a portion of a plurality of cerebral arteries. (Item 164) Item 164. The system of item 163, wherein the blood flow characteristics include at least one of blood flow, blood pressure, or blood velocity at multiple locations within the multiple cerebral arteries. (Item 165) Item 163. The system of item 162, wherein the patient-specific data includes image data. (Item 166) Item 166. The system of item 165, wherein the image data is provided of at least one of at least a portion of an extracranial artery, at least a portion of an intracranial artery, or brain tissue. (Item 167) Item 166. The system of item 165, wherein the image data is provided by computed tomography or magnetic resonance imaging techniques. (Item 168) Item 166. The system of item 165, wherein the at least one computer system is configured to generate the three-dimensional model based on the image data by identifying the location of boundaries of a plurality of cerebral artery lumens using the image data. (Item 169) Item 169. The system of item 168, wherein the at least one computer system is configured to identify the location of the boundary based on changes in brightness values in the image data. (Item 170) Item 163. The system of item 162, wherein the physics-based model includes at least one lumped parameter model representing blood flow through a boundary of the three-dimensional model. (Item 171) Item 163. The system of item 162, wherein the at least one computer system is configured to determine the information regarding the blood flow characteristics using parameters related to at least one of level of exercise, exertion, stress, high or low blood pressure, or drug therapy. (Item 172) Item 172. The system of item 171, wherein the at least one computer system is configured to determine the information regarding the blood flow characteristics using parameters related to the level of exercise, exertion, stress, hypertension, or hypotension, the parameters related to the patient's cerebral artery resistance, the patient's aortic blood pressure, or the patient's heart rate. (Item 173) 1. A method for determining patient-specific cardiovascular information using at least one computer system, comprising: inputting into said at least one computer system patient-specific data relating to a geometry of at least a portion of a plurality of cerebral arteries of said patient; generating, with the at least one computer system, a three-dimensional model representative of at least the portion of the cerebral artery of the patient based on the patient-specific data; and and determining, using the at least one computer system, information regarding characteristics of blood flow within the patient's cerebral arteries based on the three-dimensional model and a physics-based model related to the patient's cerebral arteries. (Item 174) 174. The method of claim 173, wherein the blood flow characteristics include at least one of blood flow, blood pressure, or blood velocity at multiple locations within the patient's cerebral artery. (Item 175) Item 174. The method of item 173, wherein the cerebral arteries include at least one of an extracranial artery or an intracranial artery. (Item 176) 174. The method of claim 173, wherein the three-dimensional model includes at least one of a portion of the aorta, a portion of the carotid artery, a portion of the vertebral artery, or a portion of brain tissue. (Item 177) 174. The method of claim 173, wherein the patient-specific data includes image data of at least the portion of the cerebral artery, and creating the three-dimensional model includes locating a boundary of at least the portion of the cerebral artery using the image data. (Item 178) Item 178. The method of item 177, wherein the boundary is located based on changes in luminance values in the image data. (Item 179) 174. The method of claim 173, wherein the cerebral arteries include at least one extracranial artery, comprising: identifying plaque in the at least one extracranial artery; and assessing the vulnerability of the plaque to rupture with the at least one computer system. (Item 180) 174. The method according to claim 173, wherein the revealed information on the blood flow characteristics is first information, The method further includes modifying the three-dimensional model and determining second information regarding characteristics of the blood flow within the anatomical structure of the patient based on the modified three-dimensional model. (Item 181) Item 181. The method of item 180, wherein the three-dimensional model is modified to simulate at least one of an occlusion of at least one blood vessel, or a repair of the occlusion. (Item 182) 1. A non-transitory computer readable medium, comprising: receiving patient-specific data relating to the geometry of the patient's brain; generating a three-dimensional model representing at least a portion of the patient's brain based on the patient-specific data; and A non-transitory computer-readable medium for use on at least one computer system, comprising computer-executable programming instructions for executing a method, comprising revealing information regarding characteristics of blood flow in the patient's brain based on the three-dimensional model and a physics-based model related to the patient's brain. (Item 183) The method further comprising: Item 183. The non-transitory computer readable medium of item 182, further comprising creating a three-dimensional simulation of the patient's brain representing the information regarding the blood flow characteristics at multiple locations of at least a portion of a multiple cerebral arteries of the patient along three dimensions. (Item 184) Item 184. The non-transitory computer-readable medium of item 183, wherein the information regarding the characteristics of the blood flow is indicated on the three-dimensional simulation using color or shading, and variations in the information regarding the characteristics of the blood flow are indicated by variations in color or shading.
[0037] Other embodiments and advantages will be set forth in part in the description which follows, and in part will be obvious from the description, or may be learned by the practice of the present disclosure, and will be realized and attained by means of the elements and combinations particularly pointed out hereinafter. [Brief description of the drawings]
[0038] The accompanying drawings, which are incorporated in and constitute a part of this specification, illustrate several embodiments and, together with the description, serve to explain the principles of the present disclosure. [Figure 1] 1 is a schematic diagram of a system for providing various information related to coronary blood flow in a particular patient, according to an exemplary embodiment. [Diagram 2] 1 is a flowchart of a method for providing various information related to blood flow in a particular patient, according to an exemplary embodiment. [Diagram 3] 3 is a flow chart illustrating substeps of the method of FIG. 2; [Figure 4]1 illustrates image data non-invasively acquired from a patient, according to an exemplary embodiment. [Diagram 5] 5 illustrates an exemplary three-dimensional model created using the image data of FIG. 4. [Figure 6] 5 shows a piece of image data from FIG. 4 that includes a seed for forming a first initial model. [Figure 7] 7 shows some first initial models formed by expanding the seed of FIG. 6. [Figure 8] 1 is an illustration of a trimmed solid model in accordance with an illustrative embodiment; [Figure 9] 1 illustrates an exemplary calculated FFR (cFFR) model for a patient at rest. [Figure 10] 1 shows an exemplary cFFR model for a patient under maximal hyperemia. [Figure 11] 1 illustrates an exemplary cFFR model under maximal patient exercise. [Figure 12] 1 is an illustration of a trimmed portion of a solid model that is provided to form a lumped parameter model in accordance with an illustrative embodiment; [Figure 13] 13 illustrates a portion of the centerline of the trimmed solid model of FIG. 12 provided to form a lumped parameter model. [Figure 14] 13 shows segments formed based on the trimmed solid model of FIG. 12 that are provided to form a lumped parameter model. [Figure 15] 15 shows the segments of FIG. 14 replaced with resistors provided to form a lumped parameter model. [Figure 16] 1 illustrates an example lumped parameter model representing upstream and downstream structures at inflow and outflow boundaries of a solid model in accordance with an illustrative embodiment; [Figure 17] A three-dimensional mesh created based on the solid model of FIG. 8 is shown. [Figure 18] 18 shows a portion of the three-dimensional mesh of FIG. 17. [Figure 19] 18 shows a portion of the three-dimensional mesh of FIG. 17. [Figure 20] A model of the patient's anatomy is shown containing blood flow information, and specific points on the model are identified with individual reference labels. [Figure 21] 21 is a graph of simulated blood pressure over time at several points in the aorta identified in FIG. 20, several of the points being identified in FIG. 20. [Figure 22] 21 is a graph of simulated blood flow over time at each of the points identified in FIG. 20. [Figure 23] 1 is a final report in accordance with an example embodiment. [Figure 24] 1 is a flowchart of a method for providing various information related to coronary blood flow in a particular patient, according to an exemplary embodiment. [Diagram 25] 1 illustrates a modified cFFR model identified based on a solid model created by enlarging a portion of the left anterior descending (LAD) branch and a portion of the LCX artery, according to an exemplary embodiment. [Figure 26] 1 shows an example of a modified simulated blood flow model after enlarging a portion of the LAD artery and a portion of the left circumflex artery (LCX) branch, according to an exemplary embodiment. [Figure 27] 1 is a flowchart of a method for simulating various treatment options using a reduced order model, in accordance with an illustrative embodiment; [Figure 28] 1 is a flowchart of a method for simulating various treatment options using a reduced order model, according to another example embodiment. [Figure 29] 1 is a flowchart of a method for providing various information related to myocardial perfusion in a particular patient, according to an exemplary embodiment. [Diagram 30] 11 is a flowchart of a method for providing various information related to myocardial perfusion in a particular patient, according to another exemplary embodiment. [Diagram 31] 1 illustrates a patient-specific model that provides various information related to myocardial perfusion, according to an exemplary embodiment. [Diagram 32]11 is a flowchart of a method for providing various information related to myocardial perfusion in a particular patient, according to a further exemplary embodiment. [Diagram 33] FIG. 1 is a cross-sectional view of plaque buildup along a blood vessel wall. [Diagram 34] 1 illustrates a patient-specific model that provides various information related to plaque vulnerability, according to an exemplary embodiment. [Diagram 35] 1 is a flowchart of a method for providing various information related to assessment of plaque vulnerability, myocardial volume risk, and myocardial perfusion risk in a particular patient, according to an exemplary embodiment. [Diagram 36] FIG. 36 is a schematic diagram illustrating information obtained from the method of FIG. 35, according to an exemplary embodiment. [Figure 37] 1 is a schematic diagram of the cerebral arteries. [Figure 38] 1 is a flowchart of a method for providing various information related to intracranial and extracranial blood flow in a particular patient, according to an exemplary embodiment. [Figure 39] 1 is a flowchart of a method for providing various information related to cerebral perfusion in a particular patient, according to an exemplary embodiment. [Diagram 40] 1 is a flowchart of a method for providing various information related to cerebral perfusion in a particular patient, according to another exemplary embodiment. [Diagram 41] 11 is a flowchart of a method for providing various information related to cerebral perfusion in a particular patient, according to a further exemplary embodiment. [Diagram 42] 1 is a flowchart of a method for providing various information relevant to assessment of plaque vulnerability, brain volume risk, and cerebral perfusion risk in a particular patient, according to an exemplary embodiment. DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS
[0039] Reference will now be made in detail to the exemplary embodiments, examples of which are illustrated in the accompanying drawings. Wherever possible, the same reference numbers will be used throughout the drawings to refer to the same or like parts. The description is organized according to the following summary. I. Overview II. Acquisition and pre-processing of patient-specific anatomical data III. Creation of a 3D model based on acquired anatomical data IV. Creating a model for analysis and determining boundary conditions A. Preparation of models for analysis B. Identifying Boundary Conditions i. Identifying reduced order models ii. Exemplary Lumped Parameter Models C. Creating a 3D mesh V. Performing computer analysis and outputting the results A. Conducting computer analysis B. Display of blood pressure, blood flow, and cFFR results C. Validation of Results D. Alternative Embodiments of Systems and Methods for Providing Coronary Blood Flow Information VI. Providing patient-specific treatment plans A. Using reduced order models to compare different treatment options VII. Other Results A. Assessment of myocardial perfusion B. Assessment of plaque vulnerability VIII. Other Uses A. Modeling intracranial and extracranial blood flow i. Assessment of cerebral perfusion ii. Plaque vulnerability assessment I. Overview
[0040] In an exemplary embodiment, the method and system uses information obtained non-invasively from the patient to determine various information related to blood flow in a particular patient. The determined information may relate to blood flow in the patient's coronary vasculature. Alternatively, as described in more detail below, the determined information may relate to blood flow in other parts of the patient's vasculature, such as the carotid, peripheral, abdominal, renal, and cerebral vasculature. The coronary vasculature includes a complex network of blood vessels ranging from the aorta to arterioles, capillaries, venules, veins, and the like. The coronary vasculature includes the aorta 2 (FIG. 5) that circulates blood to and within the heart and supplies blood to multiple main coronary arteries 4 (FIG. 5) (e.g., the left anterior descending (LAD) branch, the left circumflex (LCX) branch, the right coronary (RCA) artery, etc.), which may further divide into arterial branches or other types of vessels downstream of the aorta 2 and the main coronary arteries 4. Thus, the exemplary methods and systems may reveal a variety of information related to blood flow in the aorta, the main coronary arteries, and / or other coronary arteries or vessels downstream of the main coronary arteries. Although the aorta and coronary arteries (and branches extending therefrom) are described below, the disclosed methods and systems may also be applied to other types of blood vessels.
[0041] In an exemplary embodiment, the information revealed by the disclosed method and system may include, but is not limited to, various blood flow characteristics or parameters, such as blood flow velocity, pressure (or ratios thereof), flow rate, and FFR, at various locations of the aorta, main coronary artery, and / or other coronary arteries or vessels downstream of the main coronary artery. This information can be used to determine whether a lesion is functionally significant and / or whether to treat the lesion. This information can be revealed using information obtained non-invasively from the patient. As a result, a decision can be made to treat or not treat a lesion without the costs and risks associated with invasive procedures.
[0042] 1 illustrates aspects of a system for providing various information related to coronary blood flow in a particular patient, according to an exemplary embodiment. A three-dimensional model 10 of the patient's anatomy can be created using data non-invasively acquired from the patient, as described in more detail below. Other patient-specific information can also be non-invasively acquired. In an exemplary embodiment, the portion of the patient's anatomy represented by the three-dimensional model 10 may include at least a portion of the aorta and proximal portions of the main coronary arteries (and branches extending or emanating therefrom) that connect to the aorta.
[0043] Various physiological laws and relationships 20 related to coronary blood flow can be estimated from experimental data, for example, as described in more detail below. Using this three-dimensional anatomical model 10 and the estimated physiological laws 20, a number of equations 30 related to coronary blood flow can be developed, as described in more detail below. For example, equations 30 can be developed and solved using any numerical method, such as finite difference methods, finite volume methods, spectral methods, lattice Boltzmann methods, particle-based methods, level set methods, finite element methods, etc. Equations 30 may be solvable to reveal information (e.g., pressure, velocity, FFR, etc.) related to coronary blood flow in a patient's anatomy at various points of the anatomy represented by model 10.
[0044] Equation 30 may be solved using computer 40. Based on the solved equation, computer 40 may output one or more images or simulations showing information related to blood flow in the patient's anatomy represented by model 10. For example, the image(s) may include a simulated blood pressure model 50, a simulated blood flow or velocity model 52, a calculated FFR (cFFR) model 54, etc., as described in more detail below. The simulated blood pressure model 50, the simulated blood flow model 52, and the cFFR model 54 provide information regarding the respective pressures, velocities, and cFFRs at various locations along three dimensions of the patient's anatomy represented by model 10. The cFFR may be calculated as the ratio of the blood pressure at a particular location of model 10 divided by the blood pressure at the aorta, e.g., at the inflow boundary of model 10, under conditions of increased coronary blood flow, conventionally induced, e.g., by intravenous administration of adenosine.
[0045] In an exemplary embodiment, computer 40 may include one or more non-transitory computer-readable storage devices that store instructions that, when executed by a processor, computer system, or the like, may perform any of the acts described herein to provide various information related to the patient's blood flow. Computer 40 may include a desktop or portable computer, a workstation, a server, a personal digital assistant, or any other computer system. Computer 40 may include a processor, read-only memory (ROM), random access memory (RAM), input / output (I / O) adapters for connecting peripheral devices (e.g., input devices, output devices, storage devices, etc.), user interface adapters for connecting input devices, such as keyboards, mice, touch screens, voice input, and / or other devices, communication adapters for connecting computer 40 to a network, display adapters for connecting computer 40 to a display, etc. For example, the display may be used to display the three-dimensional model 10 and / or any images generated by solving equations 30, such as the simulated blood pressure model 50, the simulated blood flow model 52, and / or the cFFR model 54.
[0046] 2 illustrates aspects of a method for providing various information related to blood flow in a particular patient, according to another exemplary embodiment. The method may include acquiring patient-specific anatomical data, e.g., information about the patient's anatomy (e.g., at least a portion of the aorta and proximal portions of the main coronary arteries (and branches extending therefrom) that connect to the aorta), and pre-processing the data (step 100). The patient-specific anatomical data may be acquired non-invasively, e.g., by CCTA, as described below.
[0047] A three-dimensional model of the patient's anatomy may be created based on the acquired anatomical data (step 200). For example, this three-dimensional model may be the three-dimensional model of the patient's anatomy 10 described above in connection with FIG.
[0048] The three-dimensional model may be prepared for analysis and boundary conditions may be identified (step 300). For example, the three-dimensional model 10 of the patient's anatomy described above in connection with FIG. 1 may be trimmed and discretized into a volumetric mesh, such as a finite element mesh or a finite volume mesh. The volumetric mesh may be used to generate equations 30 described above in connection with FIG. 1.
[0049] Boundary conditions may also be specified and incorporated into equation 30 described above in connection with FIG. 1. The boundary conditions provide information about the three-dimensional model 10 at its boundaries, such as inflow boundary 322 (FIG. 8), outflow boundary 324 (FIG. 8), vessel wall boundary 326 (FIG. 8), etc. The inflow boundaries 322 may include boundaries through which flow is directed into the anatomy of the three-dimensional model, such as an end of the aorta near the aortic root (e.g., end A shown in FIG. 16). Each inflow boundary 322 may be assigned a prescribed value or field for velocity, flow, pressure, or other property, for example, by coupling a cardiac model and / or a lumped parameter model to the boundary. The outflow boundaries 324 may include boundaries through which flow is directed out of the anatomy of the three-dimensional model, such as an end of the aorta near the aortic arch (e.g., end B shown in FIG. 16), and downstream ends of the main coronary arteries and branches extending therefrom (e.g., ends a-m shown in FIG. 16). Each outflow boundary may be specified, for example, by coupling lumped parameter models or distributed (e.g., one-dimensional wave propagation) models, as described in detail below. The prescribed values of the inflow and / or outflow boundary conditions may be established by non-invasively measuring physiological characteristics of the patient, such as, but not limited to, cardiac output (volume of blood flowing out of the heart), blood pressure, myocardial mass, etc. The vessel wall boundaries may include the physical boundaries of the aorta, main coronary arteries, and / or other coronary arteries or vessels of the three-dimensional model 10.
[0050] Using the generated three-dimensional model and the identified boundary conditions, a computational analysis may be performed (step 400) to determine blood flow information for the patient. For example, the computational analysis may be performed using computer 40 as described above in connection with FIG. 1 using equation 30 to generate images, such as simulated blood pressure model 50, simulated blood flow model 52, and / or cFFR model 54, as described above in connection with FIG. 1.
[0051] The method also includes using the results to provide patient-specific treatment options (step 500). For example, the three-dimensional model 10 created in step 200 and / or the boundary conditions specified in step 300 may be adjusted to model one or more treatments, such as the placement of a coronary stent in one of the coronary arteries represented in the three-dimensional model 10, or other treatment options. A computer analysis may then be performed as described in step 400 above to generate new images, such as updated blood pressure model 50, blood flow model 52, and / or cFFR model 54. These new images may be used to reveal blood flow velocities and blood pressures if the treatment option(s) are adopted.
[0052] The systems and methods disclosed herein can be incorporated into a software tool accessed by a physician to provide a non-invasive means for quantifying blood flow in the coronary arteries and assessing the functional significance of coronary artery disease. In addition, physicians can use the software tool to predict the effect of drug, interventional, and / or surgical treatments on coronary blood flow. The software tool can also prevent, diagnose, manage, and / or treat diseases in other parts of the cardiovascular system, including arteries in the neck (e.g., carotid arteries), head (e.g., cerebral arteries), chest, abdominal (e.g., abdominal aorta and its branches), arm, or leg (e.g., femoral and popliteal arteries). The software tool can be interactive to allow physicians to create optimal personalized therapy for patients.
[0053] For example, the software tool may be at least partially incorporated into a computer system, such as computer 40 shown in FIG. 1, used by a physician or other user. The computer system may receive data acquired non-invasively from a patient (e.g., data used to create the three-dimensional model 10, data used to apply boundary conditions, or perform computer analysis, etc.). For example, the data may be entered by a physician or may be received from another source that may access and provide such data, such as a radiology or medical laboratory. 7 The data may be transmitted to the computer system via a network or other system for communicating data, or directly. The software tool may use this data to generate and display the three-dimensional model 10 or other models / meshes, and / or any simulation or other results determined by solving equation 30 described above in connection with FIG. 1, such as simulated blood pressure model 50, simulated blood flow model 52, and / or cFFR model 54. In this manner, the software tool may perform steps 100-500. In step 500, the physician may provide further input to the computer system to select possible treatment options, and the computer system may display a new simulation to the physician based on the selected possible treatment options. Additionally, each of steps 100-500 shown in FIG. 2 may be implemented using separate software packages or modules.
[0054] Alternatively, the software tool may be provided as part of a web-based service or other service, e.g., a service provided by an entity separate from the physician. The service provider may, for example, operate a web-based service and may provide a web portal or web-based application (e.g., running on a server or other computer system operated by the service provider) that is accessible to the physician or other user via a network or other method of communicating data between computer systems. For example, non-invasively acquired data from the patient may be provided to the service provider, which may use the data to generate the three-dimensional model 10 or other model / mesh, and / or any simulation or other results revealed by solving equation 30 described above in connection with FIG. 1, e.g., simulated blood pressure model 50, simulated blood flow model 52, and / or cFFR model 54. The web-based service may then transmit the three-dimensional model 10 or other model / mesh, and / or information related to the simulation, so that the three-dimensional model 10 and / or the simulation may be displayed to the physician or on the physician's computer system. In this manner, the web-based service may perform steps 100-500 and any other steps described below for providing patient-specific information. In step 500, the physician may provide further input, for example to select possible treatment options or make other adjustments to the computer analysis, which may be transmitted to a computer system operated by the service provider (e.g., via a web portal). The web-based service may generate a new simulation or other results based on the selected possible treatment options, and may again communicate information related to the new simulation to the physician, whereby the new simulation may be displayed to the physician.
[0055] It should be understood that one or more of the steps described herein may be performed by one or more human operators (e.g., a cardiologist or other physician, a patient, an employee of a service provider offering a web-based or other service offered by a third party, other users, etc.), or by one or more computer systems used by such human operator(s), such as desktop or portable computers, workstations, servers, personal digital assistants, etc. The computer system(s) may be connected via a network or other method of communicating data.
[0056] 3 illustrates a further embodiment of an exemplary method for providing various information related to blood flow in a particular patient. The embodiment illustrated in FIG. 3 may be at least partially implemented in a computer system and / or may be implemented in a software tool as part of a web-based service. II. Acquisition and pre-processing of patient-specific anatomical data
[0057] As discussed above in connection with step 100 shown in Figure 2, an exemplary method may include obtaining patient-specific anatomical data, e.g., information about the patient's heart, and pre-processing the data. In an exemplary embodiment, step 100 may include the following steps:
[0058] First, a patient may be selected, for example, by a physician who has determined that information regarding the patient's coronary blood flow is desired if the patient is experiencing symptoms associated with coronary artery disease, such as chest pain or a heart attack.
[0059] Patient-specific anatomical data, e.g., data relating to the geometry of the patient's heart, e.g., at least a portion of the patient's aorta, the proximal portion of the main coronary artery (and branches extending therefrom) connected to the aorta, and the myocardium, may be acquired. The patient-specific anatomical data may be acquired non-invasively, e.g., using a non-invasive imaging method. For example, CCTA is an imaging method in which a user operates a computed tomography (CT) scanner to observe or create images of structures, e.g., the myocardium, the aorta, the main coronary arteries, and other blood vessels connected thereto. CCTA data may be time-varying, e.g., showing changes in blood vessel shape over the cardiac cycle. CCTA may be used to generate images of the patient's heart. For example, 64 slices of CCTA data, e.g., data relating to 64 slices of the patient's heart, may be acquired and a three-dimensional image may be constructed. FIG. 4 illustrates an example of a three-dimensional image 120 generated by 64 slices of CCTA data.
[0060] Alternatively, other non-invasive imaging methods, such as magnetic resonance imaging (MRI) or ultrasound (US), or invasive imaging methods, such as digital subtraction angiography (DSA), may be used to generate images of the structures of the patient's anatomy. The imaging method may include intravenous administration of a contrast agent to the patient to allow identification of the structures of the anatomy. The resulting image data (e.g., provided by CCTA or MRI) may be provided by a third party vendor, such as a radiology lab or cardiologist, or the patient's physician.
[0061] Other patient-specific anatomical data may also be non-invasively determined from the patient. For example, physiological data such as the patient's blood pressure, baseline heart rate, height, weight, hematocrit, stroke volume, etc. may be measured. Blood pressure may be the blood pressure of the patient's brachial artery (e.g., using a blood pressure cuff), including the systolic and diastolic blood pressures.
[0062] The patient-specific anatomical data obtained as described above is transmitted over a secure communication line (e.g., over a network). For example, the data may be transmitted to a server or other computer system for performing a computer analysis, such as the computer analysis described in step 400 above. In an exemplary embodiment, the data may be transmitted to a server or other computer system operated by a service provider that offers a web-based service. Alternatively, the data may be transmitted to a computer system operated by the patient's physician or other user.
[0063] 3, the transmitted data may be reviewed to determine whether the data is acceptable (step 102). This determination may be performed by a user and / or a computer system. For example, the transmitted data (e.g., CCTA data and other data) may be verified by a user and / or a computer system to determine, for example, whether the CCTA data is complete (e.g., includes sufficient portions of the aorta and main coronary arteries) and whether it corresponds to the correct patient.
[0064] The transmitted data (e.g., CCTA data and other data) may also be pre-processed and evaluated. Pre-processing and / or evaluation may be performed by a user and / or a computer system and may include, for example, checking for misalignment, mismatch, or blurring of the CCTA data, checking for stents shown in the CCTA data, checking for other artifacts that may obstruct visibility of the vessel lumen, checking for sufficient contrast between structures (e.g., the aorta, main coronary arteries, and other vessels) and other parts of the patient, etc.
[0065] The transmitted data may be evaluated to determine whether it is acceptable based on the above-mentioned verification, pre-processing, and / or evaluation. In the above-mentioned verification, pre-processing, and / or evaluation, the user and / or computer system may be able to correct some errors or problems in the data. However, if there are too many errors or problems, the data may be determined to be unacceptable and the user and / or computer system may generate a rejection report explaining that the errors or problems necessitate the rejection of the transmitted data. In some cases, a new CCTA scan may be performed and / or the above-mentioned physiological data may be measured again from the patient. If the transmitted data is determined to be acceptable, the method may proceed to step 202, described below.
[0066] Therefore, step 102 shown in FIG. 3 and described above can be considered as a sub-step of step 100 in FIG. III. Creation of a 3D model based on acquired anatomical data
[0067] An exemplary method may include creating a three-dimensional model based on the acquired anatomical data, as described above in connection with step 200 shown in Figure 2. In an exemplary embodiment, step 200 may include the following steps:
[0068] A three-dimensional model of the coronary vessels can be generated using CCTA data. FIG. 5 shows an example of a surface of a three-dimensional model 220 generated using CCTA data. For example, the model 220 may include, for example, at least a portion of the aorta, at least one proximal one or more main coronary arteries connecting to the portion of the aorta, at least one proximal one or more branches connecting to the main coronary arteries, etc. The modeled portions of the aorta, main coronary arteries, and / or branches may be interconnected trees, with no portion being separate from the remainder of the model 220. The process of forming the model 220 is referred to as segmentation.
[0069] 3, the computer system may automatically segment at least a portion of the aorta (step 202) and the myocardium (or other cardiac tissue or other tissue that connects to the artery being modeled) (step 204). The computer system may also segment at least some of the major coronary arteries that connect to the aorta. In an exemplary embodiment, the computer system may allow a user to select the root or start of one or more coronary arteries (step 206) to segment the major coronary arteries.
[0070] The segmentation can be performed using a variety of methods. The segmentation may be performed automatically by the computer system based on user input or without user input. For example, in an exemplary embodiment, a user may provide input to the computer system to generate a first initial model. For example, the computer system may display to the user a three-dimensional image 120 (FIG. 4) or a slice thereof generated from the CCTA data. The three-dimensional image 120 may include portions having different brightness intensities. For example, lighter portions may indicate the lumen of the aorta, main coronary arteries, and / or branches. Darker portions may indicate the myocardium and other tissues of the patient's heart.
[0071] FIG. 6 illustrates a portion of a slice 222 of a three-dimensional image 120 that may be displayed to a user, the slice 222 may include a portion 224 having a relative brightness. The computer system may allow the user to select the portion 224 having a relative brightness by selecting one or more seeds 226, which may serve as the root or starting point of the coronary artery for segmentation of the main coronary artery. At the user's command, the computer system may then use the seeds 226 as starting points for forming a first initial model. The user may add the seeds 226 to the aorta and / or one or more of the individual main coronary arteries. In some cases, the user may add the seeds 226 to one or more of the branches that connect to the main coronary arteries. Alternatively, the computer system may automatically place the seeds, for example using extracted centerline information. The computer system may determine the intensity value of the image 120 where the seed 226 is located, and may form a first initial model by extending the seed 226 along portions of the image 120 that have the same intensity value (or within a range or threshold of intensity values centered around a selected intensity value). This segmentation method may therefore be referred to as "threshold-based segmentation."
[0072] 7 shows a portion 230 of a first initial model formed by expanding the seed 226 of FIG. 6. Thus, the user inputs the seed 226 as a starting point for the computer system to begin forming the first initial model. This process may be repeated until all portions of interest, e.g., portions of the aorta and / or main coronary arteries, have been segmented. Alternatively, the first initial model may be generated by the computer system without user input.
[0073] Alternatively, segmentation may be performed using a method known as “edge-based segmentation.” In an exemplary embodiment, both threshold-based and edge-based segmentation methods may be performed to form model 220, as described below.
[0074] The second initial model may be formed using an edge-based segmentation method. In this method, the lumen edges of the aorta and / or the main coronary arteries may be located. For example, in an exemplary embodiment, a user may provide input, such as a seed 226 as described above, to a computer system to generate the second initial model. The computer system may extend the seed 226 along portions of the image 120 until an edge is reached. The lumen edges may be located, for example, visually by the user and / or by the computer system (e.g., where there is a change in brightness value above a set threshold). The edge-based segmentation method may be implemented by the computer system and / or by the user.
[0075] Also, in step 204, myocardium or other tissue may be segmented based on the CCTA data. For example, the CCTA data may be analyzed to determine the location of the inner and outer surfaces of the myocardium, e.g., the left and / or right ventricle. The locations of these surfaces may be identified based on the contrast (e.g., relative darkness and brightness) of the myocardium in the CCTA data compared to other cardiac structures. In this manner, the geometry of the myocardium may be identified.
[0076] The segmentation of the aorta, myocardium, and / or main coronary arteries may be reviewed and / or revised, if necessary (step 208). This review and / or revision may be performed by a computer system and / or a user. For example, in an exemplary embodiment, the computer system automatically reviews the segmentation and, if there is an error, for example, if any portion of the aorta, myocardium, and / or main coronary arteries of model 220 is missing or inaccurate, the user may manually revise the segmentation.
[0077] For example, the first and second initial models described above may be compared to ensure that the segmentation of the aorta and / or major coronary arteries is accurate. Any discrepancies between the first and second initial models may be compared to modify the segmentation to form model 220. For example, model 220 may be an average of the first and second initial models. Alternatively, only one of the segmentation methods described above may be performed and the initial model formed by that method may be used as model 220.
[0078] The myocardial mass can be calculated (step 240). This calculation may be performed by a computer system. For example, the myocardial volume can be calculated based on the location of the myocardial surface identified as described above, and the calculated myocardial volume can be multiplied by the myocardial density to calculate the myocardial mass. The myocardial density may be preset.
[0079] The centerlines of the various vessels (e.g., the aorta, the main coronary arteries, etc.) of the model 220 (FIG. 5) may be identified (step 242). In an exemplary embodiment, this identification may be performed automatically by a computer system.
[0080] The centerlines identified in step 242 may be reviewed and / or revised, if necessary (step 244). This review and / or revision may be performed by a computer system and / or a user. For example, in an exemplary embodiment, the computer system automatically reviews the centerlines and, if there are errors, e.g., if any centerlines are missing or inaccurate, the user may manually correct the centerlines.
[0081] Calcium or plaque (which causes narrowing of the blood vessel) may be detected (step 246). In an exemplary embodiment, the computer system may automatically detect plaque, e.g., detect plaque in the three-dimensional image 120 and remove it from the model 220. Plaque may be identified in the three-dimensional image 120 because it appears brighter than the lumen of the aorta, main coronary artery, and / or branches. Thus, plaque may be detected by the computer system as having a brightness value below a set value, or may be visually detected by a user. After detecting plaque, the computer system may remove the plaque from the model 220 so that it is not considered part of the lumen or space within the blood vessel. Alternatively, the computer system may indicate plaque on the model 220 using a different color, shading, or other visual indicator than the aorta, main coronary artery, and / or branches.
[0082] The computer system may also automatically segment the detected plaque (step 248). For example, the plaque may be segmented based on CCTA data. The CCTA data may be analyzed to localize the plaque (or its surface) based on the contrast (e.g., relative darkness and brightness) of the plaque in the CCTA data compared to other cardiac structures. In this manner, the geometry of the plaque may be revealed.
[0083] The plaque segmentation may be reviewed and / or revised, if necessary (step 250). This review and / or revision may be performed by a computer system and / or a user. For example, in an exemplary embodiment, the computer system automatically reviews the segmentation and, if there are errors, e.g., if any plaque is missing or incorrectly represented, the user may manually correct the segmentation.
[0084] The computer system may automatically segment the branches that connect with the main coronary artery (step 252). For example, the branches may be segmented using a method similar to the method for segmenting the main coronary artery, e.g., as shown in Figures 6 and 7 and described above in connection with step 206. The computer system may also automatically segment plaque in the segmented branches using a method similar to the method described above in connection with steps 248 and 250. Alternatively, the branches (and any plaque contained therein) may be segmented simultaneously with the main coronary artery (e.g., in step 206).
[0085] The segmentation of the branches may be reviewed and / or revised, if necessary (step 254). This review and / or revision may be performed by a computer system and / or a user. For example, in an exemplary embodiment, the computer system automatically reviews the segmentation and, if there are errors, for example if any parts of the branches of model 220 are missing or inaccurate, the user may manually revise the segmentation.
[0086] The model 220 may be modified (step 256) if a misalignment, stent, or other artifact is located (e.g., upon review of the CCTA data in step 102). This modification may be performed by a user and / or a computer system. For example, if a misalignment or other artifact (e.g., mismatch, artifact affecting lumen visibility, etc.) is located, the model 220 may be reviewed and / or modified to avoid artifactual or spurious changes in the cross-sectional area of the vessel. If a stent is located, the model 220 may be reviewed and / or modified to indicate the location of the stent and / or modify the cross-sectional area of the vessel in which the stent is located, for example, based on the size of the stent.
[0087] The segmentation of model 220 may also be independently reviewed (step 258). This review may be performed by a user and / or a computer system. For example, the user and / or computer system may be able to identify certain errors in model 220, such as errors that are correctable and / or errors that may require at least partial reconfiguration or resegmentation of model 220. If such errors are identified, the segmentation may be determined to be unacceptable and certain steps, such as one or more of steps 202-208, 240-256, may be repeated depending on the error(s).
[0088] If the segmentation of model 220 is independently verified as acceptable, then model 220 may optionally be output and smoothed (step 260). This smoothing may be performed by a user and / or a computer system. For example, ridges, peaks, or other discontinuities may be smoothed. Model 220 may be output to a separate software module for computer analysis, etc.
[0089] 2. Therefore, the above-mentioned steps 202-208 and 240-260 shown in FIG. 3 can be considered as sub-steps of step 200 in FIG. IV. Creating a model for analysis and identifying boundary conditions
[0090] An exemplary method may include creating a model for analysis and identifying boundary conditions, as described above in connection with step 300 shown in Figure 2. In an exemplary embodiment, step 300 may include the following steps: A. Creating a model for analysis
[0091] 3, the cross-sectional areas of the various blood vessels (e.g., the aorta, the main coronary arteries, and / or the branches) of the model 220 (FIG. 5) may also be determined (step 304). In an exemplary embodiment, this determination may be performed by a computer system.
[0092] The model 220 (FIG. 5) may be trimmed (step 306) to generate a solid model. FIG. 8 shows an example of a trimmed solid model 320 created based on a model similar to the model 220 shown in FIG. 5. The solid model 320 is a three-dimensional, patient-specific geometric model. In an exemplary embodiment, the trimming may be performed by a computer system, possibly with user input. Each inflow boundary 322 and outflow boundary 324 may be trimmed such that the faces forming the respective boundaries are perpendicular to the centerline identified in step 242. The inflow boundary 322 may include a boundary through which flow is directed into the anatomy of the model 320, such as the upstream end of the aorta as shown in FIG. 8. The outflow boundary 324 may include a boundary through which flow is directed out of the anatomy of the model 320, such as the downstream end of the aorta and the downstream ends of the main coronary arteries and / or branches. B. Identifying Boundary Conditions
[0093] Boundary conditions can be provided to represent what is happening at the boundaries of a model, e.g., the three-dimensional solid model 320 of FIG. 8. For example, the boundary conditions may relate to at least one blood flow characteristic associated with the patient's modeled anatomy, e.g., at the boundaries of the modeled anatomy, where the blood flow characteristic(s) may include blood flow velocity, pressure, flow rate, FFR, etc. By properly specifying the boundary conditions, computational analysis can be performed to reveal information at various locations within the model. Examples of boundary conditions and methods for specifying such boundary conditions are described herein.
[0094] In an exemplary embodiment, the determined boundary conditions may simplify structures upstream and downstream of the portion of the blood vessel represented by solid model 320 into a one- or two-dimensional reduced order model. An exemplary set of equations and other details for identifying the boundary conditions are described, for example, in U.S. Patent Application Publication No. 2010 / 0241404 and U.S. Provisional Application No. 61 / 210,401, both of which are entitled "Patient-Specific Hemodynamics of the Cardiovascular System," and are incorporated herein by reference in their entireties.
[0095] The boundary conditions may vary depending on the patient's physiological state, since blood flow through the heart may vary depending on the patient's physiological state. For example, FFR is typically measured under physiological hyperemic conditions, which typically occur when a patient is experiencing increased cardiac blood flow, such as due to stress. FFR is the ratio of coronary pressure to aortic pressure under maximum stress. Hyperemia may be induced pharmacologically, for example with adenosine. Figures 9-11 show examples of calculated FFR (cFFR) models that show the change in the ratio of coronary pressure to aortic pressure in model 320 depending on the patient's physiological state (at rest, under maximum hyperemia, or under maximum exercise). Figure 9 shows a morphology with a minimum ratio of coronary pressure to aortic pressure throughout model 320 when the patient is at rest. Figure 10 shows a morphology with a larger ratio of coronary pressure to aortic pressure throughout model 320 when the patient is at maximum hyperemia. Figure 11 shows a morphology with an even larger ratio of coronary pressure to aortic pressure throughout model 320 when the patient is at maximum exercise.
[0096] Referring again to FIG. 3, boundary conditions for a hyperemic condition may be identified (step 310). In an exemplary embodiment, the effect of adenosine may be modeled using a 1-5 fold decrease in coronary resistance, an approximately 0-20% decrease in aortic blood pressure, and an approximately 0-20% increase in heart rate. For example, the effect of adenosine may be modeled using a 4 fold decrease in coronary resistance, an approximately 10% decrease in aortic blood pressure, and an approximately 10% increase in heart rate. Although an exemplary embodiment identifies boundary conditions for a hyperemic condition, it is understood that boundary conditions may be identified for other physiological states, such as rest, different degrees of hyperemia, different degrees of exercise, exertion, stress, or other conditions.
[0097] The boundary conditions provide information about the three-dimensional solid model 320 at its boundaries, such as the inflow boundary 322, outflow boundary 324, vessel wall boundary 326, etc. shown in Figure 8. The vessel wall boundary 326 may include the physical boundaries of the aorta, main coronary arteries, and / or other coronary arteries or vessels of the model 320.
[0098] Each inflow or outflow boundary 322, 324 may be assigned a predefined value or field of values for velocity, flow, pressure, or other blood flow characteristics. Alternatively, each inflow or outflow boundary 322, 324 may be assigned by coupling to the boundary a cardiac model, a lumped parameter model or a distributed (e.g., one-dimensional wave propagation) model, another type of one-dimensional or two-dimensional model, or other type of model. Specific boundary conditions may be determined based on, for example, the geometry of the inflow or outflow boundary 322, 324 determined from acquired patient-specific information or other measured parameters, such as cardiac output, blood pressure, myocardial mass calculated in step 240, etc. i. Identifying Reduced-Order Models
[0099] Upstream and downstream structures that interface with solid model 320 may be represented as reduced order models that represent the upstream and downstream structures. For example, Figures 12-15 illustrate aspects of a method for creating a lumped parameter model from three-dimensional patient-specific anatomical data at one of the outflow boundaries 324, according to an exemplary embodiment. This method can be performed separately from and prior to the method illustrated in Figures 2 and 3.
[0100] FIG. 12 shows a portion 330 of a solid model 320 of a main coronary artery or one of the branches extending therefrom, and FIG. 13 shows a portion of the centerline determined in step 242 of the portion 330 shown in FIG.
[0101] The portion 330 can be divided into segments 332. FIG. 14 shows an example of segments 332 that can be formed from the portion 330. Selection of the length of the segment 332 can be performed by a user and / or a computer system. The segment 332 can vary in length, for example, depending on the geometric shape of the segment 332. Various techniques can be used to segment the portion 330. For example, one or more separate segments 332 can be provided for diseased portions, e.g., portions with relatively narrow cross sections, lesions, and / or stenoses (abnormal narrowing of a blood vessel). The diseased portions and stenoses can be identified, for example, by measuring the cross-sectional area along the entire length of the centerline and locally calculating the smallest cross-sectional area.
[0102] The segments 332 may be approximated by a circuit diagram that includes one or more (linear or nonlinear) resistors 334 and / or other circuit elements (e.g., capacitors, inductors, etc.). Figure 15 shows an example of a segment 332 replaced with a series of linear and nonlinear resistors 334. The individual resistances of the resistors 334 may be determined based on, for example, the estimated flow and / or pressure across the corresponding segment 332.
[0103] This resistance may be a constant resistance, a linear resistance, or a nonlinear resistance, for example, depending on the estimated flow rate through the corresponding segment 332. For more complex geometries, such as stenoses, the resistance may vary with flow rate. The resistance of various geometries may be accounted for based on computer analysis (e.g., finite difference, finite volume, spectral, lattice Boltzmann, particle-based, level set, isogeometric, or finite element methods, or other computational fluid dynamics (CFD) analysis techniques), and multiple solutions from the computer analysis performed under various flow and pressure conditions may be used to derive patient-, vessel-, and / or lesion-specific resistances. The results may be used to account for the resistance of various features and geometries of any segment that may be modeled. As a result, deriving patient-, vessel-, and / or lesion-specific resistances as described above may enable the computer system to recognize and evaluate more complex geometries, such as asymmetric stenoses, multiple lesions, bifurcated and branched lesions, and tortuous vessels.
[0104] Capacitors may also be included, the capacitance of which may be measured, for example, in response to the elasticity of the vessel wall of the corresponding segment, and inductors may also be included, the inductance of which may be measured, for example, in response to inertial effects associated with the acceleration or deceleration of the blood volume flowing through the corresponding segment.
[0105] Individual values for resistance, capacitance, inductance, and other variables associated with other electrical elements used in the lumped parameter model can be derived based on data from a large number of patients, where similar vessel geometries may have approximately the same values. Thus, empirical models can be developed from patient-specific data from a large population to create a library of values corresponding to specific geometric features that can be applied to similar patients for future analysis. Geometry can be matched between two different vessel segments to automatically select values for a patient's segment 332 from a previous simulation. ii. Example Lumped Parameter Model
[0106] Alternatively, lumped parameter models may be predefined instead of performing the steps described above in relation to Figures 12-15. For example, Figure 16 shows example lumped parameter models 340, 350, 360 representing structures upstream and downstream of inflow and outflow boundaries 322, 324 of a solid model 320. End A is located at the inflow boundary 322, and ends a-m and B are located at the outflow boundary.
[0107] A lumped parameter heart model 340 can be used to account for the boundary conditions at end A of the inflow boundary 322 of the solid model 320 . A lumped parameter cardiac model 340 can be used to represent blood flow from the heart under hyperemic conditions. The lumped parameter cardiac model 340 uses various parameters (e.g., P LA , R AV , L AV , R V-Art , L V-Art , and E(t)), which may be determined based on known information about the patient, such as the aortic pressure, the patient's systolic and diastolic blood pressure (e.g., measured in step 100), the patient's cardiac output (e.g., the volume of blood leaving the heart, calculated based on the patient's stroke volume and heart rate, measured in step 100), and / or experimentally determined constants.
[0108] The lumped parameter coronary model 350 can be used to account for boundary conditions at ends a-m of the outflow boundary 324 of the solid model 320, which are located at the downstream end of the main coronary artery and / or branches extending therefrom. The lumped parameter coronary model 350 can be used to represent blood flow exiting the modeled vessel through ends a-m under hyperemic conditions. The lumped parameter coronary model 350 can be calculated by using various parameters (e.g., R a , C a , R a-micro , C im , and R V), which can be determined based on known information about the patient, such as the calculated myocardial mass (e.g., measured in step 240) and the termination impedance at ends a-m (e.g., the cross-sectional area of the blood vessel at ends a-m measured in step 304).
[0109] For example, the calculated myocardial mass can be used to estimate baseline (resting) average coronary blood flow through multiple outflow boundaries 324. This relationship is given by Q∝Q0M α The equation may be based on an empirically derived physiological law (e.g., physiological law 20 of FIG. 1 ) that correlates the mean coronary blood flow Q to the myocardial mass M (e.g., measured in step 240) as: where α is a predefined scaling exponent and Q0 is a predefined constant. The total coronary blood flow Q at the outflow boundary 324 under baseline (resting) conditions, and the patient's blood pressure (e.g., measured in step 100), can then be used to identify the total resistance R at the outflow boundary 324 based on the predefined empirically derived equation.
[0110] The total resistance R may be distributed among the ends a-m based on their respective cross-sectional areas (e.g., measured in step 304). i ∝R i,0 di β (R i is the flow resistance at the i-th outlet, and R i,0 is a default constant, and d i where R is the diameter of the outlet and β is a predefined power exponent, e.g., −3 to −2, −2.7 for coronary blood flow, −2.9 for cerebral blood flow, etc. The coronary blood flow through each end a-m and the mean pressure at each end a-m (e.g., determined based on the individual cross-sectional areas of the vessel ends a-m measured in step 304) can be used to determine the sum of the resistances of the lumped parameter coronary artery model 350 at the corresponding ends a-m (e.g., R a +R a-micro +R V). Other parameters (e.g., R a / R a-micro , C a , C im ) may be an experimentally determined constant.
[0111] A Windkessel model 360 can be used to account for the boundary conditions at end B of the outflow boundary 324 of the solid model 320, located at the downstream end of the aorta towards the aortic arch. The Windkessel model 360 can be used to represent blood flow out of the modeled aorta through end B under hyperemic conditions. The Windkessel model 360 can be used to account for the boundary conditions at end B of the outflow boundary 324 of the solid model 320, located at the downstream end of the aorta towards the aortic arch. p , R d , and C), which may be determined based on known information about the patient, such as the patient's cardiac output as described above in connection with the lumped parameter cardiac model 340, the baseline mean coronary blood flow as described above in connection with the lumped parameter coronary artery model 350, the aortic pressure (e.g., determined based on the cross-sectional area of the aorta at end B measured in step 304), and / or experimentally determined constants.
[0112] The boundary conditions, e.g., lumped parameter models 340, 350, 360 (or any constants contained therein), or other reduced order models, may be adjusted based on other factors. For example, resistance values may be adjusted (e.g., increased) if a patient has a low blood flow to vessel size ratio due to a relatively reduced ability to dilate blood vessels under physiological stress. Resistance values may also be adjusted if a patient has diabetes, is taking medication, has previously experienced a cardiac event, etc.
[0113] Alternative lumped parameter or distributed one-dimensional network models may be used to represent the coronary vessels downstream of the solid model 320. Imaging of myocardial perfusion using MRI, CT, PET, or SPECT may be used to assign parameters to such models. Alternative imaging sources, such as magnetic resonance angiography (MRA), retrospective cinegating or prospective cinegating computed tomography angiography (CTA), etc., may also be used to assign parameters to such models. Retrospective cinegating may be used in conjunction with image processing methods to obtain ventricular volumetric changes over the cardiac cycle to assign parameters to the lumped parameter cardiac model.
[0114] Simplifying parts of the patient's anatomy using lumped parameter models 340, 350, 360, or other reduced order one- or two-dimensional models, allows the computational analysis (e.g., step 402 of FIG. 3 described below) to be performed more quickly while maintaining high accuracy of the final results, especially when the computational analysis is performed multiple times, such as when evaluating possible treatment options (e.g., step 500 of FIG. 2) in addition to the untreated state (e.g., step 400 of FIGS. 2 and 3).
[0115] In an exemplary embodiment, the identification of the boundary conditions may be performed by a computer system based on user input, for example, patient-specific physiological data acquired in step 100 . C. Creating 3D Meshes
[0116] Referring again to FIG. 3, a three-dimensional mesh can be generated based on the solid model 320 generated in step 306 (step 312). FIGS. 17-19 show an example of a three-dimensional mesh 380 created based on the solid model 320 generated in step 306. The mesh 380 includes a plurality of nodes 382 (grid points or mesh points) along the surface of the solid model 320 and throughout the interior of the solid model 320. The mesh 380 may be created using tetrahedral elements (having points that form the nodes 382) as shown in FIGS. 18 and 19. Alternatively, elements having other shapes may be used, such as hexahedral elements or other polyhedral elements, curved elements, etc. In an exemplary embodiment, the number of nodes 382 may be in the millions, for example 5 million to 50 million. The number of nodes 382 increases as the mesh 380 becomes finer. A larger number of nodes 382 can provide information at more points in the model 320, but the increased number of nodes 382 can result in a more time consuming computer analysis to perform due to the increased number of equations to solve (e.g., equation 30 in FIG. 1 ). In an exemplary embodiment, generation of mesh 380 can be performed by a computer system, possibly with user input (e.g., specifying the number of nodes 382, element shapes, etc.).
[0117] Referring again to FIG. 3, the mesh 380 and the identified boundary conditions may be verified (step 314). This verification may be performed by a user and / or a computer system. For example, the user and / or computer system may identify certain errors in the mesh 380 and / or boundary conditions that may require reconfiguration of the mesh 380 and / or boundary conditions, e.g., if the mesh 380 is deformed or does not have sufficient spatial resolution, if the boundary conditions are not sufficient to perform the computer analysis, if the resistances identified in step 310 appear to be inaccurate, etc. In that case, the mesh 380 and / or boundary conditions may be determined to be unacceptable and one or more of steps 304-314 may be repeated. If the mesh 380 and / or boundary conditions are determined to be acceptable, the method may proceed to step 402, described below.
[0118] Additionally, the user may verify that the acquired patient-specific information or other measured parameters, such as cardiac output, blood pressure, height, weight, and myocardial mass calculated in step 240, have been entered correctly and / or calculated correctly.
[0119] 2. Therefore, the above-mentioned steps 304-314 shown in FIG. 3 can be considered as sub-steps of step 300 in FIG. V. Conducting computer analysis and outputting the results
[0120] As described above in connection with step 400 shown in FIG. 2, the exemplary method may include performing a computer analysis and outputting the results. In an exemplary embodiment, step 400 may include the following steps: A. Conducting computer analysis
[0121] 3, a computational analysis can be performed by a computer system (step 402). In an exemplary embodiment, step 402 can take from a few minutes to a few hours, depending on, for example, the number of nodes 382 in mesh 380 (FIGS. 17-19).
[0122] The analysis involves generating a set of equations that describe blood flow in model 320 from which mesh 380 has been generated. As mentioned above, in an exemplary embodiment, the desired information relates to a simulation of blood flow through model 320 under hyperemic conditions.
[0123] The analysis also includes solving three-dimensional equations of blood flow using a computer system with a numerical method, which may be any known method, such as finite difference, finite volume, spectral, lattice Boltzmann, particle-based, level set, isogeometric, or finite element methods, or other computational fluid dynamics (CFD) numerical techniques.
[0124] Using these numerical methods, blood can be modeled as a Newtonian, non-Newtonian, or multiphase fluid. The patient's hematocrit or other factors measured in step 100 may be used to identify blood viscosity for incorporation into the analysis. The vessel walls can be assumed to be rigid or flexible. In the latter case, equations of vessel wall mechanics, e.g., elastodynamic equations, may be solved together with the blood flow equations. The time-varying three-dimensional image data acquired in step 100 may be used as input to model changes in vessel shape over the cardiac cycle. An exemplary set of equations and steps for performing a computational analysis can be found, for example, in "Method for Predictive Modeling for Cardiac Organ Modeling," in J.D.M. No. 6,236,878, entitled "Planning Medical Interventions and Simulating Physiological Conditions," as well as U.S. Patent Application Publication No. 2010 / 0241404 and U.S. Provisional Application No. 61 / 210,401, both entitled "Patient-Specific Hemodynamics of the Cardiovascular System," all of which are incorporated herein by reference in their entireties.
[0125] A computer analysis using the generated model and boundary conditions can measure blood flow and pressure at each node 382 of a mesh 380 representing the three-dimensional solid model 320. For example, the results of the computer analysis can include values of various parameters at each node 382, such as, but not limited to, blood flow velocity, pressure, flow rate, or calculated parameters such as cFFR, as described below, and the parameters can be incorporated into the three-dimensional solid model 320. As a result, the results of the computer analysis can provide a user with information that would normally be determined invasively.
[0126] 3, the results of the computer analysis may be verified (step 404). This verification may be performed by a user and / or a computer system. For example, the user and / or computer system may be able to identify certain errors in the results that may require reconfiguration or revision of the mesh 380 and / or boundary conditions, e.g., insufficient information due to an insufficient number of nodes 382, an excessive number of nodes 382 causing the analysis to take too long, etc.
[0127] If the results of the computer analysis are determined to be unacceptable at step 404, the user and / or computer system may determine, for example, whether and how to revise or refine the solid model 320 generated in step 306 and / or the mesh 380 generated in step 312, whether and how to revise or refine the boundary conditions identified in step 310, or make other revisions to any of the inputs for the computer analysis. One or more of the steps described above, e.g., steps 306-314, 402, and 404, may then be repeated based on the determined revisions or refinements. B. Displaying blood pressure, blood flow and cFFR results
[0128] 3, if the results of the computer analysis are determined to be acceptable in step 404, the computer system may output certain results of the computer analysis. For example, the computer system may display images generated based on the results of the computer analysis, such as the images described above in connection with FIG. 1, such as the simulated blood pressure model 50, the simulated blood flow model 52, and / or the cFFR model 54. As discussed above, these images may show the simulated blood pressure, blood flow, and cFFR under the simulated hyperemic conditions, for example, because the boundary conditions identified in step 310 were identified for the hyperemic conditions.
[0129] The simulated blood pressure model 50 (FIG. 1) illustrates the local blood pressure (e.g., in millimeters of mercury or mmHg) throughout the patient anatomy represented by the mesh 380 of FIGS. 17-19 under simulated hyperemic conditions. A computer analysis can measure the local blood pressure at each node 382 of the mesh 380, and the simulated blood pressure model 50 can assign a color, shading, or other visual indicator corresponding to each pressure, thereby allowing the simulated blood pressure model 50 to visually indicate the variation in pressure throughout the model 50 without having to assign individual values for each node 382. For example, the simulated blood pressure model 50 illustrated in FIG. 1 illustrates that for this particular patient, under simulated hyperemic conditions, the pressure would be generally uniform, with the aorta being higher (indicated by the darker shading), and that the pressure gradually and continuously decreases as blood flows downstream into the main coronary arteries and into the branches (indicated by the gradual and continuous lighter shading toward the downstream ends of the branches). The simulated blood pressure model 50 may be accompanied by a scale indicating specific numerical values of blood pressure, as shown in FIG.
[0130] In an exemplary embodiment, the simulated blood pressure model 50 may be provided in color and may use a color spectrum to indicate the variation of pressure throughout the model 50. The color spectrum may include, in order from highest to lowest pressure, red, orange, yellow, green, blue, indigo, and purple. For example, the upper limit (red) may indicate approximately 110 mmHg or higher (or 80 mmHg, 90 mmHg, 100 mmHg, etc.), the lower limit (purple) may indicate approximately 50 mmHg or lower (or 20 mmHg, 30 mmHg, 40 mmHg, etc.), with green indicating approximately 80 mmHg (or some other value approximately halfway between the upper and lower limits). Thus, in some patients, the simulated blood pressure model 50 may show most or all of the aorta as red or other color toward the upper end of the spectrum, and the color may gradually change through the spectrum (to purple) toward the distal ends of the coronary arteries and branches extending therefrom. The distal ends of the coronary arteries of a particular patient may have a variety of colors, for example, ranging from red to purple, depending on the local blood pressure measured at each distal end.
[0131] The simulated blood flow model 52 (FIG. 1) illustrates local blood velocities (e.g., in centimeters per second or cm / sec) throughout the patient anatomy represented by mesh 380 of FIGS. 17-19 under simulated hyperemic conditions. A computer analysis may measure local blood velocities at each node 382 of mesh 380, and the simulated blood flow model 52 may assign a color, shading, or other visual indicator corresponding to each velocity, thereby allowing the simulated blood flow model 52 to visually indicate the variability in velocity in the model 52 without having to assign individual values for each node 382. For example, the simulated blood flow model 52 illustrated in FIG. 1 illustrates that for this particular patient, under simulated hyperemic conditions, velocities are generally higher in certain portions of the main coronary artery and branches (indicated by the darker shading of portion 53 in FIG. 1). The simulated blood flow model 52 may be accompanied by a scale indicating specific numerical values of blood velocity, as illustrated in FIG. 1.
[0132] In an exemplary embodiment, the simulated blood flow model 52 may be provided in color, and a color spectrum may be used to indicate velocity variations throughout the model 52. The color spectrum may include, in order from highest to lowest velocity, red, orange, yellow, green, blue, indigo, and purple. For example, the upper limit (red) may indicate approximately 100 (or 150) cm / sec or greater, the lower limit (purple) may indicate approximately 0 cm / sec, with green indicating approximately 50 cm / sec (or some other value approximately halfway between the upper and lower limits). Thus, in some patients, the simulated blood flow model 52 may show most or all of the aorta as a mixture of colors toward the lower end of the spectrum (e.g., green to purple), and the colors may change gradually through the spectrum (e.g., toward the upper end of the spectrum (to red)) at certain locations where measured blood velocity increases.
[0133] The cFFR model 54 (FIG. 1) illustrates the regional cFFR throughout the patient anatomy represented by the mesh 380 of FIGS. 17-19 under simulated hyperemic conditions. As discussed above, the cFFR may be calculated as the ratio of the regional blood pressure revealed by the computer analysis at a particular node 382 (e.g., as shown in the simulated blood pressure model 50) divided by the aortic blood pressure, for example, at the inflow boundary 322 (FIG. 8). The computer analysis may reveal the cFFR for each node 382 of the mesh 380, and the cFFR model 54 may assign a color, shading, or other visual indicator corresponding to each cFFR, thereby allowing the cFFR model 54 to visually indicate the variation in cFFR throughout the model 54 without having to specify an individual value for each node 382. For example, the cFFR model 54 shown in Figure 1 indicates that for this particular patient, under simulated hyperemic conditions, the cFFR will be generally uniform and approximately 1.0 in the aorta, with a gradual and continuous decrease in cFFR as blood flows downstream into the main coronary arteries and into the branches. The cFFR model 54 may also show cFFR values at specific points throughout the cFFR model 54, as shown in Figure 1. The cFFR model 54 may also be accompanied by a scale showing the specific numerical value of the cFFR, as shown in Figure 1.
[0134] In an exemplary embodiment, the cFFR model 54 may be provided in color and a color spectrum may be used to indicate the variation in pressure across the model 54. The color spectrum may include red, orange, yellow, green, blue, indigo, and purple, ordered from lowest cFFR (indicative of functionally significant pathology) to highest cFFR. For example, the upper limit (purple) may indicate a cFFR of 1.0, the lower limit (red) may indicate approximately 0.7 (or 0.75 or 0.8) or less, with green indicating approximately 0.85 (or other value approximately halfway between the upper and lower limits). For example, the lower limit may be identified based on a lower limit (e.g., 0.7, 0.75, or 0.8) used to identify whether the cFFR measurement indicates a functionally significant pathology or other characteristic that may require intervention. Thus, in some patients, cFFR model 54 may show most or all of the aorta as purple or other color toward the upper end of the spectrum, and the color may gradually change through the spectrum (e.g., anywhere from red to purple) toward the distal ends of the coronary arteries and branches extending therefrom. The distal ends of the coronary arteries of a particular patient may have a variety of colors, e.g., anywhere from red to purple, depending on the local value of cFFR measured for each distal end.
[0135] After identifying that the cFFR has fallen below a lower limit used to reveal the presence of a functionally significant lesion or other feature that may require intervention, the artery or branch may be evaluated to identify the location of the functionally significant lesion(s). The computer system or user may identify the location of the functionally significant lesion(s) based on the geometry of the artery or branch (e.g., using the cFFR model 54). For example, the functionally significant lesion(s) may be located by finding a narrowing or stenosis located near (e.g., upstream) the location of the cFFR model 54 having the regional lowest cFFR value. The computer system may show or display to the user the portion(s) of the cFFR model 54 (or other model) that contains the functionally significant lesion(s).
[0136] Other images may also be generated based on the results of the computer analysis. For example, the computer system may provide additional information regarding the major coronary arteries, for example, as shown in Figures 20-22. A coronary artery may be selected by the computer system if, for example, that particular coronary artery has the lowest cFFR. Alternatively, a user may select a particular coronary artery.
[0137] Figure 20 shows a model of a patient's anatomy including the results of a computer analysis, with specific points on the model identified with individual reference labels (e.g., LM, LAD1, LAD2, LAD3, etc.) In the exemplary embodiment shown in Figure 21, a point on the LAD artery is provided, which is the main coronary artery with the lowest cFFR for this particular patient under simulated hyperemic conditions.
[0138] 21 and 22 show graphs of certain variables over time at some or all of these points (e.g., LM, LAD1, LAD2, AD3, etc.) and / or at certain other locations on the model (e.g., in the aorta, etc.). FIG. 21 is a graph of pressure (e.g., millimeters of mercury or mmHg) over time at the aorta and points LAD1, LAD2, and LAD3 shown in FIG. 20. The top plot on the graph shows the pressure in the aorta, the second plot from the top shows the pressure at point LAD1, the third plot from the top shows the pressure at point LAD2, and the bottom plot shows the pressure at point LAD3. FIG. 22 is a graph of flow rate (e.g., cubic centimeters per second or cc / sec) over time at points LM, LAD1, LAD2, and LAD3 shown in FIG. 20. Additionally, other graphs can be provided, such as graphs of shear stress over time at some or all of these points and / or other points. The top plot on the graph shows flow at point LM, the second plot from the top shows flow at point LAD1, the third plot from the top shows flow at point LAD2, and the bottom plot shows flow at point LAD3. Graphs can also be provided that show the change in these variables, e.g., blood pressure, flow, velocity, or cFFR, along the entire length of a particular main coronary artery and / or branches extending therefrom.
[0139] In some cases, the various graphs and other results described above may be compiled into a report (step 406). For example, the images or other information described above may be inserted into a document having a predefined template. The template may be generic for a number of pre-defined patients and may be used to report the results of the computer analysis to a physician and / or patient. The document or report may be completed automatically by the computer system after the computer analysis is completed.
[0140] For example, the final report may include the information shown in FIG. 23. FIG. 23 includes the cFFR model 54 of FIG. 1 and also includes summary information, such as the lowest cFFR value in each of the main coronary arteries and branches extending therefrom. For example, FIG. 23 shows that the lowest cFFR value in the LAD artery is 0.66, the lowest cFFR value in the LCX artery is 0.72, and the lowest cFFR value in the RCA artery is 0.80. Other summary information may include the patient's name, the patient's age, the patient's blood pressure (BP) (e.g., obtained in step 100), the patient's heart rate (HR) (e.g., obtained in step 100), and the like. The final report may also include versions of the images and other information generated as described above that the physician or other user can access to reveal further information. The images generated by the computer system may be formatted to allow the physician or other user to place a cursor at any point to identify the variables described above, such as blood pressure, velocity, flow, cFFR, and the like, at that point.
[0141] The final report may also be sent to the physician and / or patient. The final report may be sent using any known communication method, such as wireless or wired networks, mail, etc. Alternatively, the physician and / or patient may be notified that the final report is available for download or receipt. The physician and / or patient may then log into a web-based service to download the final report over a secure communication line. C. Verifying the results
[0142] 3, the results of the computer analysis may be independently verified (step 408). For example, a user and / or computer system may identify particular errors in the results of the computer analysis, e.g., images and other information generated in step 406, that may require re-performance of any of the above-mentioned steps. If such errors are identified, the results of the computer analysis may be determined to be unacceptable, and certain steps may be repeated, e.g., steps 100, 200, 300, 400, sub-steps 102, 202-208, 240-260, 304-314, and 402-408, etc.
[0143] 2. Therefore, the above steps 402-408 shown in FIG. 3 can be considered as sub-steps of step 400 in FIG.
[0144] Another method for validating the results of the computer analysis may include measuring any of the variables included in the results, such as blood pressure, velocity, flow, cFFR, etc., from the patient using another method. In an exemplary embodiment, the variables may be measured (e.g., invasively) and then compared to the results revealed by the computer analysis. For example, the FFR may be determined at one or more points within the patient's anatomy represented by solid model 320 and mesh 380, for example, using a pressure wire inserted into the patient as described above. The FFR measured at a location may be compared to the cFFR at the same location, and this comparison may be performed at multiple locations. In some cases, the computer analysis and / or boundary conditions may be adjusted based on the comparison. D. Another embodiment of a system and method for providing coronary blood flow information
[0145] Another embodiment of a method 600 for providing various information related to coronary blood flow in a particular patient is shown in Figure 24. Method 600 can be implemented in a computer system as described above, such as a computer system used to perform one or more of the steps shown in Figure 3 above. Method 600 may be implemented with one or more inputs 610 and may include generating one or more models 620 based on the inputs 610, specifying one or more conditions 630 based on the inputs 610 and / or the models 620, and deriving one or more solutions 640 based on the models 620 and the conditions 630.
[0146] The input 610 may include medical image data 611 of the patient's aorta, coronary arteries (and branches extending therefrom), and heart, such as CCTA data (e.g., acquired in step 100 of FIG. 2). The input 610 may also include measurements 612 of the patient's brachial blood pressure and / or other measurements (e.g., acquired in step 100 of FIG. 2). The measurements 612 may be obtained non-invasively. The input 610 may be used to generate model(s) 620 and / or to determine condition(s) 630, described below.
[0147] As described above, one or more models 620 may be generated based on the input 610. For example, the method 600 may include generating (step 621) one or more patient-specific three-dimensional geometric models of the patient's anatomy (e.g., the aorta, coronary arteries, and branches extending therefrom) based on the image data 611. For example, the geometric models may be the solid model 320 of FIG. 8 generated in step 306 of FIG. 3 and / or the mesh 380 of FIG. 17-19 generated in step 312 of FIG. 3.
[0148] Referring again to FIG. 24, the method 600 may also include generating one or more physics-based blood flow models (step 622). The blood flow models may include models related to blood flow through the patient-specific geometric model generated in step 621, the heart and aortic circulation, the distal coronary circulation, etc. The blood flow models may be related to at least one blood flow characteristic related to the modeled anatomy of the patient, such as blood flow velocity, pressure, flow rate, FFR, etc. The blood flow models may be specified as boundary conditions at the inflow and outflow boundaries 322, 324 of the three-dimensional geometric model. The blood flow models may include reduced order models or other boundary conditions as described above in connection with step 310 of FIG. 3, such as a lumped parameter heart model 340, a lumped parameter coronary artery model 350, a Windkessel model 360, etc.
[0149] As described above, one or more conditions 630 may be identified based on the inputs 610 and / or the model 620. The conditions 630 include calculated parameters for the boundary conditions identified in step 622 (and step 310 of FIG. 3). For example, the method 600 may include identifying the conditions (step 631) by calculating patient-specific ventricular or myocardial mass based on the image data 611 (e.g., as identified in step 240 of FIG. 3).
[0150] Using the ventricular or myocardial mass calculated in step 631, the method 600 calculates the relationship Q=Q0M α 3, step 632) by calculating the resting coronary blood flow based on α, where α is a predefined scaling exponent, M is the ventricular or myocardial mass, and Q is a predefined constant. Alternatively, the relationship may be expressed as Q∝QM, as described above in connection with developing the lumped parameter model in step 310 of FIG. 3, step 632. α The signal may have the form:
[0151] The method 600 may also include characterizing the condition by calculating the total coronary resistance at rest using the coronary blood flow calculated in step 632 and the patient's measured blood pressure 612 (e.g., as described above in connection with characterizing the lumped parameter model in step 310 of FIG. 3) (step 633).
[0152] Method 600 may also include characterizing the condition by calculating (step 634) the individual resistances of each coronary artery (and branches extending therefrom) using the total coronary resistance at rest calculated in step 633 and model 620. For example, as described above in connection with step 310 of FIG. 3, the total coronary resistance at rest calculated in step 633 may be calculated based on the size of the distal ends of each coronary artery and branch (e.g., as determined from the geometric model generated in step 621) and based on the relationship R=R0d β where R is the flow resistance at a particular distal end, R0 is a predefined constant, d is the size (e.g., the diameter at the distal end), and β is a predefined power exponent, may be distributed to individual coronary arteries and branches as described above in connection with developing the lumped parameter model in step 310 of FIG. 3.
[0153] Referring again to FIG. 24, method 600 may include adjusting boundary conditions (step 635) based on one or more patient physical conditions. For example, parameters identified in steps 631-634 may be modified based on whether solution 640 is intended to simulate rest, various levels of hyperemia, various levels of exercise or exertion, different drug treatments, etc. Based on inputs 610, model 620, and conditions 630, a computer analysis may be performed (step 641) to reveal a solution 640 that includes information regarding the patient's coronary blood flow under the physical conditions selected in step 635, e.g., as described above in connection with step 402 of FIG. 3. Examples of information that may be provided from solution 640 are described below.
[0154] This combined patient-specific anatomical (geometric) and physiological (physics-based) model can be used to reveal the effect of different drug treatments or lifestyle changes (e.g., cessation of smoking, dietary changes, or increased physical activity) on coronary blood flow that change heart rate, stroke volume, blood pressure, or coronary microcirculatory function. Such information can be used to optimize drug therapy or avoid potentially dangerous effects of drug treatments. This combined model may also be used to reveal the effect on coronary blood flow of alternative forms and / or different levels of physical activity or potential risk of exposure to external forces (e.g., while playing soccer, during space flight, while scuba diving, while flying an airplane, etc.). Such information can be used to identify the type and level of physical activity that may be safe and effective for a particular patient. This combined model can also be used to predict the potential benefit of percutaneous coronary intervention on coronary blood flow in order to select the optimal intervention strategy, and / or predict the potential benefit of coronary artery bypass surgery on coronary blood flow in order to select the optimal surgical strategy.
[0155] This combined model can also be used to illustrate the potential deleterious effects of increasing burden of arterial disease on coronary blood flow, and using mechanistic or phenomenological disease progression models or empirical data, predict when ongoing disease may cause compromise of blood flow to the myocardium. Such information may allow the identification of a "guaranteed period" during which patients initially observed to be free of hemodynamically significant disease using non-invasive imaging would not be expected to require medical, interventional, or surgical therapy, or the rate at which progression may occur if adverse factors continue.
[0156] This combined model can also be used to illustrate the potential beneficial effects on coronary blood flow resulting from a reduction in the burden of coronary artery disease, and to predict, using mechanistic or phenomenological disease progression models or empirical data, whether disease regression might necessarily result in increased blood flow through the coronary arteries to the myocardium. Such information can be used to guide medical management programs, including, but not limited to, dietary modifications, increased physical activity, prescription of statins or other medications, etc. VI. Providing patient-specific treatment plans
[0157] As discussed above in connection with step 500 shown in Figure 2, an exemplary method may include providing a patient-specific treatment plan. In an exemplary embodiment, step 500 may include the following steps: Although the following steps are not shown in Figure 3, it is understood that these steps may be performed in conjunction with the steps shown in Figure 3, for example after step 406 or 408.
[0158] As discussed above, the cFFR model 54 shown in Figures 1 and 23 shows cFFR values throughout the patient's anatomy represented by mesh 380 of Figures 17-19 under untreated and simulated hyperemic conditions. With this information, a physician can prescribe treatment to the patient, such as increased exercise, dietary changes, prescribing drug therapy, or surgery on any part of the modeled anatomy or other parts of the heart (e.g., coronary artery bypass surgery, insertion of one or more coronary stents, etc.).
[0159] For purposes of identifying which treatment(s) to prescribe, a computer system can be used to predict how such treatment(s) will change the information identified from the computer analysis. For example, a particular treatment, such as the insertion of a stent(s) or other surgery, may result in a change to the geometry of the modeled anatomy. Thus, in an exemplary embodiment, the solid model 320 generated in step 306 can be revised to indicate the enlargement of one or more lumens into which the stent is inserted.
[0160] For example, the cFFR model 54 shown in FIG. 1 and FIG. 23 shows that the LAD artery has a minimum cFFR value of 0.66, the LCX artery has a minimum cFFR value of 0.72, and the RCA artery has a minimum cFFR value of 0.80. Treatment may be suggested if the cFFR values are, for example, less than 0.75. Thus, the computer system may suggest to the user revising the solid model 320 to show the enlargement of the LAD and LCX arteries to simulate the insertion of a stent into these coronary arteries. The user is prompted to select the location and amount of enlargement (e.g., length and diameter) that corresponds to the location and size of the simulated stent. Alternatively, the location and amount of enlargement may be automatically determined by the computer system based on various factors, such as the location of the node(s) having a cFFR value less than 0.75, the location of the critical defect stenosis, the size of the conventional stent, etc.
[0161] 25 illustrates an example of a modified cFFR model 510 that was developed based on a solid model created by zooming in on a portion of the LAD artery at location 512 and the LCX artery at location 514. In an exemplary embodiment, any of the steps described above, such as steps 310-314 and 402-408, may be repeated using the modified solid model. In step 406, the final report may include information related to an untreated patient (e.g., without a stent), such as the information shown in FIG. 23, as well as information related to a simulated treatment of the patient, such as the information shown in FIGS. 25 and 26.
[0162] FIG. 25 includes the modified cFFR model 510 and also includes summary information, such as the lowest cFFR value of the main coronary artery and branches extending therefrom of the modified solid model associated with the proposed treatment. For example, FIG. 25 shows that the lowest cFFR value of the LAD artery (and its downstream branches) is 0.78, the lowest cFFR value of the LCX artery (and its downstream branches) is 0.78, and the lowest cFFR value of the RCA artery (and its downstream branches) is 0.79. Thus, a comparison of the cFFR model 54 of an untreated patient (no stent) with the cFFR model 510 of the proposed treatment (stent insertion) shows that the proposed treatment may increase the lowest cFFR of the LAD artery from 0.66 to 0.78 and will also increase the lowest cFFR of the LCX artery from 0.72 to 0.76, while there will be a slight decrease in the lowest cFFR of the RCA artery from 0.80 to 0.79.
[0163] FIG. 26 shows an example of a modified simulated blood flow model 520 revealed after zooming in on portions of the LAD artery location 512 and the LCX artery location 514, as described above. FIG. 26 also includes summary information, such as blood flow values at various locations of the main coronary artery and branches extending therefrom, of the modified solid model related to the proposed treatment. For example, FIG. 26 shows blood flow values for four locations LAD1, LAD2, AD3, and LAD4 in the LAD artery and two locations LCX1 and LCX2 in the LCX artery for an untreated patient (without stent) and a treated patient (with stent insertion). FIG. 26 also shows the percentage change in blood flow values between the untreated and treated states. Thus, a comparison of the simulated blood flow model 52 of an untreated patient with the simulated blood flow model 520 of the proposed treatment shows that the proposed treatment may increase flow through the LAD and LCX arteries by 9% to 19% depending on location at all locations: LAD1-LAD4, LCX1, and LCX2.
[0164] Other information, such as coronary artery blood pressure, may also be compared between the untreated and treated states. Based on this information, the physician can discuss with the patient whether to proceed with the proposed treatment option.
[0165] Other treatment options may also result in modifying the solid model 320 in various ways. For example, coronary artery bypass surgery may result in the creation of new lumens or passageways in the solid model 320, and removal of a lesion may also result in the enlargement of a lumen or passageway. Other treatment options may not result in modifying the solid model 320. For example, increased exercise or exertion, diet or other lifestyle changes, prescription of drug treatments, etc. may result in altering the boundary conditions identified in step 310, for example, by vasoconstriction, dilation, decreasing heart rate, etc. For example, a patient's heart rate, cardiac output, stroke volume, blood pressure, coronary microcirculatory function, configuration of the lumped parameter model, etc. may vary depending on the drug treatment prescribed, the type and frequency of exercise (or other exertion) employed, the type of lifestyle changes adopted (e.g., cessation of smoking, dietary changes, etc.), thereby affecting the boundary conditions identified in step 310 in various ways.
[0166] In an exemplary embodiment, modified boundary conditions may be empirically determined using data from a large number of patients, and similar treatment options may require modifying the boundary conditions in much the same way. Empirical models can be developed from patient-specific data from large populations to create libraries of boundary conditions, or functions for calculating boundary conditions, corresponding to specific treatment options that can be applied to similar patients in future analyses.
[0167] After modifying the boundary conditions, the steps described above, e.g., steps 312, 314, and 402-408, may be repeated using the modified boundary conditions, and in step 406, a final report may include information related to the untreated patient, e.g., the information shown in FIG. 23, as well as information related to the simulated treatment of the patient, e.g., the information shown in FIGS. 25 and 26.
[0168] Alternatively, a user interface may be provided that allows the physician, patient, or other user to interact with the three-dimensional model (e.g., solid model 320 of FIG. 8). The model 320 may be divided into user-selectable segments that the user can edit to reflect one or more treatment options. For example, the user may select a segment that contains a stenosis (or an occlusion, e.g., an acute occlusion) and adjust the segment to remove the stenosis, or the user may add a segment to the model 320 to be a bypass. The user may also be instructed to specify other treatment options and / or changes in physiological parameters that may alter the boundary conditions identified above, such as changes in cardiac output, heart rate, stroke volume, blood pressure, exercise or exertion level, hyperemia level, drug therapy, etc. In an alternative embodiment, the computer system may determine or suggest the treatment options.
[0169] The user interface may enable interaction with the three-dimensional model 320 to allow a user to simulate a stenosis (or occlusion, e.g., an acute occlusion). For example, a user may select a segment to include a stenosis, and the computer system can be used to predict how the addition of the stenosis will change information determined from the computer analysis. Thus, the methods described herein can be used to predict the effects of occluding an artery.
[0170] The user interface may also allow for interaction with the three-dimensional model 320 to simulate damaged arteries or removal of arteries that may occur in certain surgical procedures, such as during removal of a cancerous tumor. The model may also be modified to simulate the effects of impeding blood flow through certain arteries to predict the likelihood of collateral pathways to provide sufficient blood flow to the patient. A. Using reduced order models to compare different treatment options
[0171] In an exemplary embodiment, the computer system may enable a user to more quickly simulate various treatment options by replacing the three-dimensional solid model 320 or mesh 380 with a reduced order model. Figure 27 shows a schematic diagram associated with a method 700 for simulating various treatment options using a reduced order model, according to an exemplary embodiment. The method 700 may be implemented in the computer system described above.
[0172] One or more patient-specific simulated blood flow models representing blood flow or other parameters may be output from the computer analysis described above (step 701). For example, the simulated blood flow models may include the simulated blood pressure model 50 of FIG. 1, the simulated blood flow model 52 of FIG. 1, the cFFR model 54 of FIG. 1, etc., but using the methods shown in FIG. 2 and FIG. 3 above. As described above, the simulated blood flow models may include a three-dimensional geometric model of the patient's anatomy.
[0173] To condition the reduced order model, functional information can be extracted from the simulated blood flow model (step 702). For example, the functional information can include blood pressure, flow, or velocity information as determined using the computational analysis described above.
[0174] A reduced order (e.g., zero-dimensional or one-dimensional) model may be provided to replace the three-dimensional solid model 320 used to generate the patient-specific simulated blood flow model generated in step 701, and the reduced order model may be used to reveal information about the patient's coronary blood flow (step 703). For example, the reduced order model may be a lumped parameter model generated as described above in connection with step 310 of FIG. 3. The lumped parameter model is thus a simplified model of the patient's anatomy and may be used to reveal information about the patient's coronary blood flow without having to solve the more complex simultaneous equations associated with the mesh 380 of FIGS. 17-19.
[0175] The information revealed from solving the reduced order model in step 703 may then be mapped or extrapolated to a three-dimensional solid model of the patient's anatomy (e.g., solid model 320) (step 704), and the user may modify the reduced order model as desired to simulate various treatment options and / or changes in the patient's physiological parameters that the user may select (step 705). Selectable physiological parameters may include cardiac output, exercise or exertion level, level of hyperemia, type of drug therapy, etc. Selectable treatment options may include removal of stenosis, addition of bypass, etc.
[0176] The reduced order model may then be modified based on the user selected treatment option and / or physiological parameter, and the modified reduced order model may be used to reveal information about the patient's coronary blood flow associated with the selected treatment option and / or physiological parameter (step 703). The information revealed from solving the reduced order model in step 703 may then be mapped or extrapolated to the three-dimensional solid model 320 of the patient's anatomy to predict the effect of the selected treatment option and / or physiological parameter on the coronary blood flow of the patient's anatomy (step 704).
[0177] Steps 703-705 may be repeated for a variety of different treatment options and / or physiological parameters to compare the predicted effects of the various treatment options to each other and to information about coronary blood flow in untreated patients. As a result, predicted outcomes for the various treatment options and / or physiological parameters can be evaluated in comparison to each other and to information about untreated patients without having to again perform more complex analyses using the three-dimensional mesh 380. Alternatively, reduced order models may be used, which may allow a user to more easily and quickly analyze and compare different treatment options and / or physiological parameters.
[0178] 28 illustrates further aspects of an exemplary method for simulating various treatment options using a reduced order model, according to an exemplary embodiment. Method 700 may be implemented on the computer system described above.
[0179] A patient-specific geometric model may be generated (step 711) based on the patient's image data, as described above in connection with step 306 of Figure 3. For example, the image data may include CCTA data acquired in step 100 of Figure 2, and the geometric model may be the solid model 320 of Figure 8 generated in step 306 of Figure 3, and / or the mesh 380 of Figures 17-19 generated in step 312 of Figure 3.
[0180] Using this patient-specific three-dimensional geometric model, a computer analysis may be performed (step 712) to reveal information about the patient's coronary blood flow, for example, as described above in connection with step 402 of Figure 3. The computer analysis may output one or more three-dimensional patient-specific simulated blood flow models representing blood flow or other parameters, such as the simulated blood pressure model 50 of Figure 1, the simulated blood flow model 52 of Figure 1, the cFFR model 54 of Figure 1, etc.
[0181] The simulated blood flow model may be segmented (e.g., as described above in connection with FIG. 14) based on anatomical features of the model (step 713). For example, branches extending from a main coronary artery may be provided as separate segments (step 714), portions containing stenosis or disease may be provided as segments (step 716), and portions between the branches and portions containing stenosis or disease may be provided as separate segments (step 715). Various degrees of resolution may be provided in segmenting the simulated blood flow model, such that each vessel may include multiple short, separate segments, or longer segments, including, for example, the entire vessel. Also, various techniques may be provided for segmenting the simulated blood flow model, including generating a centerline and segmenting based on the generated centerline, or detecting branch points and segmenting based on the detected branch points. Diseased portions and stenosis may be identified, for example, by measuring the cross-sectional area along the entire length of the centerline and calculating the locally smallest cross-sectional area. Steps 711 to 716 can be considered as sub-steps of step 701 in FIG.
[0182] The segments may be replaced by elements of a lumped parameter model, such as resistors, capacitors, inductors, etc., as described above in connection with FIG. 15. Individual values of other variables related to resistance, capacitance, inductance, and other electrical elements used in the lumped parameter model may be derived from the simulated blood flow model provided in step 712. For example, for the branches and the segments between the branches and the segments containing stenosis or disease, the information derived from the simulated blood flow model may be used to assign linear resistances to the corresponding segments (step 717). For segments with complex geometries, such as stenosis or disease, the resistance may vary with flow rate. Thus, as described above in connection with FIG. 15, multiple computational analyses may be used to obtain simulated blood flow models at various flow and pressure conditions to derive patient-specific, vessel-specific, and lesion-specific resistance functions for these complex geometries. Thus, for segments containing stenosis or disease, the information derived from these multiple computational analyses, or models derived from previous data, may be used to assign nonlinear flow-dependent resistances to the corresponding segments (step 718). Steps 717 and 718 can be considered as sub-steps of step 702 in FIG.
[0183] Using the resistances measured in steps 717 and 718, a reduced order (e.g., zero dimensional or one dimensional) model can be generated (step 719). For example, the reduced order model can be a lumped parameter model generated as described above in connection with step 310 of FIG. 3. This lumped parameter model is thus a simplified model of the patient's anatomy and can be used to reveal information about the patient's coronary blood flow without having to solve the more complex simultaneous equations associated with mesh 380 of FIGS. 17-19.
[0184] A user interface may be provided (step 720) that allows a user to interact with the reduced order model created in step 719. For example, a user may select and edit different segments of the reduced order model to simulate different treatment options and / or edit various physiological parameters. For example, an intervention such as the insertion of a stent for repair of a diseased area may be modeled by decreasing the resistance of the segment where the stent is inserted. The formation of a bypass may be modeled by adding a segment with low resistance in parallel to the diseased segment.
[0185] The modeled reduced order model may be solved to reveal information about the patient's coronary blood flow under the treatment and / or physiological parameter changes selected in step 720 (step 721). The flow and pressure solution values at each segment identified in step 721 may then be compared to the three-dimensional solution identified in step 712, and any differences may be minimized by adjusting the resistance functions of those segments (e.g., as identified in steps 717 and 718) and solving the reduced order model (e.g., step 721) until the solutions match. As a result, the reduced order model may be created and then solved with a simplified set of equations that allows for relatively quick calculations (e.g., compared to a full three-dimensional model) and can be used to determine flow and pressure that may closely approximate the results of the full three-dimensional computational solution. The reduced order model allows for relatively quick iterations to model a variety of different treatment options.
[0186] Information revealed from solving the reduced order model in step 721 may then be mapped or extrapolated (step 722) to a three-dimensional solid model of the patient's anatomy (e.g., solid model 320). Steps 719-722 may be similar to steps 703-705 of Figure 27 and may be repeated as desired by the user to simulate various combinations of treatment options and / or physiological parameters.
[0187] Alternatively, rather than calculating the resistance along the segments from a three-dimensional model (e.g., as described above for steps 717 and 718), the flows and pressures at intervals along the centerline may be prescribed as lumped parameters or in a one-dimensional model. The effective resistance or loss coefficient can be found subject to the boundary conditions and the prescribed flow and pressure constraints.
[0188] Also, the flow and pressure gradients across the individual segments can be used to calculate the epicardial coronary resistance using a solution derived from the reduced order model (e.g., as described above for step 721). The epicardial coronary resistance can be calculated as the equivalent resistance of the epicardial coronary artery (the portion of the coronary artery and branches extending therefrom included in the patient-specific model reconstructed from medical image data). This may have clinical significance in explaining why patients with diffuse atherosclerosis in the coronary arteries may exhibit symptoms of ischemia (blood supply restriction). Also, flow per unit of myocardial tissue volume (or mass) and / or flow per unit of cardiac work under simulated pharmacologically induced hyperemia or various exercise intensity conditions can be calculated from the data from the reduced order model.
[0189] As a result, the accuracy of three-dimensional blood flow modeling can be combined with the computational simplicity and relative speed inherent in one-dimensional and lumped parameter modeling techniques. Three-dimensional computational methods can be used to numerically derive patient-specific one-dimensional or lumped parameter models that incorporate numerically derived empirical models of pressure loss of normal segments, stenoses, bifurcations, and other anatomical features. Improved diagnosis of patients with cardiovascular disease can be provided, and medical, interventional, and surgical treatment planning can be implemented more quickly.
[0190] Additionally, the accuracy of 3D computational fluid dynamics techniques can be combined with the computational simplicity and power of lumped parameter and 1D models of blood flow. 3D geometric and physiological models can be automatically decomposed into reduced order 1D or lumped parameter models. The 3D models can be used to calculate linear or nonlinear hemodynamic effects of blood flow through normal segments, stenoses, and / or branches, and to set the parameters of empirical models. The 1D or lumped parameter models can be used to more efficiently and quickly determine blood flow and pressure in patient-specific models and display the results of the lumped parameter or 1D solution.
[0191] Patient-specific anatomical-physiological reduced-order models can be used to characterize the effects on coronary blood flow of different drug treatments or lifestyle changes (e.g., cessation of smoking, dietary changes, or increased physical activity) that modify heart rate, stroke volume, blood pressure, or coronary microcirculatory function. Such information can be used to optimize drug therapy or to avoid potentially dangerous effects of drug treatments. Reduced-order models may also be used to characterize the effects on coronary blood flow of alternative forms and / or levels of physical activity or potential exposure to external forces (e.g., playing soccer, during space flight, scuba diving, flying an airplane, etc.). Such information can be used to identify the types and levels of physical activity that may be safe and effective for a particular patient. Reduced-order models may also be used to predict the potential benefit of percutaneous coronary intervention on coronary blood flow to select the optimal intervention strategy and / or predict the potential benefit of coronary artery bypass grafting on coronary blood flow to select the optimal surgical strategy.
[0192] Reduced order models can also be used to illustrate the potentially deleterious effects of increasing burden of arterial disease on coronary blood flow, and mechanistic or phenomenological disease progression models or empirical data can be used to predict when ongoing disease may cause impairment of blood flow to the myocardium. Such information may allow the identification of a "guaranteed period" during which patients initially observed to be free of hemodynamically significant disease using non-invasive imaging would not be expected to require medical, interventional, or surgical therapy, or the rate at which progression may occur if adverse factors continue.
[0193] Reduced order models can also be used to illustrate the potential beneficial effects on coronary blood flow resulting from a reduction in the burden of coronary artery disease, and mechanistic or phenomenological disease progression models or empirical data can be used to predict whether disease regression will necessarily result in increased blood flow through the coronary arteries to the myocardium. Such information can be used to guide medical management programs, including, but not limited to, dietary changes, increased physical activity, prescription of statins or other medications, etc.
[0194] The reduced order model may also be incorporated into an angiography system to allow live calculation of treatment options while the physician is examining the patient in the cardiac catheterization lab. The model may be registered in the same orientation as the angiography display to allow for parallel or overlapping results of live angiograms of the coronary arteries and simulated blood flow solutions. The physician may plan and modify the treatment plan as observations are made during the procedure, allowing relatively rapid feedback before a medical decision is made. The physician may invasively measure pressure, FFR, or blood flow and use the measurements to further refine the model before performing a predictive simulation.
[0195] The reduced order model may also be incorporated into a medical imaging system or workstation and, if derived from a library of previous patient-specific simulation results, may be used in conjunction with a geometric segmentation algorithm to resolve blood flow information relatively quickly after an image scan is completed.
[0196] Reduced order models can also be used to model the effectiveness of new drug therapies, or the costs / benefits of treatment options, in large populations of patients. A database of multiple patient-specific lumped parameter models (e.g., hundreds, thousands, or more) can provide models to solve in a relatively short time. Relatively rapid iteration and optimization is provided for simulation of drugs, therapies, or clinical trials. By adapting models to represent treatments, patient drug responses, or surgical interventions, predictions of efficacy can be obtained without the need to conduct large-scale clinical trials, which can be expensive and potentially risky. VII. Other results A. Assessment of myocardial perfusion
[0197] Other results may also be calculated. For example, computer analysis may provide results quantifying myocardial perfusion (blood flow through the myocardium). Quantifying myocardial perfusion may help identify areas of reduced myocardial blood flow, for example due to ischemia (restriction in blood supply), scarring, or other cardiac disorders.
[0198] 29 shows a schematic diagram relating to a method 800 for providing various information related to myocardial perfusion in a particular patient, according to an exemplary embodiment. Method 800 may be implemented on a computer system as described above, such as a computer system used to perform one or more of the steps shown in FIG. 3 above.
[0199] The method 800 may be performed using one or more inputs 802. The inputs 802 may include medical image data 803 of the patient's aorta, coronary arteries (and branches extending therefrom), and heart, such as CCTA data (e.g., acquired in step 100 of FIG. 2). The inputs 802 may also include additional physiological data 804 measured from the patient, such as the patient's brachial blood pressure 804, heart rate, and / or other measurements (e.g., acquired in step 100 of FIG. 2). The additional physiological data 804 may be acquired non-invasively. The inputs 802 may be used to perform the steps described below.
[0200] A three-dimensional geometric model of the patient's myocardial tissue may be created based on the image data 803 (step 810), and the geometric model may be divided into segments or volumes (step 812). For example, FIG. 31 illustrates a three-dimensional geometric model 846 including a three-dimensional geometric model 838 of the patient's myocardial tissue divided into segments 842. The size and location of the individual segments 842 may be determined based on the location of the outflow boundary 324 ( FIG. 8 ) of the coronary artery (and branches extending therefrom), the size of the vessels (e.g., adjacent vessels) connecting to or within each segment 842, and the like. The division of the geometric myocardial model 838 into segments 842 may be performed using various known methods, such as fast marching methods, generalized fast marching methods, level set methods, diffusion equations, equations governing flow in porous media, and the like.
[0201] The three-dimensional geometric model may also include a portion of the patient's aorta and coronary arteries (and branches extending therefrom), which may be modeled (step 814) based on the image data 803. For example, the three-dimensional geometric model 846 of FIG. 31 includes a three-dimensional geometric model 837 of the patient's aorta and coronary arteries (and branches extending therefrom) and a three-dimensional geometric model 838 of the patient's myocardial tissue created in step 810.
[0202] Referring again to FIG. 29, a computer analysis may be performed to reveal a solution containing information about the patient's coronary blood flow under physical conditions identified by a user (step 816), for example as described above in connection with step 402 of FIG. 3. For example, the physical conditions may include rest, a selected level of hyperemia, a selected level of exercise or exertion, or other conditions. The solution may provide information such as blood flow and pressure under specific physical conditions at various locations in the patient's anatomy modeled in step 814. The computer analysis may be performed with boundary conditions for the outflow boundary 324 (FIG. 8) derived from a lumped parameter model or a one-dimensional model. A one-dimensional model may be created to fill in the segment 842, as described below in connection with FIG. 30.
[0203] Based on the blood flow information revealed in step 816, the perfusion of blood flow entering each segment 842 of the myocardium created in step 812 can be calculated (step 818). For example, this perfusion can be calculated by dividing the flow rate from each outlet of the outflow boundary 324 (FIG. 8) by the volume of the segmented myocardium that the outlet perfuses.
[0204] The perfusion of each segment of myocardium determined in step 818 may be displayed (step 820) on a geometric model of the myocardium (e.g., the three-dimensional geometric model 838 of the patient's myocardial tissue shown in FIG. 31) generated in steps 810 or 812. For example, FIG. 31 illustrates that segments 842 of the myocardium of the geometric model 838 may be illustrated with different shading or colors to indicate the perfusion of blood flow entering each segment 842.
[0205] 30 shows another schematic diagram relating to a method 820 for providing various information related to myocardial perfusion in a particular patient, according to an exemplary embodiment. The method 820 may be implemented on a computer system as described above, such as a computer system used to perform one or more of the steps shown in FIG.
[0206] The method 820 may be performed using one or more inputs 832, which may include the patient's aorta, coronary arteries (and branches extending therefrom), and cardiac medical image data 833, such as CCTA data (e.g., acquired in step 100 of FIG. 2). The inputs 832 may be used to perform the steps described below.
[0207] A three-dimensional geometric model of the patient's myocardial tissue may be created (step 835) based on the image data 833. The model may also include a portion of the patient's aorta and coronary arteries (and branches extending therefrom), which may be created based on the image data 803. For example, as discussed above, FIG. 31 illustrates a three-dimensional geometric model 836 that includes a geometric model 837 of the patient's aorta and coronary arteries (and branches extending therefrom) and a geometric model 838 of the patient's myocardial tissue. Step 835 may include steps 810 and 814 of FIG. 29 discussed above.
[0208] Referring again to Figure 30, the geometric myocardial model 838 may be divided into volumes or segments 842 (step 840). Step 840 may include step 812 of Figure 29 described above. As mentioned above, Figure 31 illustrates a three-dimensional geometric model 846 that includes a geometric model 838 of a patient's myocardial tissue divided into segments 842.
[0209] Referring again to FIG. 30, the geometric model 846 may be modified to include the next generation of branches 857 in the coronary artery tree (step 855). The location and size of the branches 857 (shown as dotted lines in FIG. 31) may be determined based on the centerline of the coronary artery (and branches extending therefrom). This centerline may be determined based on image data 833, for example (step 845). An algorithm may also be used to determine the location and size of the branches 857 based on a morphometric model (a model used to predict the location and size of the vessel downstream of a known outlet of the outflow boundary 324 (FIG. 8)) and / or physiological branching laws related to vessel size (step 850). This morphometric model may extend to the downstream ends of the coronary arteries (and branches extending therefrom) included in the geometric model 837 and may be provided on the epicardial surface (outer layer of cardiac tissue) or included within the geometric model 838 of the myocardial wall.
[0210] The myocardium may be further segmented (step 860) based on the branches 857 created in step 855. For example, FIG.
[0211] Additional branches 857 may be created in subsegment 862, which may be further segmented into smaller segments 867 (step 865). The steps of creating branches and subsegmenting volumes may be repeated until a desired volume size and / or branch size resolution is obtained. Model 846 expanded to include new branches 857 in steps 855 and 865 can then be used to calculate coronary blood flow and myocardial perfusion entering a subsegment, for example subsegment 867 generated in step 865.
[0212] Thus, the computer analysis described above can be performed using the extended model. The results of the computer analysis can provide information related to blood flow entering the generated morphometric model (including the branches 857 generated in steps 855 and 865) which may extend from a patient-specific coronary artery model, e.g., model 837 of FIG. 31, into each perfused subsegment 867 generated in step 865. The computer analysis can be performed using static myocardial perfusion volumes or a dynamic model incorporating data from a coupled cardiac mechanics model.
[0213] 32 shows another schematic diagram relating to a method 870 for providing various information related to myocardial perfusion in a particular patient, according to an exemplary embodiment. The method 870 may be implemented on a computer system as described above, such as a computer system used to perform one or more of the steps shown in FIG.
[0214] The method 870 may be implemented using one or more inputs 872. The inputs 872 may include medical image data 873 of the patient's aorta, coronary arteries (and branches extending therefrom), and heart, such as CCTA data (e.g., acquired in step 100 of FIG. 2). The inputs 872 may also include additional physiological data 874 measured from the patient, such as the patient's brachial blood pressure, heart rate, and / or other measurements (e.g., acquired in step 100 of FIG. 2). The additional physiological data 874 may be acquired non-invasively. The inputs 872 may further include cardiac perfusion data 875 measured from the patient (e.g., using CT, PET, SPECT, etc.). The inputs 872 may be used to implement the steps described below.
[0215] A three-dimensional geometric model of the patient's aorta and coronary arteries (and branches extending therefrom) may be created (step 880) based on the image data 873. For example, FIG. 31 illustrates a three-dimensional geometric model 837 of the patient's aorta and coronary arteries (and branches extending therefrom). Step 880 may be similar to step 814 of FIG. 29 described above.
[0216] The computer analysis may be performed, for example, as described above in connection with step 402 of FIG. 3, to develop a solution that includes information about the patient's coronary blood flow under physical conditions identified by the user (step 882). For example, the physical conditions may include rest, a selected level of hyperemia, a selected level of exercise or exertion, or other conditions. The solution may provide information such as blood flow and pressure under specific physical conditions at various locations in the patient's anatomy modeled in step 880. Step 882 may be similar to step 816 of FIG. 29 described above.
[0217] A three-dimensional geometric model of the patient's myocardial tissue may also be created (step 884) based on the image data 873. For example, as described above, Figure 31 illustrates a three-dimensional geometric model 836 that includes a three-dimensional geometric model 838 of the patient's myocardial tissue (e.g., as created in step 884) and a three-dimensional geometric model 837 of the patient's aorta and coronary arteries (and branches extending therefrom) (e.g., as created in step 880). Step 884 may be similar to step 810 of Figure 29 described above.
[0218] The geometric model may be divided into segments or sub-volumes, step 886. For example, Figure 31 shows a geometric model 846 that includes a model 838 of a patient's myocardial tissue divided into segments 842. Step 886 may be similar to step 812 of Figure 29 described above.
[0219] Based on the blood flow information revealed in step 882, the perfusion of blood flow into each of the segments 842 of the myocardium created in step 886 can be calculated (step 888). Step 888 may be similar to step 818 of FIG. 29 described above.
[0220] The calculated perfusion of each segment of myocardium may be displayed (step 890) on a geometric model of the myocardium (e.g., the three-dimensional geometric model 838 of the patient's myocardial tissue shown in FIG. 31) generated in step 884 or 886. For example, FIG. 31 illustrates that the myocardial segments 842 of the geometric model 838 may be illustrated with different shading or colors to indicate the perfusion of blood flow entering each segment 842. Step 890 may be similar to step 820 of FIG. 29 described above.
[0221] The simulated perfusion data mapped onto the three-dimensional geometric model of the myocardium in step 890 may be compared (step 892) to the measured cardiac perfusion data 875. This comparison may be performed, for example, on a voxel-based representation of the myocardium or on different discrete representations of the myocardium. This comparison may use different colors and / or shading on the three-dimensional representation of the myocardium to indicate differences between the simulated and measured perfusion data.
[0222] Boundary conditions at the outlets of the three-dimensional geometric model created in step 880 may be adjusted to reduce the error between the simulated and measured perfusion data (step 894). For example, to reduce the error, the boundary conditions may be adjusted to reduce the prescribed flow resistance of blood vessels supplying regions where the simulated perfusion is lower than the measured perfusion (e.g., segments 842, 862, or 867). Other parameters of the boundary conditions may also be adjusted. Alternatively, the branching structure of the model may be modified. For example, the geometric model created in step 880 may be expanded as described above in connection with Figures 30 and 31 to create a morphometric model. The boundary conditions and / or parameters of the morphometric model may be tuned empirically or systematically using parameter estimation or data assimilation methods, such as the method described in U.S. Patent Application Publication No. 2010 / 0017171, entitled "Method for Tuning Patient-Specific Cardiovascular Simulations," or other methods.
[0223] Steps 882, 888, 890, 892, 894, and / or other steps of Figure 32 may be repeated, for example, until the error between the simulated and measured perfusion data falls below a predefined threshold. As a result, computer analysis can be performed using a model relating anatomical information, coronary blood flow information, and myocardial perfusion information. Such models may be useful for diagnostic purposes or to predict the benefit of drug, interventional, or surgical therapy.
[0224] As a result, coronary blood flow and myocardial perfusion under resting and / or stress conditions can be simulated in a patient-specific geometric model constructed from three-dimensional medical imaging data. The measured myocardial perfusion data may be used in combination with the simulated myocardial perfusion results to adjust boundary conditions (e.g., as described above in connection with FIG. 32) until the simulated myocardial perfusion results match the measured myocardial perfusion data within a predetermined tolerance. More accurate patient-specific coronary blood flow calculations may be provided and cardiologists may be able to predict coronary blood flow and myocardial perfusion in situations where measurement data may not be available, such as when simulating patients under maximal exercise or exertion, simulated treatments, or other conditions.
[0225] The patient-specific three-dimensional model of the left and / or right ventricular myocardium may be divided into perfused segments or sub-volumes. The patient-specific three-dimensional geometric model of the coronary arteries, as revealed from the medical image data, may be combined with a morphometric model of the remaining coronary artery tree on the epicardial surface or part of the left and / or right ventricular myocardial wall represented by the perfused sub-volumes to form an enlarged model. The percentage of the total myocardial volume downstream of a given location in the enlarged model, e.g., a diseased location, may be calculated. The percentage of the total myocardial blood flow at a given location in the enlarged model, e.g., a diseased location, may be calculated. The enlarged model may be used to calculate coronary blood flow and myocardial perfusion. The coronary blood flow model may be modified until the simulated perfusion matches the measured perfusion data within a specified tolerance. B. Plaque vulnerability assessment
[0226] The computer analysis can also provide results that quantify the patient-specific biomechanical forces acting on plaque that may accumulate in the patient's aorta and coronary arteries (and branches extending therefrom), such as atherosclerotic plaque in the coronary arteries. Biomechanical forces can result from pulsatile pressure, flow, and cardiac motion.
[0227] FIG. 33 shows an example of plaque 900 that has built up along a vessel wall 902, e.g., the wall of one of the main coronary arteries or one of the branches extending therefrom. A pressure and / or surface area difference between the upstream and downstream ends of the plaque may generate a force 904 acting on the plaque 900 at least along the direction of blood flow, e.g., due to blood flowing through the vessel. Another force 906 may act on the surface of the plaque 900 at least along a direction toward and perpendicular to the vessel wall 902. The force 906 may be due to the blood pressure of the blood flowing through the vessel. Yet another force 908 may act on the surface of the plaque 900 at least along the direction of blood flow, and may be due to blood flow forces, such as at rest and during exercise.
[0228] The results also assess the risk of plaque rupture (e.g., plaque accumulated in the vessel wall becomes unstable and breaks or ruptures) and the myocardial volume that may be affected by such rupture. The results can be evaluated under various simulated physiological conditions such as at rest and during exercise. The risk of plaque rupture can be defined as the ratio of simulated plaque stress to plaque strength estimated using CCTA or MRI-derived material composition data (e.g., as revealed in step 100 of FIG. 2).
[0229] For example, Fig. 34 shows an example of results that the computer analysis may output. The results may include the three-dimensional geometric model 846 of Fig. 31, which may include a three-dimensional geometric model 837 of the patient's aorta and coronary arteries (and branches extending therefrom) and a three-dimensional geometric model 838 of the patient's myocardial tissue divided into segments 842. The results may also indicate a location 910 in one of the coronary arteries (or branches extending therefrom) that may reveal a vulnerable plaque, which may be identified based on an assessment of the risk of plaque rupture, as described in more detail below, and / or based on input from a user. Also, as shown in Fig. 34, a segment 912 of the myocardium (of the plurality of segments 842) may be identified as having a high probability of hypoperfusion due to rupture of the plaque identified at location 910.
[0230] 35 and 36 are schematic diagrams illustrating aspects of a method 920 for providing various information related to the assessment of plaque vulnerability, myocardial volume risk, and myocardial perfusion risk in a particular patient, according to an exemplary embodiment. Method 920 can be implemented on a computer system as described above, such as a computer system used to perform one or more of the steps shown in FIG. 3 above. Method 920 can be implemented with one or more inputs 922, and may include generating one or more models 930 based on the inputs 922, performing one or more biomechanical analyses 940 based on one or more of the models 930, and providing various results based on the models 930 and the biomechanical analyses 940.
[0231] The input 922 may include medical image data 923 of the patient's aorta, coronary arteries (and branches extending therefrom), and heart, such as CCTA data (e.g., acquired in step 100 of FIG. 2). The input 922 may also include additional physiological data 924 measured from the patient, such as the patient's brachial blood pressure, heart rate, and / or other measurements (e.g., acquired in step 100 of FIG. 2). The additional physiological data 924 may be acquired non-invasively. The input 922 may also be used to generate the model 930 and / or to perform a biomechanical analysis 940, described below.
[0232] As described above, one or more models 930 may be generated based on the input 922. For example, the method 920 may include generating a hemodynamic model 932 including calculated blood flow and pressure information at various locations throughout a three-dimensional geometric model of the patient's anatomy. The model of the patient's anatomy may be created using medical image data 923, such as the solid model 320 of FIG. 8 generated in step 306 of FIG. 3, and / or the mesh 380 of FIGS. 17-19 generated in step 312 of FIG. 3, and in an exemplary embodiment, the hemodynamic model 932 may be a simulated blood pressure model 50 (FIG. 1), a simulated blood flow model 52 (FIG. 1), a cFFR model 54 (FIG. 1), or other simulation generated after performing a computational analysis, for example, as described above in connection with step 402 of FIG. 3. The solid mechanical model including the fluid-structure interaction model may be solved by computational analysis using known numerical methods. The plaque and vascular properties may be modeled as linear or nonlinear, isotropic or anisotropic. This solution can provide the stresses and strains in the plaque and the interface between the plaque and the blood vessel. In the exemplary embodiment shown in FIG.
[0233] The method 920 may include performing a biomechanical analysis 940 (step 942) using the hemodynamic model 932 by calculating pressure 906 (FIG. 33) and shear stress 908 (FIG. 33) acting on the plaque luminal surface due to blood flow forces during various physiological states, such as at rest and during various levels of movement or exertion. The pressure 906 and shear stress 908 can be calculated based on information from the hemodynamic model 932, such as blood pressure and blood flow.
[0234] In some cases, the method 920 may also include generating a geometric analysis model 934 for quantifying deformation of a blood vessel from four-dimensional image data, e.g., image data acquired at multiple phases of the cardiac cycle, e.g., systole and diastole. The image data may be acquired using various known imaging methods. The geometric analysis model 934 may include information about the position, deformation, orientation, and size of the blood vessel at different phases of the cardiac cycle, e.g., due to cardiac motion. For example, various types of deformations of the patient's aorta, coronary arteries (and branches extending therefrom), and plaque, e.g., longitudinal lengthening or shortening, twisting, radial expansion or compression, and bending, may be simulated by the geometric analysis model 934.
[0235] The method 920 may also include performing a biomechanical analysis 940 using the geometric analysis model 934 by calculating various deformation characteristics of the patient's aorta, coronary arteries (and branches extending therefrom), and plaque due to pulsatile pressure from the heart (step 944), such as longitudinal lengthening or shortening, twisting, radial expansion or compression, and bending. Such deformation characteristics may be calculated based on information from the geometric analysis model 934, such as changes in position, orientation, and size of the blood vessels over multiple phases of the cardiac cycle.
[0236] The calculation of deformation features can be simplified by revealing the centerline or surface mesh of the modeled geometry (e.g., the geometry of the patient's aorta, coronary arteries (and branches extending therefrom), plaque, etc.). Branch ostia, calcified lesions, and soft plaque can be used as landmarks to reveal the changes in the modeled geometry between different phases. In regions without landmarks, the cross-sectional area contour along the entire length of the modeled geometry can be used to identify corresponding locations between the two image frames (to "register" the two image frames). A deformable registration algorithm based on the raw image data can be used to extract the three-dimensional deformation field. The calculated three-dimensional deformation field can then be projected onto a curvilinear axis aligned with the modeled geometry (e.g., total vessel length) to calculate the tangential and normal components of the deformation field. The modeled geometry (e.g., vessel length), the angle of branch separation, and the resulting difference between systole and diastole of the curvature can be used to reveal the strain occurring in the vessel.
[0237] The method 920 may also include generating a plaque model 936 to characterize the composition and characteristics of the plaque from the medical image data 923. For example, the plaque model 936 may include information regarding the density and other material properties of the plaque.
[0238] The method 920 may also include generating a vessel wall model 938 for calculating information about the plaque, the vessel wall, and / or the interface between the plaque and the vessel wall. For example, the vessel wall model 938 may include information about stress and strain, which may be calculated based on the composition and characteristics of the plaque included in the plaque model 936, the pressure 906 and shear stress 908 calculated in step 942, and / or the deformation characteristics calculated in step 944.
[0239] The method 920 may include performing a biomechanical analysis 940 with the vessel wall model 938 (step 946) by calculating stresses (e.g., acute or cumulative stresses) on the plaque due to blood flow forces and strains induced by cardiac motion. For example, the flow induced forces 904 (FIG. 33) acting on the plaque may be calculated. The stresses or forces on the plaque due to blood flow forces and strains induced by cardiac motion may be calculated based on information from the vessel wall model 938, such as the stresses and strains on the plaque.
[0240] The method 920 may include uncovering further information based on one or more of the models 930 and one or more of the biomechanical analyses 940 described above.
[0241] A plaque rupture vulnerability index may be calculated (step 950). The plaque rupture vulnerability index may be calculated based on, for example, the total hemodynamic stress, the stress frequency, the stress direction, and / or the plaque strength, or other characteristics. For example, a region around the plaque may be isolated from a three-dimensional model 930 of the plaque, e.g., the plaque model 936. The strength of the plaque may be determined from material properties provided to the plaque model 936. Hemodynamic and tissue stresses on the plaque due to pulsatile pressure, flow, and cardiac motion may be calculated under simulated baseline and exercise (or exertion) conditions using the hemodynamic stresses and cardiac motion-induced strains previously calculated in step 946. The vulnerability of the plaque may be assessed based on the ratio of plaque stress to plaque strength.
[0242] A myocardial volume risk index (MVRI) may also be calculated (step 952). The MVRI may be defined as the percentage of the total myocardial volume affected by plaque rupture and occlusion (closure or blockage) of a vessel at a given location in the arterial tree. The MVRI may be calculated based on the portion of the myocardium supplied by a vessel downstream of a given plaque, which may take into account the size of the plaque relative to the size of the downstream vessel, and the probability of that plaque flowing into a different vessel based on a three-dimensional hemodynamic solution.
[0243] The myocardium may be modeled and divided into segments 842 supplied by each vessel in the hemodynamic simulation (e.g., as described in connection with steps 835 and 840 of FIG. 30). The geometric model may be modified to include next generation branches 857 in the coronary artery tree (e.g., as described in connection with step 855 of FIG. 30), and the myocardium may be further segmented (e.g., as described in connection with step 860 of FIG. 30). Additional branches 857 may be created in subsegment 862, which may be further segmented into smaller segments 867 (e.g., as described in connection with step 865 of FIG. 30). Physiological relationships such as those described above may be used to relate vessel size to the proportional amount of myocardium supplied.
[0244] The potential paths taken by ruptured plaques can be revealed. Hemodynamic solutions can be used to reveal the probability of plaque fragments or emboli flowing into different downstream vessels.
[0245] The size of the ruptured plaque can be compared to the size of the downstream vessel to reveal whether the plaque may ultimately cause an obstruction to blood flow. This information can be combined with a vulnerability index to provide a probability distribution map of the volume of myocardium that may be affected by the ruptured plaque. An MVRI can be assigned to each segment that may be affected. Figure 34 shows an example of a segment 912 where a vulnerable plaque at location 910 in a distal vessel has a high probability of affecting a small area of myocardium.
[0246] A myocardial perfusion risk index (MPRI) may also be calculated (step 954). The MPRI may be defined as the percentage of total myocardial blood flow that is affected by plaque rupture and occlusion of a vessel at a given location in the arterial tree. For example, a plaque rupture in the distal portion of the LAD artery will result in a lower MVRI than a plaque rupture in the proximal portion of the LAD artery. However, these indices may be different if some myocardial volume affected by vulnerable plaque in the vasa vasorum is non-viable (e.g., due to scar tissue that may form after a myocardial infarction). Thus, the MPRI indicates the potential loss of perfusion to that myocardial segment rather than the affected volume as indicated by the MVRI. The perfusion rate to each segment 842, 862, or 867 of FIG. 31 may be calculated, and the loss of perfusion may be calculated based on the vulnerability index, the hemodynamic solution, and the size of the plaque and vessel.
[0247] As a result, pulsatile blood pressure, pulsatile blood flow, pulsatile blood shear stress, and / or plaque stress due to pulsatile cardiac motion can be calculated, plaque strength can be estimated based on medical imaging data, and indices related to plaque vulnerability, myocardial volume risk, and myocardial perfusion risk can be quantified. VIII. Other uses
[0248] The above-described embodiments relate to evaluating information regarding coronary blood flow in a patient. Alternatively, these embodiments may apply to blood flow in other parts of the body, such as, but not limited to, the carotid, peripheral, abdominal, renal, femoral, popliteal, and cerebral arteries. A. Modeling intracranial and extracranial blood flow
[0249] Next, embodiments related to cerebral arteries will be described. Numerous diseases can affect or be affected by blood flow and blood pressure in extracranial or intracranial arteries. Atherosclerosis in extracranial arteries, such as the carotid and vertebral arteries, can limit blood flow to the brain. Severe atherosclerosis can lead to transient ischemic attacks or ischemic strokes. Aneurysmal disease in intracranial or extracranial arteries can lead to the risk of embolization leading to ischemic stroke or aneurysm rupture leading to hemorrhagic stroke. Other conditions, such as head trauma, hypertension, cancer of the head and neck, arteriovenous malformations, orthostatic intolerance, can also affect cerebral blood flow. Furthermore, reduced cerebral blood flow can induce symptoms such as fainting or affect chronic neurological diseases such as dementia secondary to Alzheimer's or Parkinson's disease.
[0250] Patients with known or suspected extracranial or intracranial arterial disease may typically undergo one or more of the following noninvasive diagnostic tests: US, MRI, CT, or PET. However, these tests may not efficiently provide anatomical and physiological data of the extracranial and intracranial arteries in most patients.
[0251] 37 is a schematic diagram of the cerebral arteries, including intracranial (inside the skull) and extracranial (outside the skull) arteries. Methods for determining patient-specific intracranial and extracranial blood flow information may be generally similar to the methods for determining patient-specific coronary blood flow information described above.
[0252] 38 is a schematic diagram illustrating an embodiment of a method 1000 for providing various information related to intracranial and extracranial blood flow in a particular patient. Method 1000 may be performed on a computer system similar to that used to perform one or more of the steps illustrated in FIG. 3, for example, above. Method 1000 may be performed with one or more inputs 1010 and may include generating one or more models 1020 based on the inputs 1010, specifying one or more conditions 1030 based on the inputs 1010 and / or the models 1020, and deriving one or more solutions 1040 based on the models 1020 and the conditions 1030.
[0253] The input 1010 may include medical image data 1011, such as CCTA data (e.g., acquired in a manner similar to that described above in connection with step 100 of FIG. 2), of the patient's intracranial and extracranial arteries, e.g., the patient's aorta, carotid artery (shown in FIG. 37), vertebral artery (shown in FIG. 37), and brain. The input 1010 may also include measurements 1012 of the patient's brachial blood pressure, carotid blood pressure (e.g., using tonometry), and / or other measurements (e.g., acquired in a manner similar to that described above in connection with step 100 of FIG. 2). The measurements 1012 may be acquired non-invasively. The input 1010 may be used to generate model(s) 1020 and / or to identify condition(s) 1030, as described below.
[0254] As described above, one or more models 1020 may be generated based on the input 1010. For example, the method 1000 may include generating one or more patient-specific three-dimensional geometric models of the patient's intracranial and extracranial arteries based on the image data 1011 (step 1021). The three-dimensional geometric models 1021 may be generated using methods similar to those described above for generating the solid model 320 of FIG. 8 and the mesh 380 of FIGS. 17-19. For example, steps similar to steps 306 and 312 of FIG. 3 may be used to generate the three-dimensional solid model and mesh representing the patient's intracranial and extracranial arteries.
[0255] Referring again to FIG. 38, the method 1000 may also include generating one or more physics-based blood flow models (step 1022). For example, the blood flow models may be models representing flow through the patient-specific geometric model generated in step 1021, the cardiac and arterial circulation, the distal intracranial and extracranial circulation, etc. The blood flow models may include reduced order models as described above in connection with step 310 of FIG. 3, such as lumped parameter models or distributed (one-dimensional wave propagation) models of the inflow and / or outflow boundaries of the three-dimensional geometric model 1021. Alternatively, the inflow and / or outflow boundaries may specify prescribed values or fields for velocity, flow rate, pressure, or other properties, etc. Alternatively, the inflow boundaries may be coupled to a cardiac model including, for example, the aortic arch. Parameters of the inflow and / or outflow boundaries may be adjusted to match measured or selected physiological conditions, including, but not limited to, cardiac output and blood pressure.
[0256] As described above, one or more conditions 1030 may be identified based on the input 1010 and / or the model 1020. The conditions 1030 include calculated parameters for the boundary conditions identified in step 1022 (and step 310 of FIG. 3). For example, the method 1000 may include identifying the conditions by calculating a patient-specific brain or head volume based on image data 1011 (e.g., acquired in a manner similar to that described above in connection with step 240 of FIG. 3) (step 1031).
[0257] The method 1000 uses the brain or head volume calculated in step 1031 to calculate the relationship Q=QM α The method may include characterizing the condition (step 1032) by calculating resting cerebral blood flow Q based on (where α is a predefined scaling exponent, M is the brain mass measured from the brain or head volume, and Q0 is a predefined constant) (e.g., similar to the physiological relationship described above in connection with the lumped parameter model in step 310 of FIG. 3). Alternatively, the relationship may be Q∝Q0M, as described above in connection with characterizing the lumped parameter model in step 310 of FIG. 3. α The signal may have the form:
[0258] The method 1000 may also include characterizing the conditions by calculating a total resting cerebral resistance using the resulting coronary blood flow calculated in step 1032 and the patient's measured blood pressure 1012 (e.g., similar to the method described above in connection with characterizing the lumped parameter model in step 310 of FIG. 3) (step 1033). For example, the total cerebral blood flow Q under baseline (resting) conditions at the outflow boundary of the three-dimensional geometric model 1021 identified in step 1032 and the measured blood pressure 1012 may be used to characterize a total resistance R at the outflow boundary based on a predefined empirically derived equation. Resistance, capacitance, inductance, and other variables related to various electrical elements used in the lumped parameter model may be incorporated into the boundary conditions (e.g., as described above in connection with characterizing the lumped parameter model in step 310 of FIG. 3).
[0259] Method 1000 may also include accounting for the condition by calculating the individual resistances of each intracranial and extracranial artery using the total resting cerebral resistance calculated in step 1033 and model 1020 (step 1034). For example, similar to the method described above in connection with step 310 of FIG. 3, the total resting cerebral resistance R calculated in step 1033 may be calculated based on the size of the distal end of each of the intracranial and extracranial arteries (e.g., as determined from the geometric model generated in step 1021) and the relationship R=R0d β where R is the flow resistance at a particular distal end, R0 is a predefined constant, d is the size (e.g., the diameter of the distal end), and β is a predefined power exponent, may be distributed to individual intracranial and extracranial arteries as described above in connection with developing the lumped parameter model in step 310 of FIG. 3 .
[0260] Referring again to FIG. 38, method 1000 may include adjusting boundary conditions (step 1035) based on one or more physical conditions of the patient. For example, the parameters identified in steps 1031-1034 may be modified based on whether solution 1040 is intended to simulate rest, various levels of stress, various levels of baroreceptor response or other autonomic feedback control, various levels of hyperemia, various levels of exercise, exertion, hypertension or hypotension, various drug treatments, postural changes, and / or other conditions. Parameters (e.g., parameters related to boundary conditions of the outflow boundary) may also be adjusted based on vasodilatory capacity (the ability of blood vessels to expand) of intracranial and extracranial arteries, for example due to microvascular dysfunction or endothelial health.
[0261] Based on the inputs 1010, the model 1020, and the conditions 1030, a computer analysis may be performed, for example as described above in connection with step 402 of FIG. 3, to determine a solution 1040 (step 1041) that includes information about the patient's coronary blood flow under the physical conditions selected in step 1035. Examples of information that may be provided from the solution 1040 may be similar to the examples provided above in connection with FIGS. 1 and 21-24, such as a simulated blood pressure model, a simulated blood flow model, etc. The results may also be used to determine, for example, flow rates, total cerebral blood flow, vessel wall shear stress, traction or shear forces acting on vessel walls or atherosclerotic plaques or aneurysms, particle / blood residence times, vessel wall motion, blood shear rates, etc. The results may also be used to analyze where emboli leaving a particular region in the vasculature are most likely to travel through the blood circulation.
[0262] The computer system may allow the user to simulate various changes in geometry. For example, the model 1020, e.g., the patient-specific geometric model generated in step 1021, may be modified to predict the effects of occluding an artery (e.g., acute occlusion). During some surgical procedures, such as during removal of a cancerous tumor, one or more extracranial arteries may be damaged or removed. Thus, the patient-specific geometric model generated in step 1021 may also be modified to simulate the effects of impeding blood flow to one or more of the extracranial arteries to predict the likelihood of collateral pathways to provide sufficient blood flow to the patient.
[0263] The computer system may allow a user to simulate the outcome of various treatment options, e.g., interventional or surgical repair of an acute occlusion. This simulation may be performed more quickly by replacing the three-dimensional solid models or meshes representing the intracranial and extracranial arteries, as described above, with reduced order models, as described above in connection with Figures 27 and 28. As a result, reduced order models, e.g., one-dimensional or lumped parameter models, may more efficiently and quickly evaluate blood flow and pressure in a patient-specific model and display the results of the solution.
[0264] The response to vasodilator / stimuli by a particular patient can be predicted based on the patient's hemodynamic information at rest or based on data based on populations with different disease states. For example, at baseline (resting), a simulation is run with a flow distribution (e.g., as described above in connection with step 1032) that is specified based on power law and brain mass (e.g., as described above in connection with step 1041). The resistance value (e.g., determined in steps 1033 and 1034) may be adjusted to allow sufficient perfusion. Alternatively, data from patient populations with factors such as diabetes, drug treatments, and past cardiac events are used to specify different resistances. Adjustment of the resistance under resting conditions can be used alone or in combination with hemodynamic information (e.g., vessel wall shear stress, or the relationship between flow and vessel size) to reveal the remaining ability of distal cerebral vessels to dilate. Patients who require a reduction in resistance to meet resting flow requirements and who have a high ratio of flow to vessel size may have a reduced ability to further dilate their vessels under physiological stress.
[0265] The flow and pressure gradients (e.g., determined in step 1041) across individual segments of the cerebral arteries can be used to calculate cerebral arterial resistance. Cerebral resistance can be calculated as the equivalent resistance of a portion of the extracranial and intracranial arteries included in a patient-specific geometric model (e.g., generated in step 1021) generated from medical imaging data. Cerebral resistance can have clinical significance in explaining why patients with diffuse atherosclerosis in the extracranial and / or intracranial arteries can exhibit symptoms of syncope (temporary loss of consciousness or posture, e.g., fainting) or ischemia (restriction of blood supply).
[0266] Also, the flow rate per unit of brain tissue volume (or mass) under baseline or altered physiological conditions can be calculated based on the flow rate information revealed in step 1041, for example, and the brain tissue volume or mass calculated in step 1031. This calculation can be useful in understanding the effect of reduced blood flow on chronic neurological disorders. This calculation can also be useful in selecting or refining drug therapy, for example, dosage of antihypertensive drugs. Additional results can include quantification of the effects of trauma, concussion, external physiological stress, hypergravity, weightlessness, space flight, deep sea decompression (e.g., bends sickness), and the like.
[0267] This combined patient-specific anatomical (geometric) and physiological (physics-based) model can be used to characterize the effects of various drug treatments or lifestyle changes (e.g., smoking cessation, dietary changes, or increased physical activity) on cerebral artery blood flow that alter heart rate, stroke volume, blood pressure, or cerebral artery microcirculatory function. This combined model may also be used to characterize the effects on cerebral artery blood flow of alternative forms and / or levels of physical activity or potential risk of exposure to external forces (e.g., playing soccer, during space flight, scuba diving, flying an airplane, etc.). Such information can be used to identify the type and level of physical activity that may be safe and effective for a particular patient. This combined model can also be used to predict the potential benefit of percutaneous interventions on cerebral artery blood flow to select the optimal intervention strategy, and / or to predict the potential benefit of carotid endarterectomy or external carotid to internal carotid bypass surgery on cerebral artery blood flow to select the optimal surgical strategy.
[0268] This combined model can also be used to illustrate the potential deleterious effects of increasing arterial disease burden on cerebral arterial blood flow, and using mechanistic or phenomenological disease progression models or empirical data, predict when ongoing disease may cause impairment of blood flow to the brain. Such information may allow the identification of a "guaranteed period" during which patients initially observed to be free of hemodynamically significant disease using non-invasive imaging would not be expected to require medical, interventional, or surgical therapy, or the rate at which progression may occur if adverse factors continue.
[0269] This combined model can also be used to illustrate the potential beneficial effects on cerebral artery blood flow resulting from a reduction in disease burden, and to predict, using mechanistic or phenomenological disease progression models or empirical data, when regression of disease may result in increased blood flow to the brain. Such information can be used to guide medical management programs, including, but not limited to, dietary modifications, increased physical activity, prescription of statins or other medications, etc.
[0270] This combined model can also be used to predict the effects of occluding an artery. In some surgical procedures, such as removing a cancerous tumor, some extracranial arteries may be damaged or removed. Simulating the effects of impeding blood flow to one of the extracranial arteries may allow prediction of the likelihood of a collateral pathway to provide sufficient blood flow to a particular patient. i. Assessment of cerebral perfusion
[0271] Other results can also be calculated. For example, computer analysis can provide results quantifying cerebral perfusion (blood flow through the cerebrum). Quantifying cerebral perfusion can help identify areas of reduced cerebral blood flow.
[0272] 39 shows a schematic diagram relating to a method 1050 for providing various information related to cerebral perfusion in a particular patient, according to an exemplary embodiment. The method 1050 may be implemented on a computer system similar to that used to implement one or more of the steps illustrated in FIG. 3 above, for example, as described above.
[0273] The method 1050 can be implemented using one or more inputs 1052. The inputs 1052 can include medical image data 1053, such as CCTA data (e.g., acquired in a manner similar to that described above in connection with step 100 of FIG. 2), of the patient's intracranial and extracranial arteries, such as the patient's aorta, carotid artery (shown in FIG. 37), vertebral artery (shown in FIG. 37), and brain. The inputs 1052 can also include additional physiological data 1054 measured from the patient, such as the patient's brachial blood pressure, heart rate, and / or other measurements (e.g., acquired in a manner similar to that described above in connection with step 100 of FIG. 2). The additional physiological data 1054 can be acquired non-invasively. The inputs 1052 can be used to implement the steps described below.
[0274] A three-dimensional geometric model of the patient's brain tissue may be created (step 1060) based on the image data 1053, and the geometric model may be divided into segments or volumes (step 1062) (e.g., in a manner similar to that described above in connection with FIGS. 29-32). The size and location of the individual segments may be determined based on the location of the outflow boundaries of the intracranial and extracranial arteries, the size of the vessels within or connecting to the respective segments (e.g., adjacent vessels), etc. The division of the geometric model into segments may be performed using various known methods, such as fast marching methods, generalized fast marching methods, level set methods, diffusion equations, equations governing flow in porous media, etc.
[0275] The three-dimensional geometric model may also include portions of the patient's intracranial and extracranial arteries, which may be modeled (step 1064) based on the image data 1053. For example, in steps 1062 and 1064, a three-dimensional geometric model may be created that includes brain tissue and the intracranial and extracranial arteries.
[0276] The computer analysis may be performed, for example, as described above in connection with step 402 of FIG. 3, to reveal a solution containing information about the patient's cerebral artery blood flow under physical conditions identified by the user (step 1066). For example, the physical conditions may include rest, various levels of stress, various levels of baroreceptor response or other autonomic feedback control, various levels of hyperemia, various levels of exercise or exertion, different drug treatments, changes in posture, and / or other conditions. The solution may provide information such as blood flow and pressure under specific physical conditions at various locations in the patient's anatomy modeled in step 1064. The computer analysis may be performed with boundary conditions for the outflow boundary derived from a lumped parameter model or a one-dimensional model. A one-dimensional model may be created to fill in segments of brain tissue, as described below in connection with FIG. 40.
[0277] Based on the blood flow information revealed in step 1066, the perfusion of blood flow into each brain segment created in step 1062 can be calculated (step 1068). For example, this perfusion can be calculated by dividing the flow rate from each outlet of the outflow boundary by the volume of the segmented brain that the outlet perfuses.
[0278] The perfusion of each brain segment determined in step 1068 may be displayed (step 1070) on the geometric model of the brain generated in steps 1060 or 1062. For example, the brain segments shown in the geometric model created in step 1060 may be illustrated with different shading or colors to indicate the perfusion of blood entering each segment.
[0279] 40 shows another schematic diagram relating to a method 1100 for providing various information related to cerebral perfusion in a particular patient, according to an exemplary embodiment. The method 1100 may be implemented on a computer system similar to those described above, for example, the computer system used to implement one or more of the steps shown in FIG. 3 above.
[0280] The method 1100 can be performed using one or more inputs 1102, which may include medical image data 1103, such as CCTA data (e.g., acquired in a manner similar to that described above in connection with step 100 of FIG. 2), of a patient's aorta, carotid artery (shown in FIG. 37), vertebral artery (shown in FIG. 37), and brain. The inputs 1102 can be used to perform the steps described below.
[0281] A three-dimensional geometric model of the patient's brain tissue may be created (step 1110) based on the image data 1103. The model may also include portions of the patient's aorta, carotid arteries (shown in FIG. 37), and vertebral arteries (shown in FIG. 37), which may be created based on the image data 1103. For example, as described above, a three-dimensional geometric model may be created that includes the brain tissue and the intracranial and extracranial arteries. Step 1110 may include steps 1060 and 1064 of FIG. 39 described above.
[0282] The geometric brain tissue model created in step 1110 may be divided into volumes or segments (step 1112). Step 1112 may include step 1062 of FIG. 39 described above. The geometric brain tissue model may also be further modified to include next generation branches in the brain tree (step 1118) (e.g., in a manner similar to that described above in connection with FIGS. 29-32). The location and size of the branches may be determined based on the midline of the intracranial and extracranial arteries. The midline may be determined based on image data 1103, for example (step 1114). An algorithm may also be used to determine the location and size of the branches based on a morphometric model (a model used to predict the location and size of blood vessels downstream of a known outlet of the outflow boundary) and / or physiological branching laws related to blood vessel size (step 1116). The morphometric model may extend to the downstream ends of the intracranial and extracranial arteries included in the geometric model and may be provided on the outer layer of the brain tissue or may be included within the geometric model of the brain tissue.
[0283] Based on the branches created in step 1118, the brain may be further segmented (step 1120) (e.g., in a manner similar to that described above in connection with Figures 29-32). Additional branches may be created in the subsegments, which may be further segmented into smaller segments (step 1122) (e.g., in a manner similar to that described above in connection with Figures 29-32). The steps of creating branches and subsegmenting volumes may be repeated until a desired volume size and / or branch size resolution is obtained. The geometric model expanded to include the new branches in steps 1118 and 1122 can then be used to calculate cerebral blood flow and cerebral perfusion entering the subsegments, e.g., the subsegments generated in step 1122.
[0284] The expanded model can then be used to perform the computational analysis described above. The results of the computational analysis can provide information related to blood flow entering the generated morphometric model (including the branches generated in steps 1118 and 1122), which may extend from the patient-specific cerebral artery model into each perfusion subsegment generated in step 1122.
[0285] 41 shows another schematic diagram relating to a method 1150 for providing various information related to cerebral perfusion in a particular patient, according to an exemplary embodiment. The method 1150 may be implemented in a computer system as described above, such as a computer system used to perform one or more of the steps shown in FIG. 3 above.
[0286] The method 1150 can be implemented using one or more inputs 1152. The inputs 1152 may include medical image data 1153 of the patient's aorta, carotid artery (shown in FIG. 37), vertebral artery (shown in FIG. 37), and brain, such as CCTA data (e.g., acquired in a manner similar to that described above in connection with step 100 of FIG. 2). The inputs 1152 may also include additional physiological data 1154 measured from the patient, such as the patient's brachial blood pressure, heart rate, and / or other measurements (e.g., acquired in step 100 of FIG. 2). The additional physiological data 1154 may be acquired non-invasively. The inputs 1152 may further include cerebral perfusion data 1155 measured from the patient (e.g., using CT, PET, SPECT, etc.). The inputs 1152 can be used to implement the steps described below.
[0287] A three-dimensional geometric model of the patient's intracranial and extracranial arteries may be created (step 1160) based on the image data 1153. Step 1160 may be similar to step 1064 of FIG. 39 described above.
[0288] The computer analysis may be performed, for example, as described above in connection with step 402 of FIG. 3, to reveal a solution containing information about the patient's cerebral blood flow under physical conditions identified by the user (step 1162). For example, the physical conditions may include rest, various levels of stress, various levels of baroreceptor response or other autonomic feedback control, various levels of hyperemia, various levels of exercise or exertion, different drug treatments, changes in posture, and / or other conditions. The solution may provide information such as blood flow and pressure under specific physical conditions at various locations in the patient's anatomy modeled in step 1160. Step 1162 may be similar to step 1066 of FIG. 39 described above.
[0289] A three-dimensional geometric model of the patient's brain tissue may also be created (step 1164) based on the image data 1153. For example, a three-dimensional geometric model may be created that includes brain tissue and intracranial and extracranial arteries in steps 1160 and 1164. Step 1164 may be similar to step 1060 of FIG. 39 described above.
[0290] This geometric model may be divided into segments or sub-volumes, step 1166. Step 1166 may be similar to step 1062 of FIG.
[0291] Based on the blood flow information revealed in step 1162, the perfusion of blood flow into each segment of brain tissue created in step 1166 can be calculated (step 1168). Step 1168 may be similar to step 1068 of FIG. 39 described above.
[0292] The calculated perfusion of each segment of brain tissue may be displayed (step 1170) on the geometric model of the brain tissue generated in steps 1164 or 1166. Step 1170 may be similar to step 1070 of FIG. 39 described above.
[0293] The simulated perfusion data mapped onto the three-dimensional geometric model of brain tissue in step 1170 may be compared (step 1172) to the measured brain perfusion data 1155. This comparison may use different colors and / or shading on the three-dimensional representation of the brain tissue to indicate differences between the simulated and measured perfusion data.
[0294] Boundary conditions at the outlet of the three-dimensional geometric model created in step 1160 may be adjusted to reduce the error between the simulated and measured perfusion data (step 1174). For example, to reduce the error, the boundary conditions may be adjusted to reduce the prescribed flow resistance of blood vessels supplying regions where the simulated perfusion is lower than the measured perfusion (e.g., the segment created in step 1166). Other parameters of the boundary conditions may be adjusted. Alternatively, the branching structure of the model may be modified. For example, the geometric model created in step 1160 may be expanded as described above in connection with FIG. 40 to create a morphometric model. The boundary conditions and / or parameters of the morphometric model may be tuned empirically or systematically using parameter estimation or data assimilation methods, such as those described in U.S. Patent Application Publication No. 2010 / 0017171, entitled "Method for Tuning Patient-Specific Cardiovascular Simulations," or other methods.
[0295] Steps 1162, 1168, 1170, 1172, 1174, and / or other steps of Figure 41 may be repeated, for example, until the error between the simulated and measured perfusion data falls below a predefined threshold. As a result, computer analysis can be performed using anatomical, cerebral blood flow, and models relating cerebral perfusion information. Such models may be useful for diagnostic purposes or to predict the benefit of drug, interventional, or surgical therapy.
[0296] As a result, extracranial and intracranial arterial blood flow and cerebral perfusion under baseline conditions or altered physiological conditions can be calculated. The cerebral perfusion data may be used in combination with the simulated cerebral perfusion results to adjust boundary conditions of the intracranial arterial blood flow calculation until the simulated cerebral perfusion results match the measured cerebral perfusion data within a predetermined tolerance. Thus, more accurate patient-specific extracranial and intracranial arterial blood flow calculations may be provided, allowing physicians to predict cerebral arterial blood flow and cerebral perfusion during certain physical conditions, e.g., during exercise, exertion, postural changes, or simulated medical treatments, when measurement data may not be available. The patient-specific three-dimensional model of the brain may be divided into perfusion segments or sub-volumes and may reveal whether the patient is receiving sufficient marginal perfusion to various regions of the brain.
[0297] A patient-specific three-dimensional geometric model of the intracranial arteries can be generated from medical imaging data and combined with a morphometric model (e.g., as described above in connection with FIG. 40) of the remaining intracranial arterial tree portion represented by perfused segments or sub-volumes to form an enlarged model. The percentage of the total brain volume (or mass) downstream of a given location, e.g., a diseased location, in the enlarged model can be calculated. Also, the percentage of the total cerebral blood flow at a given location, e.g., a diseased location, in the enlarged model can be calculated. Furthermore, defects seen in functional imaging studies (e.g., functional magnetic resonance imaging (fMRI)), perfusion CT or MRI can identify vascular malformations, anatomical variations, impaired autoregulation mechanisms, hypotension, or other pathologies, which may be useful for patients with ischemic stroke, syncope, orthostatic intolerance, trauma, or chronic neurological diseases. ii. Plaque vulnerability assessment
[0298] Computer analysis can also provide the ability to quantify patient-specific biomechanical forces acting on plaques, such as carotid atherosclerotic plaques, that may accumulate during a patient's intracranial arteries and extracranial movements. Biomechanical forces may result from pulsatile pressure, flow, and neck motion.
[0299] 42 is a schematic diagram illustrating aspects of a method 1200 for providing various information related to the assessment of plaque vulnerability, brain volume risk, and cerebral perfusion risk in a particular patient, according to an exemplary embodiment. The method 1200 can be implemented on a computer system similar to that used to implement one or more of the steps illustrated in FIG. 3, for example, as described above. The method 1200 can be implemented with one or more inputs 1202, and the method can include generating one or more models 1202 based on the inputs 1210, performing one or more biomechanical analyses 1220 based on one or more of the models 1210, and providing various results based on the models 1210 and the biomechanical analyses 1220.
[0300] The input 1202 may include medical image data 1203, such as CCTA data (e.g., obtained in a manner similar to that described above in connection with step 100 of FIG. 2), of the patient's intracranial and extracranial arteries, such as the patient's aorta, carotid artery (shown in FIG. 37), vertebral artery (shown in FIG. 37), and brain. The input 1202 may also include additional physiological data 1204 measured from the patient, such as the patient's brachial blood pressure, heart rate, and / or other measurements (e.g., obtained in a manner similar to that described above in connection with step 100 of FIG. 2). The additional physiological data 1204 may be obtained non-invasively. The input 1202 may also be used to generate the model 1210 and / or to perform the biomechanical analysis 1220 described below.
[0301] As described above, one or more models 1210 may be generated based on the input 1202. For example, the method 1200 may include generating a hemodynamic model 1212 including calculated blood flow and pressure information at various locations throughout a three-dimensional geometric model of the patient's anatomy. The model of the patient's anatomy may be created using medical image data 1203, and in an exemplary embodiment, the hemodynamic model 1212 may be a simulated blood pressure model, a simulated blood flow model, or other simulation generated after performing a computational analysis, for example, as described above in connection with step 402 of FIG. 3. The solid mechanics model, including the fluid-structure interaction model, may be solved by computational analysis using known numerical methods. The properties of the plaque and blood vessels may be modeled as linear or nonlinear, isotropic or anisotropic. The solution may provide stresses and strains of the plaque and the interface between the plaque and the blood vessel. The steps for generating the hemodynamic model 1212 may be similar to the steps for generating the hemodynamic model 932 of FIG. 35 described above.
[0302] The method 1200 may include performing a biomechanical analysis 1220 using a hemodynamic model 1212 by calculating pressure and shear stress acting on the plaque luminal surface due to hemoflow forces (step 1222) during various physiological states, such as at rest and during various levels of movement or exertion. The pressure and shear stress may be calculated based on information from the hemodynamic model 1212, such as blood pressure and blood flow. Step 1222 may be similar to step 942 of FIG. 35 described above.
[0303] In some cases, method 1200 may also include generating a geometric analysis model for quantifying vascular deformation from four-dimensional image data, e.g., image data acquired at multiple phases of the cardiac cycle, e.g., systole and diastole, in a manner similar to that described above for geometric analysis model 934 of Figure 35. Method 1200 may also include performing a biomechanical analysis 1220 using the geometric analysis model by calculating various deformation characteristics, e.g., longitudinal lengthening or shortening, twisting, radial expansion or compression, and bending, of the patient's intracranial and extracranial arteries and plaques due to pulsatile pressure from the heart, in a manner similar to that described above for step 944 of Figure 35.
[0304] The method 1200 may also include generating a plaque model 1214 to characterize the composition and characteristics of the plaque from the medical image data 1203. For example, the plaque model 1214 may include information regarding the density and other material properties of the plaque.
[0305] The method 1200 may also include generating a vessel wall model 1216 for calculating information about the plaque, the vessel wall, and / or the interface between the plaque and the vessel wall. For example, the vessel wall model 1216 may include information about stress and strain, which may be calculated based on the composition and characteristics of the plaque included in the plaque model 1214 and the pressure and shear stress calculated in step 1220. In some cases, the stress and strain may be calculated using calculated deformation characteristics, as described above. The steps for generating the plaque model 1214 and / or the vessel wall model 1216 may be similar to the steps for generating the plaque model 936 and / or the vessel wall model 938 of FIG. 35 described above.
[0306] The method 1200 may include performing a biomechanical analysis 1220 with the vessel wall model 1216 (step 1224) by calculating stresses on the plaque due to blood flow forces and strains induced by neck motion. For example, the flow induced forces 904 (FIG. 33) acting on the plaque may be calculated. The stresses or forces on the plaque due to blood flow forces and strains induced by neck motion may be calculated based on information from the vessel wall model 1216, such as the stresses and strains on the plaque. Step 1224 may be similar to step 946 of FIG. 35 described above.
[0307] The method 1200 may include uncovering further information based on one or more of the models 1210 and one or more of the biomechanical analyses 1220 described above.
[0308] A plaque rupture vulnerability index may be calculated (step 1230). The plaque rupture vulnerability index may be calculated based on, for example, total hemodynamic stress, stress frequency, stress direction, and / or plaque strength, or other characteristics. For example, a region around the plaque may be isolated from the three-dimensional model 1210 of the plaque, e.g., plaque model 1214. The strength of the plaque may be determined from material properties provided in the plaque model 1214. Hemodynamic and tissue stresses on the plaque due to pulsatile pressure, flow, and neck motion may be calculated under simulated baseline and exercise (or exertion) conditions using the hemodynamic stresses and motion-induced strains already calculated in step 1224. The vulnerability of the plaque may be evaluated based on the ratio of plaque stress to plaque strength. Step 1230 may be similar to step 950 of FIG. 35 described above. For example, a plaque rupture vulnerability index may be calculated for plaques located in extracranial arteries for stroke assessment.
[0309] A brain volume risk index (CVRI) may also be calculated (step 1232). The CVRI may be defined as the percentage of the total brain volume affected by plaque rupture or embolization and occlusion (closure or blockage) of a vessel at a given location in the arterial tree. The CVRI may be calculated based on the portion of the brain supplied by a vessel downstream of a given plaque, which may take into account the size of the plaque relative to the size of the downstream vessel, and the probability of the plaque flowing into a different vessel based on a three-dimensional hemodynamic solution. The CVRI may be evaluated before or after a disease state or intervention. Step 1232 may be similar to step 952 of FIG. 35 described above.
[0310] Brain tissue can be modeled and divided into segments supplied by each blood vessel in the hemodynamic simulation (e.g., as described in connection with steps 1110 and 1112 of FIG. 40). The geometric model can be modified to include next generation branches in the brain tree (e.g., as described in connection with step 1118 of FIG. 40), and the brain tissue can be further segmented (e.g., as described in connection with step 1120 of FIG. 40). Additional branches can be created in the subsegments, which can be further segmented into smaller segments (e.g., as described in connection with step 1122 of FIG. 40). Physiological relationships such as those described above can be used to relate blood vessel size to the proportional amount of brain tissue supplied.
[0311] The potential paths taken by ruptured plaques can be revealed. Hemodynamic solutions can be used to reveal the probability of plaque fragments or emboli flowing into different downstream vessels.
[0312] The size of the ruptured plaque can be compared to the size of downstream vessels to reveal whether the plaque may ultimately result in an obstruction to blood flow. This information can be combined with a vulnerability index to provide a probability distribution map of the volume of brain tissue that may be affected by a ruptured plaque. A CVRI can be assigned to each segment that may be affected.
[0313] A cerebral perfusion risk index (CPRI) may also be calculated (step 1234). CPRI may be defined as the percentage of total cerebral blood flow affected by plaque rupture and occlusion of a vessel at a given location in the arterial tree. CPRI indicates the potential loss of perfusion to that brain tissue segment, rather than the volume affected as indicated by CVRI. For example, the impact of a carotid plaque rupture or embolus may vary depending on the geometry of the patient's Circle of Willis (shown in FIG. 37), and such anatomical differences may result in different CVRI and CPRI values. Perfusion rates to each segment of brain tissue may be calculated, and loss of perfusion may be calculated based on vulnerability index, hemodynamic solutions, and plaque and vessel size. CPRI may be evaluated before or after disease states or interventions. Step 1234 may be similar to step 954 of FIG. 35 described above.
[0314] As a result, the biomechanical forces acting on carotid atherosclerotic plaques due to pulsatile pressure, pulsatile blood flow, and / or possibly neck motion can be assessed. The total stresses experienced by the plaque due to pulsatile pressure, pulsatile blood flow, and / or possibly neck motion can also be quantified. The solution can take into account multiple sources of patient-specific hemodynamic stress acting on the plaque or the interface between the plaque and the vessel wall. Also, based on medical imaging data and indices related to plaque vulnerability, brain volume risk, and cerebral perfusion risk, plaque strength can be estimated and carotid perfusion risk can be quantified.
[0315] By identifying anatomical and physiological data of extracranial and intracranial arteries as described below, blood flow changes can be predicted at the arterial or organ level for specific patients with various physical conditions. In addition, other information may be provided, such as the risk of transient ischemic attack, ischemic stroke, or aneurysm rupture, the forces acting on atherosclerotic plaques or aneurysms, the predicted effects of drug, interventional, or surgical therapies on intracranial or extracranial blood flow, blood pressure, vessel wall stress, or cerebral perfusion. Blood flow, blood pressure, and vessel wall stress in intracranial or extracranial arteries, as well as global and regional cerebral perfusion, can also be quantified, and the functional significance of diseases can be revealed.
[0316] In addition to quantifying blood flow in the three-dimensional geometric model constructed from the image data (e.g., as described above in step 1212), the model can also be modified to simulate disease progression or regression, or the effects of medical, percutaneous, or surgical interventions. In an exemplary embodiment, the progression of atherosclerosis can be modeled by iterating the solution over time, e.g., by determining values of shear stress or particle residence time, and adapting the geometric model to progress the development of atherosclerotic plaques based on hemodynamic factors and / or patient-specific biochemical measurements. Additionally, the effects of changes in blood flow, heart rate, blood pressure, and other physiological variables on extracranial and / or intracranial arterial blood flow or cerebral perfusion may be modeled by modifying boundary conditions and used to calculate the cumulative effects of these variables over time.
[0317] Any aspect described in any embodiment may be used in any other embodiment described herein. Any of the devices and instruments described herein may be used in any suitable medical procedure, may be advanced through any suitable body lumen and cavity, and may be used to image any suitable body part.
[0318] It will be apparent to those skilled in the art that various modifications and variations can be made in the disclosed systems and processes without departing from the scope of the present disclosure. Other embodiments will be apparent to those skilled in the art from consideration of the specification and practice of the disclosure herein. It is intended that the specification and examples be considered as exemplary only, with the true scope and spirit of the present disclosure being indicated by the following claims.
Claims
1. 1. A system for planning a treatment for a patient, the system comprising: at least one computer system; The at least one computer system comprises: receiving patient-specific data relating to a geometry of an anatomical structure of the patient; generating a three-dimensional model representing at least a portion of the anatomical structure of the patient based on the patient-specific data; determining first information regarding blood flow characteristics within the anatomical structure of the patient based on the three-dimensional model and the patient-specific information regarding a physiological condition of the patient; generating a reduced order model of the portion of the anatomical structure by using the first information to define one or more parameters of the reduced order model; modifying one or more parameters of the reduced order model based on one or more physiological parameters including a type of drug treatment; determining second information regarding the blood flow characteristics within the anatomical structure of the patient based on the modified one or more parameters of the reduced order model; A system configured to:
2. 10. The system of claim 1, wherein the at least one computer system is configured to modify the information of the physiological condition of the patient based on input received from a user, the input including a selection of a plan for treating the patient with a drug.
3. the selected plan for treating the patient further includes a change in at least one of cardiac output, a level of exertion, or a level of hyperemia; The system of claim 2 , wherein the at least one computer system is further configured to modify the information of the physiological condition of the patient based on the selected plan of treatment.
4. 4. The system of claim 3, wherein the at least one computer system is further configured to modify the information of the physiological condition of the patient by altering a parameter related to blood flow through the anatomical structure of the patient.
5. The system of claim 4 , wherein the altered parameter related to blood flow comprises at least one of coronary resistance, aortic blood pressure, or heart rate.
6. 10. The system of claim 1, wherein the at least one computer system is further configured to determine differences between the first information and the second information at a plurality of locations within the anatomical structure of the patient.
7. 2. The system of claim 1, wherein each of the first and second information includes at least one of blood pressure, blood velocity, blood flow, or fractional flow reserve in the patient's anatomy.
8. 10. The system of claim 1, wherein the anatomical structure of the patient includes at least one of a portion of a plurality of arteries in the patient's heart, neck, head, chest, abdomen, arms, or legs.
9. 1. A non-transitory computer readable medium for use on a computer system, the non-transitory computer readable medium comprising computer executable programming instructions for performing a method for planning a treatment for a patient, The method comprises: receiving patient-specific data relating to a geometry of an anatomical structure of the patient; generating a three-dimensional model representing at least a portion of the anatomical structure of the patient based on the patient-specific data; determining first information regarding blood flow characteristics within the anatomical structure of the patient based on the three-dimensional model and the patient-specific information regarding a physiological condition of the patient; generating a reduced order model of the portion of the anatomical structure by using the first information to define one or more parameters of the reduced order model; determining second information regarding the blood flow characteristics within the anatomical structure of the patient based on a desired modeled change in the one or more parameters of the reduced order model based on one or more physiological parameters including a type of drug treatment; A non-transitory computer readable medium,
10. 10. The non-transitory computer readable medium of claim 9, wherein the second information is determined further based on a selected regimen of treatment associated with changes in at least one of the patient's cardiac output, heart rate, stroke volume, blood pressure, level of exercise or exertion, or level of hyperemia.
11. 11. The non-transitory computer-readable medium of claim 10, wherein the method further comprises modifying the information regarding the physiological state of the patient by altering a parameter associated with blood flow through the anatomical structure of the patient.
12. 12. The non-transitory computer readable medium of claim 11, wherein the altered parameter related to blood flow comprises at least one of coronary artery resistance, aortic blood pressure, or heart rate.
13. The method comprises: determining differences between the first information and the second information at a plurality of locations within the anatomical structure of the patient; 10. The non-transitory computer readable medium of claim 9, further comprising:
14. 10. The non-transitory computer readable medium of claim 9, wherein each of the first information and the second information comprises at least one of blood pressure, blood velocity, blood flow, or fractional flow reserve in the patient's anatomical structure.
15. 10. The non-transitory computer readable medium of claim 9, wherein the anatomical structure of the patient includes at least one of a portion of a plurality of arteries in the patient's heart, neck, head, chest, abdomen, arms, or legs.
Citation Information
Patent Citations
Collection system of fault information
JP1982069352A
Amphibious vehicle
JP1982084208A
Method for measuring extent of movement of moving object
JP1984044607A
Speed controller for DC brushless motor
JP1984047990A
Cerebral circulation models and applications
JP2002501774A
Cited By
Systems, methods, and devices for medical image analysis, diagnosis, risk stratification, decision making and / or disease tracking
US12396695B2
Systems, devices, and methods for non-invasive image-based plaque analysis and risk determination
US12440180B2
Systems, methods, and devices for medical image analysis, diagnosis, risk stratification, decision making and / or disease tracking
US12499539B2
Systems, methods, and devices for medical image analysis, diagnosis, risk stratification, decision making and / or disease tracking
US12555228B2
Systems, methods, and devices for medical image analysis, diagnosis, risk stratification, decision making and / or disease tracking
US12558048B2
